0001193125-11-244540.txt : 20110909 0001193125-11-244540.hdr.sgml : 20110909 20110909161413 ACCESSION NUMBER: 0001193125-11-244540 CONFORMED SUBMISSION TYPE: 485BPOS PUBLIC DOCUMENT COUNT: 8 FILED AS OF DATE: 20110909 DATE AS OF CHANGE: 20110909 EFFECTIVENESS DATE: 20110909 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BLACKROCK HEALTHCARE FUND, INC. CENTRAL INDEX KEY: 0000709140 IRS NUMBER: 133143879 STATE OF INCORPORATION: MA FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 485BPOS SEC ACT: 1933 Act SEC FILE NUMBER: 002-80150 FILM NUMBER: 111083663 BUSINESS ADDRESS: STREET 1: 100 BELLEVUE PARKWAY CITY: WILMINGTON STATE: DE ZIP: 08536 BUSINESS PHONE: 800-441-7762 MAIL ADDRESS: STREET 1: 100 BELLEVUE PARKWAY CITY: WILMINGTON STATE: DE ZIP: 08536 FORMER COMPANY: FORMER CONFORMED NAME: MERRILL LYNCH HEALTHCARE FUND INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SCI TECH INC DATE OF NAME CHANGE: 19830216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BLACKROCK HEALTHCARE FUND, INC. CENTRAL INDEX KEY: 0000709140 IRS NUMBER: 133143879 STATE OF INCORPORATION: MA FISCAL YEAR END: 0430 FILING VALUES: FORM TYPE: 485BPOS SEC ACT: 1940 Act SEC FILE NUMBER: 811-03595 FILM NUMBER: 111083664 BUSINESS ADDRESS: STREET 1: 100 BELLEVUE PARKWAY CITY: WILMINGTON STATE: DE ZIP: 08536 BUSINESS PHONE: 800-441-7762 MAIL ADDRESS: STREET 1: 100 BELLEVUE PARKWAY CITY: WILMINGTON STATE: DE ZIP: 08536 FORMER COMPANY: FORMER CONFORMED NAME: MERRILL LYNCH HEALTHCARE FUND INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SCI TECH INC DATE OF NAME CHANGE: 19830216 0000709140 S000002246 BLACKROCK HEALTHCARE FUND, INC. C000005795 Investor A C000005796 Investor B C000005797 Investor C C000005798 Institutional C000005799 Class R 485BPOS 1 d485bpos.htm BLACKROCK HEALTHCARE FUND BLACKROCK HEALTHCARE FUND

As filed with the Securities and Exchange Commission on September 9, 2011

Securities Act File No. 002-80150

Investment Company Act File No. 811-03595

 

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM N-1A

REGISTRATION STATEMENT

   UNDER   
   THE SECURITIES ACT OF 1933    x
   Pre-Effective Amendment No.    ¨
   Post-Effective Amendment No. 37    x
   and/or   
   REGISTRATION STATEMENT   
   UNDER   
   THE INVESTMENT COMPANY ACT OF 1940    x
   Amendment No. 38    x

(Check appropriate box or boxes)

 

 

BLACKROCK HEALTHCARE FUND, INC.

(Exact Name of Registrant as Specified in Charter)

 

 

100 Bellevue Parkway

Wilmington, Delaware 19809

(Address of Principal Executive Office)

Registrant’s Telephone Number, including Area Code (800) 441-7762

John M. Perlowski

BlackRock Healthcare Fund, Inc.

55 East 52nd Street

New York, New York 10055

United States of America

(Name and Address of Agent for Service)

 

 

Copies to:

 

Frank P. Bruno, Esq.   Ira P. Shapiro, Esq.
Sidley Austin LLP   BlackRock Advisors, LLC
787 Seventh Avenue   55 East 52nd Street
New York, New York 10019-6018   New York, New York 10055

 

 

It is proposed that this filing will become effective (check appropriate box)

  x Immediately upon filing pursuant to paragraph (b)
  ¨ On (date) pursuant to paragraph (b)
  ¨ 60 days after filing pursuant to paragraph (a)(1)
  ¨ On (date) pursuant to paragraph (a)(1)
  ¨ 75 days after filing pursuant to paragraph (a)(2)
  ¨ On (date) pursuant to paragraph (a)(2) of Rule 485.

If appropriate, check the following box:

  ¨ This post-effective amendment designates a new effective date for a previously filed post-effective amendment.

 

Title of Securities Being Registered:

   Shares of beneficial interest, par value $.001 per share.

 

 

 


SIGNATURES

Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant certifies that it meets all of the requirements for effectiveness of this Post-Effective Amendment to the Registration Statement pursuant to Rule 485(b) under the Securities Act and has duly caused this Registration Statement to be signed on its behalf by the undersigned, duly authorized, in the City of New York and the State of New York, on September 9, 2011.

 

BLACKROCK HEALTHCARE FUND, INC.
By  

/S/    JOHN M. PERLOWSKI        

 

John M. Perlowski

President and Chief Executive Officer

Pursuant to the requirements of the Securities Act of 1933, this Post-Effective Amendment to its Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/S/    JOHN M. PERLOWSKI        

John M. Perlowski

  

President and Chief Executive Officer (Principal Executive Officer)

  September 9, 2011

/S/    NEAL J. ANDREWS        

Neal J. Andrews

  

Chief Financial Officer (Principal Financial and Accounting Officer)

  September 9, 2011

DAVID O. BEIM*

David O. Beim

   Director  

RONALD W. FORBES*

Ronald W. Forbes

   Director  

DR. MATINA S. HORNER*

Dr. Matina S. Horner

   Director  

RODNEY D. JOHNSON*

Rodney D. Johnson

   Director  

HERBERT I. LONDON*

Herbert I. London

   Director  

CYNTHIA A. MONTGOMERY*

Cynthia A. Montgomery

   Director  

JOSEPH P. PLATT*

Joseph P. Platt

   Director  

ROBERT C. ROBB, JR.*

Robert C. Robb, Jr.

   Director  

TOBY ROSENBLATT*

Toby Rosenblatt

   Director  

KENNETH L. URISH*

Kenneth L. Urish

   Director  

FREDERICK W. WINTER*

Frederick W. Winter

   Director  

RICHARD S. DAVIS*

Richard S. Davis

   Director  

HENRY GABBAY*

Henry Gabbay

   Director  
*By:  

/S/    BEN ARCHIBALD        

Ben Archibald (Attorney-in-Fact)

     September 9, 2011

 

2


EXHIBIT INDEX

 

Index No.

  

Description of Exhibit

EX-101.INS    XBRL Instance Document
EX-101.SCH    XBRL Taxonomy Extension Schema Document
EX-101.CAL    XBRL Taxonomy Extension Calculation Linkbase
EX-101.DEF    XBRL Taxonomy Extension Definition Linkbase
EX-101.LAB    XBRL Taxonomy Extension Labels Linkbase
EX-101.PRE    XBRL Taxonomy Extension Presentation Linkbase

 

3

EX-101.INS 3 cik0000709140-20110826.xml XBRL INSTANCE DOCUMENT 0000709140 cik0000709140:S000002246Member rr:AfterTaxesOnDistributionsMember cik0000709140:C000005795Member 2011-08-29 2011-08-29 0000709140 cik0000709140:S000002246Member rr:AfterTaxesOnDistributionsAndSalesMember cik0000709140:C000005795Member 2011-08-29 2011-08-29 0000709140 cik0000709140:S000002246Member cik0000709140:SP500Member 2011-08-29 2011-08-29 0000709140 cik0000709140:S000002246Member cik0000709140:Russell3000HealthCareIndexMember 2011-08-29 2011-08-29 0000709140 cik0000709140:S000002246Member cik0000709140:C000005799Member 2011-08-29 2011-08-29 0000709140 cik0000709140:S000002246Member cik0000709140:C000005798Member 2011-08-29 2011-08-29 0000709140 cik0000709140:S000002246Member cik0000709140:C000005797Member 2011-08-29 2011-08-29 0000709140 cik0000709140:S000002246Member cik0000709140:C000005796Member 2011-08-29 2011-08-29 0000709140 cik0000709140:S000002246Member cik0000709140:C000005795Member 2011-08-29 2011-08-29 0000709140 cik0000709140:S000002246Member 2011-08-29 2011-08-29 0000709140 2011-08-29 2011-08-29 iso4217:USD xbrli:pure false 2011-08-26 2011-08-29 2011-04-30 485BPOS 0000709140 BLACKROCK HEALTHCARE FUND, INC. <div> &lt;div style="display:none;" &gt;~ http://www.blackrock.com/role/ScheduleAnnualFundOperatingExpensesBlackrockHealthcareFundInc1 column period compact * column dei_LegalEntityAxis compact cik0000709140_S000002246Member column rr_ProspectusShareClassAxis compact * row primary compact * ~&lt;/div&gt; </div> -0.0230 -0.2236 0.2200 0.1025 0.1420 0.0038 0.1890 -0.2629 0.2302 0.0336 -0.0207 -0.0208 0.0157 0.0361 0.0263 0.0588 0.1506 -0.0135 -0.0233 0.0117 0.0112 0.0147 0.0250 0.0174 0.0231 0.0229 0.0070 0.0005 0.0213 0.0203 0.0188 0.0294 0.0235 0.0021 0.0141 0.0160 0.0127 <div class="MetaData"> <p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: ARIAL;" class="_mt" size="3"><b> </b><b><i><a name="toc19193_6"> </a>Performance Information </i></b></font></p></div> <div> <div class="MetaData"> <p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: ARIAL;" class="_mt" size="2">During the period shown in the bar chart above, the highest return for a quarter was 13.87% (quarter ended June 30, 2003) and the lowest return for a quarter was &#8211;17.14% (quarter ended March 31, 2008). The year-to-date return as of June&nbsp;30, 2011 was 16.99%. </font></p></div> </div> Sales charges are not reflected in the bar chart. If they were, returns would be less than those shown. <div class="MetaData"> <p style="margin-top: 0px; margin-bottom: 0px;" align="center"><font style="font-family: ARIAL;" class="_mt" size="2"><b>Investor A Shares </b></font></p> <p style="margin-top: 0px; margin-bottom: 0px;" align="center"><font style="font-family: ARIAL;" class="_mt" size="2"><b>ANNUAL TOTAL RETURNS </b></font></p> <p style="margin-top: 0px; margin-bottom: 0px;" align="center"><font style="font-family: ARIAL;" class="_mt" size="2"><b>BlackRock Healthcare Fund, Inc. </b></font></p> <p style="margin-top: 0px; margin-bottom: 0px;" align="center"><font style="font-family: ARIAL;" class="_mt" size="2"><b>As of 12/31 </b></font></p></div> 0.1387 2003-06-30 -0.1714 2008-03-31 <div> &lt;div style="display:none;" &gt;~ http://www.blackrock.com/role/ScheduleAnnualTotalReturnsBlackrockHealthcareFundIncBarChart column period compact * column primary compact * row dei_LegalEntityAxis compact cik0000709140_S000002246Member row rr_ProspectusShareClassAxis compact * ~&lt;/div&gt; </div> 0.1699 2011-06-30 0.0025 0.0100 0.0100 0.00 0.0050 You may qualify for sales charge discounts if you and your family invest, or agree to invest in the future, at least&nbsp;<font class="_mt">$25,000</font> in the fund complex advised by BlackRock Advisors, LLC ("BlackRock"). 25000 <div class="MetaData"> <p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: ARIAL;" class="_mt" size="2"><b>Example: </b></font></p></div> <div> <div class="MetaData"> <p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: ARIAL;" class="_mt" size="2">This Example is intended to help you compare the cost of investing in the Fund with the cost of investing in other mutual funds. This Example assumes that you invest $10,000 in the Fund for the time periods indicated and then redeem all of your shares at the end of those periods. The Example also assumes that your investment has a 5% return each year and that the Fund's operating expenses remain the same. Although your actual costs may be higher or lower, based on these assumptions your costs would be: </font></p></div> </div> <div class="MetaData"> <p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: ARIAL;" class="_mt" size="2">You would pay the following expenses if you did not redeem your shares: </font></p></div> <div> &lt;div style="display:none;" &gt;~ http://www.blackrock.com/role/ScheduleExpenseExampleNoRedemptionTransposedBlackrockHealthcareFundInc row period compact * row primary compact * column dei_LegalEntityAxis compact cik0000709140_S000002246Member column rr_ProspectusShareClassAxis compact * ~&lt;/div&gt; </div> 250 243 770 748 1316 1280 2587 2736 <div> &lt;div style="display:none;" &gt;~ http://www.blackrock.com/role/ScheduleExpenseExampleTransposedBlackrockHealthcareFundInc row period compact * row primary compact * column dei_LegalEntityAxis compact cik0000709140_S000002246Member column rr_ProspectusShareClassAxis compact * ~&lt;/div&gt; </div> 677 700 343 134 222 998 1120 748 418 685 1340 1516 1280 723 1175 2305 2587 2736 1590 2524 <div class="MetaData"> <p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: ARIAL;" class="_mt" size="3"><b> </b><b><i><a name="toc19193_3"> </a>Fees and Expenses of the Fund </i></b></font></p></div> <div> <div class="MetaData"> <p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: ARIAL;" class="_mt" size="2">This table describes the fees and expenses that you may pay if you buy and hold shares of Healthcare Fund.&nbsp;<font class="_mt">You may qualify for sales charge discounts if you and your family invest, or agree to invest in the future, at least&nbsp;<font class="_mt">$25,000</font> in the fund complex advised by BlackRock Advisors, LLC ("BlackRock").</font> More information about these and other discounts is available from your financial professional and in the "Details About the Share Classes" section on page 16 of the Fund's prospectus and in the "Purchase of Shares" section on page II-58 of Part II of the Fund's statement of additional information. </font></p></div> </div> 0.0158 0.0247 0.0240 0.0132 0.0219 highest return lowest return 0.0100 0.0100 0.0100 0.0100 0.0100 0 0.045 0.01 0 0 0.0525 0 0 0 0 <div class="MetaData"> <p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: ARIAL;" class="_mt" size="3"><b> </b><b><i><a name="toc19193_2"> </a>Investment Objective </i></b></font></p></div> <div> <div class="MetaData"> <p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: ARIAL;" class="_mt" size="2">The investment objective of BlackRock Healthcare Fund, Inc. ("Healthcare Fund" or the "Fund") is to seek long-term capital appreciation through worldwide investment in equity securities of companies that, in the opinion of Fund management, derive or are expected to derive a substantial portion of their sales from products and services in healthcare. </font></p></div> </div> <div class="MetaData"> <p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: ARIAL;" class="_mt" size="2"><b>Annual Fund Operating Expenses</b></font></p> <p style="margin-top: 0px; margin-bottom: 1px;"><font style="font-family: ARIAL;" class="_mt" size="2"><b>(expenses that you pay each year as a percentage of the value<br />of your investment)</b></font></p></div> 0.0033 0.0047 0.0040 0.0032 0.0069 (800)&nbsp;882-0052 www.blackrock.com/funds <font style="font-family: ARIAL;" class="_mt" size="2">The information below shows you how Healthcare Fund's performance has varied year by year and provides some indication of the risks of investing in the Fund. </font> <div> <div class="MetaData"> <p style="padding-bottom: 0px; margin-top: 0px; margin-bottom: 0px;"><font style="font-family: ARIAL;" class="_mt" size="2"><font class="_mt"><font style="font-family: ARIAL;" class="_mt" size="2">The information below shows you how Healthcare Fund's performance has varied year by year and provides some indication of the risks of investing in the Fund. </font></font>The table compares the Fund's performance to that of the Standard&nbsp;&amp; Poor's<font style="font-family: ARIAL;" class="_mt" size="1"><sup style="position: relative; bottom: 0.8ex; vertical-align: baseline;">&#174;</sup></font> ("S&amp;P") 500 Index and the Russell 3000<font style="font-family: ARIAL;" class="_mt" size="1"><sup style="position: relative; bottom: 0.8ex; vertical-align: baseline;">&#174;</sup></font> Health Care Index. The Fund believes the Russell 3000<font style="font-family: ARIAL;" class="_mt" size="1"><sup style="position: relative; bottom: 0.8ex; vertical-align: baseline;">&#174;</sup></font> Health Care Index provides an appropriate performance comparison because it reflects the performance of funds with investment objectives similar to the Fund.&nbsp;<font class="_mt">As with all such investments, past performance (before and after taxes) is not an indication of future results.</font>&nbsp;<font class="_mt">Sales charges are not reflected in the bar chart. If they were, returns would be less than those shown.</font>&nbsp;<font class="_mt">However, the table includes all applicable fees and sales charges.</font> If the Fund's investment manager and its affiliates had not waived or reimbursed certain Fund expenses during these periods, the Fund's returns would have been lower. Updated information on the Fund's results can be obtained by visiting&nbsp;<font class="_mt">www.blackrock.com/funds</font> or can be obtained by phone at <font class="_mt">(800)&nbsp;882-0052</font>. </font></p></div> </div> As with all such investments, past performance (before and after taxes) is not an indication of future results. However, the table includes all applicable fees and sales charges. <div class="MetaData"> <p><strong><font size="2" class="_mt" style="font-family: Arial;">As of 12/31/10<br />Average Annual Total Returns</font></strong></p></div> <div> <div class="MetaData"> <p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: ARIAL;" class="_mt" size="2"><font class="_mt"><font style="font-family: ARIAL;" class="_mt" size="2">After-tax returns are calculated using the historical highest individual Federal marginal income tax rates and do not reflect the impact of state and local taxes.&nbsp;</font></font><font class="_mt">Actual after-tax returns depend on an investor's tax situation and may differ from those shown, and the after-tax returns shown are not relevant to investors who hold their Fund shares through tax-deferred arrangements, such as 401(k) plans or individual retirement accounts or through tax-advantaged education savings accounts.</font> <font class="_mt">After-tax returns are shown for Investor A Shares only, and the after-tax returns for Investor B, Investor C, Institutional and Class R Shares will vary.</font></font></p></div> </div> Actual after-tax returns depend on an investor's tax situation and may differ from those shown, and the after-tax returns shown are not relevant to investors who hold their Fund shares through tax-deferred arrangements, such as 401(k) plans or individual retirement accounts or through tax-advantaged education savings accounts. After-tax returns are shown for Investor A Shares only, and the after-tax returns for Investor B, Investor C, Institutional and Class R Shares will vary. <div> &lt;div style="display:none;" &gt;~ http://www.blackrock.com/role/ScheduleAverageAnnualTotalReturnsTransposedBlackrockHealthcareFundInc row period compact * row primary compact * column dei_LegalEntityAxis compact cik0000709140_S000002246Member column rr_ProspectusShareClassAxis compact * column rr_PerformanceMeasureAxis compact * ~&lt;/div&gt; </div> <font style="font-family: ARIAL;" class="_mt" size="2">After-tax returns are calculated using the historical highest individual Federal marginal income tax rates and do not reflect the impact of state and local taxes.&nbsp;</font> <div class="MetaData"> <p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: ARIAL;" class="_mt" size="2"><b>Portfolio Turnover: </b></font></p></div> 1.38 <div> <div class="MetaData"> <p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: ARIAL;" class="_mt" size="2">The Fund pays transaction costs, such as commissions, when it buys and sells securities (or "turns over" its portfolio). A higher portfolio turnover may indicate higher transaction costs and may result in higher taxes when shares are held in a taxable account. These costs, which are not reflected in annual fund operating expenses or in the Example, affect the Fund's performance. During the most recent fiscal year, the Fund's turnover rate was&nbsp;<font class="_mt">138%</font> of the average value of its portfolio. </font></p></div> </div> 2011-08-29 <div class="MetaData"> <p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: ARIAL;" class="_mt" size="3"><b> </b><b><i><a name="toc19193_5"> </a>Principal Risks of Investing in the Fund </i></b></font></p></div> You may lose part or all of your investment in the Fund or your investment may not perform as well as other similar investments. <div> <div class="MetaData"> <p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: ARIAL;" class="_mt" size="2">Risk is inherent in all investing. The value of your investment in Healthcare Fund, as well as the amount of return you receive on your investment, may fluctuate significantly from day to day and over time.&nbsp;<font class="_mt">You may lose part or all of your investment in the Fund or your investment may not perform as well as other similar investments.</font> The following is a summary description of certain risks of investing in the Fund. </font></p> <p style="margin-top: 0px; margin-bottom: -6px;"><font class="_mt" size="1"> </font>&nbsp;</p> <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr><td valign="top" width="1%" align="left"><font style="font-family: ARIAL;" class="_mt" size="2"><font style="font-family: Times New Roman;" class="_mt" size="2"><font style="font-family: WINGDINGS;" class="_mt">n</font></font><font style="font-family: ARIAL;" class="_mt" size="2"> </font></font></td> <td valign="top" width="1%">&nbsp;</td> <td valign="top" align="left"> <p align="left"><font style="font-family: ARIAL;" class="_mt" size="2"><b><i>Convertible Securities Risk</i></b> &#8212; The market value of a convertible security performs like that of a regular debt security; that is, if market interest rates rise, the value of a convertible security usually falls. In addition, convertible securities are subject to the risk that the issuer will not be able to pay interest or dividends when due, and their market value may change based on changes in the issuer's credit rating or the market's perception of the issuer's creditworthiness. Since it derives a portion of its value from the common stock into which it may be converted, a convertible security is also subject to the same types of market and issuer risk as apply to the underlying common stock. </font></p></td></tr></table> <p style="margin-top: 0px; margin-bottom: -6px;"><font class="_mt" size="1"> </font>&nbsp;</p> <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr><td valign="top" width="1%" align="left"><font style="font-family: ARIAL;" class="_mt" size="2"><font style="font-family: Times New Roman;" class="_mt" size="2"><font style="font-family: WINGDINGS;" class="_mt">n</font></font><font style="font-family: ARIAL;" class="_mt" size="2"> </font></font></td> <td valign="top" width="1%">&nbsp;</td> <td valign="top" align="left"> <p align="left"><font style="font-family: ARIAL;" class="_mt" size="2"><b><i>Depositary Receipts Risk</i></b> &#8212; The issuers of unsponsored depositary receipts are not obligated to disclose information that is, in the United States, considered material. Therefore, there may be less information available regarding these issuers, and there may not be a correlation between such information and the market value of the depositary receipts. Depositary receipts are generally subject to the same risks as the foreign securities that they evidence or into which they may be converted. </font></p></td></tr></table> <p style="margin-top: 0px; margin-bottom: -6px;"><font class="_mt" size="1"> </font>&nbsp;</p> <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr><td valign="top" width="1%" align="left"><font style="font-family: ARIAL;" class="_mt" size="2"><font style="font-family: Times New Roman;" class="_mt" size="2"><font style="font-family: WINGDINGS;" class="_mt">n</font></font><font style="font-family: ARIAL;" class="_mt" size="2"> </font></font></td> <td valign="top" width="1%">&nbsp;</td> <td valign="top" align="left"> <p align="left"><font style="font-family: ARIAL;" class="_mt" size="2"><b><i>Development Stage Company Risk</i></b> &#8212; Some of the companies in which the Fund invests may be in early stages of development. These companies are more likely than developed companies to lose substantial value if they experience problems developing their products or if there are changes in their management. </font></p></td></tr></table> <p style="margin-top: 0px; margin-bottom: -6px;"><font class="_mt" size="1"> </font>&nbsp;</p> <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr><td valign="top" width="1%" align="left"><font style="font-family: ARIAL;" class="_mt" size="2"><font style="font-family: Times New Roman;" class="_mt" size="2"><font style="font-family: WINGDINGS;" class="_mt">n</font></font><font style="font-family: ARIAL;" class="_mt" size="2"> </font></font></td> <td valign="top" width="1%">&nbsp;</td> <td valign="top" align="left"> <p align="left"><font style="font-family: ARIAL;" class="_mt" size="2"><b><i>Equity Securities Risk</i></b> &#8212; Stock markets are volatile. The prices of equity securities fluctuate based on changes in a company's financial condition and overall market and economic conditions. </font></p></td></tr></table> <p style="margin-top: 0px; margin-bottom: -6px;"><font class="_mt" size="1"> </font>&nbsp;</p> <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr><td valign="top" width="1%" align="left"><font style="font-family: ARIAL;" class="_mt" size="2"><font style="font-family: Times New Roman;" class="_mt" size="2"><font style="font-family: WINGDINGS;" class="_mt">n</font></font><font style="font-family: ARIAL;" class="_mt" size="2"> </font></font></td> <td valign="top" width="1%">&nbsp;</td> <td valign="top" align="left"> <p align="left"><font style="font-family: ARIAL;" class="_mt" size="2"><b><i>Foreign Securities Risk</i></b> &#8212; Foreign investments often involve special risks not present in U.S. investments that can increase the chances that the Fund will lose money. These risks include: </font></p></td></tr></table> <p style="margin-top: 0px; margin-bottom: -6px;"><font class="_mt" size="1"> </font>&nbsp;</p> <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr><td width="2%"><font class="_mt" size="1">&nbsp;</font></td> <td valign="top" width="3%" align="left"><font style="font-family: ARIAL;" class="_mt" size="2">&#8212;</font></td> <td valign="top" align="left"><font style="font-family: ARIAL;" class="_mt" size="2">The Fund generally holds its foreign securities and cash in foreign banks and securities depositories, which may be recently organized or new to the foreign custody business and may be subject to only limited or no regulatory oversight. </font></td></tr></table> <p style="margin-top: 0px; margin-bottom: -6px;"><font class="_mt" size="1"> </font>&nbsp;</p> <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr><td width="2%"><font class="_mt" size="1">&nbsp;</font></td> <td valign="top" width="3%" align="left"><font style="font-family: ARIAL;" class="_mt" size="2">&#8212;</font></td> <td valign="top" align="left"><font style="font-family: ARIAL;" class="_mt" size="2">Changes in foreign currency exchange rates can affect the value of the Fund's portfolio. </font></td></tr></table> <p style="margin-top: 0px; margin-bottom: -6px;"><font class="_mt" size="1"> </font>&nbsp;</p> <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr><td width="2%"><font class="_mt" size="1">&nbsp;</font></td> <td valign="top" width="3%" align="left"><font style="font-family: ARIAL;" class="_mt" size="2">&#8212;</font></td> <td valign="top" align="left"><font style="font-family: ARIAL;" class="_mt" size="2">The economies of certain foreign markets may not compare favorably with the economy of the United States with respect to such issues as growth of gross national product, reinvestment of capital, resources and balance of payments position. </font></td></tr></table> <p style="margin-top: 0px; margin-bottom: -6px;"><font class="_mt" size="1"> </font>&nbsp;</p> <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr><td width="2%"><font class="_mt" size="1">&nbsp;</font></td> <td valign="top" width="3%" align="left"><font style="font-family: ARIAL;" class="_mt" size="2">&#8212;</font></td> <td valign="top" align="left"><font style="font-family: ARIAL;" class="_mt" size="2">The governments of certain countries may prohibit or impose substantial restrictions on foreign investments in their capital markets or in certain industries. </font></td></tr></table> <p style="margin-top: 0px; margin-bottom: -6px;"><font class="_mt" size="1"> </font>&nbsp;</p> <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr><td width="2%"><font class="_mt" size="1">&nbsp;</font></td> <td valign="top" width="3%" align="left"><font style="font-family: ARIAL;" class="_mt" size="2">&#8212;</font></td> <td valign="top" align="left"><font style="font-family: ARIAL;" class="_mt" size="2">Many foreign governments do not supervise and regulate stock exchanges, brokers and the sale of securities to the same extent as does the United States and may not have laws to protect investors that are comparable to U.S. securities laws. </font></td></tr></table> <p style="margin-top: 6px; margin-bottom: 0px; font-size: 1px;">&nbsp;</p> <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr><td width="2%"><font class="_mt" size="1">&nbsp;</font></td> <td valign="top" width="3%" align="left"><font style="font-family: ARIAL;" class="_mt" size="2">&#8212;</font></td> <td valign="top" align="left"><font style="font-family: ARIAL;" class="_mt" size="2">Settlement and clearance procedures in certain foreign markets may result in delays in payment for, or delivery of, securities not typically associated with settlement and clearance of U.S. investments. </font></td></tr></table> <p style="margin-top: 0px; margin-bottom: -6px;"><font class="_mt" size="1"> </font>&nbsp;</p> <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr><td valign="top" width="1%" align="left"><font style="font-family: ARIAL;" class="_mt" size="2"><font style="font-family: Times New Roman;" class="_mt" size="2"><font style="font-family: WINGDINGS;" class="_mt">n</font></font><font style="font-family: ARIAL;" class="_mt" size="2"> </font></font></td> <td valign="top" width="1%">&nbsp;</td> <td valign="top" align="left"> <p align="left"><font style="font-family: ARIAL;" class="_mt" size="2"><b><i>Healthcare-Related Securities Risk</i></b> &#8212; Healthcare companies are strongly affected by worldwide scientific or technological developments. Their products may rapidly become obsolete. Many healthcare companies are also subject to significant government regulation and may be affected by changes in governmental policies. </font></p></td></tr></table> <p style="margin-top: 0px; margin-bottom: -6px;"><font class="_mt" size="1"> </font>&nbsp;</p> <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr><td valign="top" width="1%" align="left"><font style="font-family: ARIAL;" class="_mt" size="2"><font style="font-family: Times New Roman;" class="_mt" size="2"><font style="font-family: WINGDINGS;" class="_mt">n</font></font><font style="font-family: ARIAL;" class="_mt" size="2"> </font></font></td> <td valign="top" width="1%">&nbsp;</td> <td valign="top" align="left"> <p align="left"><font style="font-family: ARIAL;" class="_mt" size="2"><b><i>Healthcare Sector (Concentration) Risk</i></b> &#8212; As a sector fund that invests in healthcare companies, the Fund is subject to the risks associated with this sector. This makes the Fund more vulnerable to price changes of healthcare company securities and factors that affect the healthcare sector than a more broadly diversified mutual fund. Healthcare companies are strongly affected by worldwide scientific or technological developments. Their products may rapidly become obsolete. Many healthcare companies are also subject to significant government regulation and may be affected by changes in governmental policies. Because the Fund invests primarily in one sector, there is the risk that the Fund will perform poorly during a downturn in that sector. </font></p></td></tr></table> <p style="margin-top: 0px; margin-bottom: -6px;"><font class="_mt" size="1"> </font>&nbsp;</p> <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr><td valign="top" width="1%" align="left"><font style="font-family: ARIAL;" class="_mt" size="2"><font style="font-family: Times New Roman;" class="_mt" size="2"><font style="font-family: WINGDINGS;" class="_mt">n</font></font><font style="font-family: ARIAL;" class="_mt" size="2"> </font></font></td> <td valign="top" width="1%">&nbsp;</td> <td valign="top" align="left"> <p align="left"><font style="font-family: ARIAL;" class="_mt" size="2"><b><i>Market Risk and Selection Risk</i></b> &#8212; Market risk is the risk that one or more markets in which the Fund invests will go down in value, including the possibility that the markets will go down sharply and unpredictably. Selection risk is the risk that the securities selected by Fund management will underperform the markets, the relevant indices or the securities selected by other funds with similar investment objectives and investment strategies. This means you may lose money. </font></p></td></tr></table> <p style="margin-top: 0px; margin-bottom: -6px;"><font class="_mt" size="1"> </font>&nbsp;</p> <table style="border-collapse: collapse;" class="MetaData" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr><td valign="top" width="1%" align="left"><font style="font-family: ARIAL;" class="_mt" size="2"><font style="font-family: Times New Roman;" class="_mt" size="2"><font style="font-family: WINGDINGS;" class="_mt">n</font></font><font style="font-family: ARIAL;" class="_mt" size="2"> </font></font></td> <td valign="top" width="1%">&nbsp;</td> <td class="MetaData" valign="top" align="left"> <p align="left"><font style="font-family: ARIAL;" class="_mt" size="2"><b><i>Non-Diversification Risk</i></b> &#8212; The Fund is a non-diversified fund. Because the Fund may invest in securities of a smaller number of issuers, it may be more exposed to the risks associated with and developments affecting an individual issuer than a fund that invests more widely. </font></p></td></tr></table> <p style="margin-top: 0px; margin-bottom: -6px;"><font class="_mt" size="1"> </font>&nbsp;</p> <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr><td valign="top" width="1%" align="left"><font style="font-family: ARIAL;" class="_mt" size="2"><font style="font-family: Times New Roman;" class="_mt" size="2"><font style="font-family: WINGDINGS;" class="_mt">n</font></font><font style="font-family: ARIAL;" class="_mt" size="2"> </font></font></td> <td valign="top" width="1%">&nbsp;</td> <td valign="top" align="left"> <p align="left"><font style="font-family: ARIAL;" class="_mt" size="2"><b><i>Rights Risk</i></b> &#8212; The failure to exercise subscription rights to purchase common stock would result in the dilution of the Fund's interest in the issuing company. The market for such rights is not well developed, and, accordingly, the Fund may not always realize full value on the sale of rights. </font></p></td></tr></table> <p style="margin-top: 0px; margin-bottom: -6px;"><font class="_mt" size="1"> </font>&nbsp;</p> <table style="border-collapse: collapse;" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr><td valign="top" width="1%" align="left"><font style="font-family: ARIAL;" class="_mt" size="2"><font style="font-family: Times New Roman;" class="_mt" size="2"><font style="font-family: WINGDINGS;" class="_mt">n</font></font><font style="font-family: ARIAL;" class="_mt" size="2"> </font></font></td> <td valign="top" width="1%">&nbsp;</td> <td valign="top" align="left"> <p align="left"><font style="font-family: ARIAL;" class="_mt" size="2"><b><i>Small Cap and Emerging Growth Securities Risk</i></b> &#8212; Small cap or emerging growth companies may have limited product lines or markets. They may be less financially secure than larger, more established companies. They may depend on a more limited management group than larger cap companies. </font></p></td></tr></table></div> </div> Non-Diversification Risk &#8212; The Fund is a non-diversified fund. Because the Fund may invest in securities of a smaller number of issuers, it may be more exposed to the risks associated with and developments affecting an individual issuer than a fund that invests more widely. <div class="MetaData"> <p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: ARIAL;" class="_mt" size="7">Fund Overview </font></p> <p style="margin-top: 0px; margin-bottom: 0px;"><font class="_mt" size="1"> </font>&nbsp;</p> <p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: ARIAL;" class="_mt" size="3"><b>Key Facts About BlackRock Healthcare Fund, Inc.</b></font></p></div> <div class="MetaData"> <p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: ARIAL;" class="_mt" size="2"><b>Shareholder Fees</b></font></p> <p style="margin-top: 0px; margin-bottom: 1px;"><font style="font-family: ARIAL;" class="_mt" size="2"><b>(fees paid directly from your investment)</b></font></p></div> <div> &lt;div style="display:none;" &gt;~ http://www.blackrock.com/role/ScheduleShareholderFeesBlackrockHealthcareFundInc column period compact * column dei_LegalEntityAxis compact cik0000709140_S000002246Member column rr_ProspectusShareClassAxis compact * row primary compact * ~&lt;/div&gt; </div> <div class="MetaData"> <p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: ARIAL;" class="_mt" size="3"><b> </b><b><i><a name="toc19193_4"> </a>Principal Investment Strategies of the Fund </i></b></font></p></div> <div> <div class="MetaData"> <p style="margin-top: 0px; margin-bottom: 0px;"><font style="font-family: ARIAL;" class="_mt" size="2">Healthcare Fund seeks to achieve its investment objective by investing in equity securities, primarily common stock, of healthcare companies. Under normal circumstances, the Fund will invest at least 80% of its assets in healthcare companies that it believes have good prospects for earnings growth. These will range from very large corporations to small, "developmental stage" companies. Healthcare companies can include, but are not limited to, businesses involved in the development, production and distribution or delivery of medical and pharmaceutical products and services, companies engaged in biotechnology and medical research and development, companies that may design, manufacture or distribute medical, dental and optical equipment and supplies, including diagnostic equipment, and companies that may also provide diagnostic services or operate health facilities and hospitals or provide related administrative, management and financial support. The Fund may also invest in convertible securities and rights. The Fund may invest without limit in foreign securities and in depositary receipts. </font></p></div> </div> year-to-date return A contingent deferred sales charge ("CDSC") of 1.00% is assessed on certain redemptions of Investor A Shares made within 18 months after purchase where no initial sales charge was paid at time of purchase as part of an investment of $1,000,000 or more. The CDSC is 4.50% if shares are redeemed in less than one year. The CDSC for Investor B Shares decreases for redemptions made in subsequent years. After six years, there is no CDSC on Investor B Shares. (See the section "Details About the Share Classes — Investor B Shares" for a complete schedule of CDSCs.) There is no CDSC on Investor C Shares after one year. EX-101.SCH 4 cik0000709140-20110826.xsd XBRL TAXONOMY EXTENSION SCHEMA 000103 - Schedule - Annual Fund Operating Expenses - {BLACKROCK HEALTHCARE FUND, INC.} link:presentationLink link:calculationLink link:definitionLink 000101 - Document - Risk/Return Summary {Unlabeled} - (BLACKROCK HEALTHCARE FUND, INC.) link:presentationLink link:calculationLink link:definitionLink 000102 - Schedule - Shareholder Fees - {BLACKROCK HEALTHCARE FUND, INC.} link:presentationLink link:calculationLink link:definitionLink 000104 - Schedule - Expense Example {Transposed} - {BLACKROCK HEALTHCARE FUND, INC.} link:presentationLink link:calculationLink link:definitionLink 000105 - Schedule - Expense Example, No Redemption {Transposed} - {BLACKROCK HEALTHCARE FUND, INC.} link:presentationLink link:calculationLink link:definitionLink 000106 - Schedule - Annual Total Returns - {BLACKROCK HEALTHCARE FUND, INC.}[Bar Chart] link:presentationLink link:calculationLink link:definitionLink 000107 - Schedule - Average Annual Total Returns {Transposed} - {BLACKROCK HEALTHCARE FUND, INC.} link:presentationLink link:calculationLink link:definitionLink 000108 - Disclosure - Risk/Return Detail Data {Elements} - (BLACKROCK HEALTHCARE FUND, INC.) link:presentationLink link:calculationLink link:definitionLink 000001 - Document - Document and Entity Information {Elements} link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 5 cik0000709140-20110826_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 6 cik0000709140-20110826_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 7 cik0000709140-20110826_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 8 cik0000709140-20110826_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 9 g191913g44s72.jpg GRAPHIC begin 644 g191913g44s72.jpg M_]C_X``02D9)1@`!``$`8`!@``#__@`?3$5!1"!496-H;F]L;V=I97,@26YC M+B!6,2XP,0#_VP"$``@&!@<&!0@'!P<*"0@*#18.#0P,#1L3%!`6(!PB(1\< M'QXC*#,K(R8P)AX?+#TM,#4V.3HY(BL_0SXX0S,X.3H.$A8:' MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7 MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1``(!`@0$`P0'!00$``$"=P`!`@,1 M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)BH*#A(6& MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76 MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_``!$(`#@`N`,!$0`"$0$#$0'_V@`, M`P$``A$#$0`_`/>W=(XVDD8(BC+,QP`/4TA'!7_QB\*6U^;'3WO-:NQG,6F6 MYF/'H>`?P)IC&R_%[2;%E.L:#XAT>!L?Z1?:>4C&?<$G]*`-&S^)GAO5/$^F MZ%I5X+^>^21_,@(*1!5+8;/()P>/SH`["D(*`*NIW\.E:5=ZCHQ-+#(OW2H4-G\012` MJZMX@?3M2AL8=.DNY)(_-)6:.,*,X_C89_"@!^J>([;2+E[>YAE\QH@]N%`_ MTEBVWRTY^]DKP!['#`UP25!(P?3TI`9UAK5OJ&IWUC$CA[0@%V`VR`Y!* M^N&5E/NOTH`CAU^WF^Q[8I!]JOI[)Z=!93 M&.R?RY;@N@57VJV-N[=R&X.,<&D`S3]=N[W69]/DT2YMU@/SSO+$5&1E>`Q/ M/TI@1WOBRULM`36'M;AX#.82D:@NN'*LV,\@;2>.<>]`&A8ZM!J%Y>6\&3]E M*9D!!5PZ!@01VP:0$SWJ1ZI!8%6\R:&28-V`0H"/_(@_(T`-CU".35[G3@C" M2W@BG9NQ#M(H`]_W9_,4`99\50)X@ETI[.8*EPMM]HWQ[3(T:R`;=V_&&'(! MY^F:8&_2`\'_`&@O%EY'/8^$K&5HTN(Q/<[209`6*HA]N"2/I3&CU+P1X*TW MP3H,-C9PH;DJ#M(#PC M3/!L/@W]HW3(;)-FG7D,UQ;K_P`\\Q.&3\"./8BF,]POM2LM,1'O+A(%],"SJ&H65QJLEY8^*H;%9X$@E"P M!WPC.058G"G]X>H-`$=U<:.D6DIH_B"VL?[,C,,7F0F8%-H7&,CLHYS0`S5Y M],U&_MKV+7].2:*'RF^T67G`\YR`6&WGZT`:MYK/A^]N=.GDU6#=93F9>,[B M8W3\/OY_"D!<;Q5HA0A=4@#8X)R0#0!SVE)X;TB[L;JW\0.\T$3QSF69W$^_ M#,=I)"$N`WRCU'>F`ZUFT>WU.*5O$4#V-O=37D$'E8=99=^[+YY7]Z^!M&,] M3B@"9+W1CXG&L3:Y:-L1DC5(-DFUL?*\F?G48R!@8)[T`7[?7-!M]1O+L:O" M3<[,K_=VC%("E#=Z!#I]I:?VW$1;W1N0V/O9=FQ_X]C\*`&>'Y?#GAZ?43;Z MW&\%U*KQQ-T@4+@(#W4=O08':F!)JVK6-WJ%I>Z=XDM+.:"*2(^9`90RN4/3 M%X"Y=8W=N&W#:3YC#H>U`$EI=^%; M76;_`%4WMG)>74PD$K1C?&!$D>T-C./DS_P(T`;5IX@TF^N5MK:_ADF8$J@/ M)QUI`?._[0^G3VWCFRU'!$%S:*J/_M(QR/R*G\:8T>N_#SXGZ1XRTRV@ENH[ M?6U0+-;2$*78#ED_O`]<#D4`=[2$0O9VLEW%=26T3W,((CE9`70'J`>HS0!D M>)[OQ)9VL+^&],M;^8L?,2XF\O`QQCU.:`/)/#OQP\4>*=;@TC2_#E@]W,&* MAYV4``$DDGV%,9[&L^M?\(UYYLK<:UY&[[/YO[KS,?=W>GO2$>/^(OC7XK\+ M:Z^CZIXX/Y4QGI_@[5/$FK M6+W7B#2[6P61(WMQ!,9"P8$G=Z8X_.@1TE(#E/&NL^)]#M&O=#TFSOK6"!YK MDSS%&4*,_*._`-,#SWPG\7_%_C2_GLM'\.Z:\T$?FN)+AD&W('\S0,ZN;6OB ME%$SKX3TF4J,[$ON3],X%`$'PX^(^J^,-?U72=5T>/3I]/0%T5FW!MV""#0! M@^-/BQXP\$:BD&I^&;(0S[C;RK.S*Z@^HZ'ID>]`'1_#GQMXE\;11ZC<:18V M^D,70RQ3EI`Z]MIH`ZKQ)=>(+6RB?P[I]K>W!?$B7,QC54P>0?7.*0CA/`'Q M'\6^.+\LGAVSBTJ"41W%R)SP?1<_>/3\Q3&=[JG_`"']#_ZZR_\`HIJ0B#Q? MX0TOQKH;Z7J:-MSOBE3AXG_O#_#O3`^;/%7P6\6>&9GFLK=M5LD.5GM!EP/> M/[P/TR/>@9#X9^,7C#PM*MO-=-J%K&=K6][EF7'8-]X?J!Z4`?1?@;XAZ-X[ ML6DL&,-[$H,]I(?GC]Q_>7/!?LX?\CC MJO\`UX_^U%H&SZ+U&_M]*TRZU&[?9;6L332L!G"J,GCOP*0CGO#V@:<_B.\\ M;6%U(ZZ[:PL(RFT!=J[6]Q_%+7[G3O# M\.B:6O;(/:@#H_#'AZS\*^'++1K)<16Z8+8P7;JS M'W)R:!":I_R']#_ZZR_^BFI`;%`!0!R?C#X=>'?&ENPU"S6.\Q\EY"`LJGW/ M\0]CFF!\TV,6J?"_XK6]O+)^]L[E$=EX6:%L9_`J?P/TH&?85(1\G_`?_DJ5 MG_UPF_\`0:8SZPI"/E?XZ?\`)6&_ZX0_RIC1]44A'GGQO*#X3:MNZ[X=OU\U M/Z9IC.*_9J\S[)XDS_J]\&WZXDS_`$H!G+_M#_\`)1;7_L'1_P#HO3807.C'3E7_2H].219"F>?OYX] M<$^<"8IQYOMXZUX*190+8V2#IO"CS9`.V=`D\4#R*,@K'S(WT'S?7'O3&?3U(1\ MG_`?_DJ5G_UPF_\`0:8SZPI"/E?XZ?\`)6&_ZX0_RIC1]44A'BO[1'B*&W\/ M67AZ*0&ZNYA/(@ZK&N<9^K$8_P!TTQHZCX-^$IO"G@:,7L9CO[]_M,R,,%`0 M`JGW`&<=B30!Y#^T/_R46U_[!T?_`*')0"/I32?^0-8_]<$_]!%(1A>-_&*^ M$+;2F%NMQ-?WT=HL9?;@-G+=.W'YBF!I>*_^1.UO_KQG_P#1;4`>!?LX?\CC MJO\`UX_^U%H&SZ-O;*WU&PN+&[B$MM<1M%+&>C*1@C\J0CG].U_3K3Q>O@:R MM&C%CIJW"L&RJ(&5%3US@@TP.GI`>2_M#_\`).K7_L(Q_P#H$E,:+GP#_P"2 M80_]?4O\Q0!Z=2$8^J?\A_0_^NLO_HIJ`/-OB#\)=2\=_$!+_P"V166F+9+& M9MOF/O!;C9D>O7-,9?T/2/BCX0MH["*XTKQ#IT?RQ>?*\4R*.V['3Z[ORH`D MUJS^*GB>V?3XQI7AZTDXEFBN'EF*]PI`X_0^]`&SX`^&>D>`;=WMW:[U*9=L MMW(H!(_NJ/X5SVR<]SP*`-CQ/!XFGM(D\,W5A;39/FM>(S#;CC;M[Y]:!'CW MAGX*>,O">O0:QIFM:2+F$,`)!(RD$$$$;?>@9[4L>N?\(UY;3V?]N>1CS`K> M1YN.N.NVD(\9\3?!GQIXKU]]:U+6=(^U,%7$:R*H"C`P,&F,[F33_BM,AC_M MSP_;Y_Y:16TC,OT#G:=K9U_7]0GU_6BP<37(PB,.A"<\CMDX' M&`*`._NQ<&SG%HR+LC5-5UG1_M`B6( M")9%4*,D<8/&]D:A%S!-G`&*`.5U/X5>._$7BC3]9 MUWQ%I]Q]DF1TB0.JHH8$A5VX&<4`>@>-]*\5ZS8OI_A^]TZVM;F"2&Y-TCE_ MF&/E(Z<$]:`/.O!WPF\<>!]1GOM)U?13+/%Y3>>DK#;D'C`'I0!V+V7Q79"J MZOX;0G^)8))-?UBVU":\M6A=HRV\L70@\@#&$Q MQ[4`>I4A'E'C[P)XZ\<12:?-JNC1:4ET9[=!'()-HW!`QP GRAPHIC 10 BarChart1.jpg IDEA: XBRL DOCUMENT begin 644 BarChart1.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``8$!08%!`8&!08'!P8("A`*"@D) M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_ MVP!#`0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P``1"`$L`AP#`2(``A$!`Q$!_\0` M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4% M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#I_`/@WPQ= M>!/#EQ<^'-%FGETVVDDDDL8F9V,2DL25R23SFM74?"'A.RLY)QX0TFX9*[DE8\F4GS;GGJVG@Z1Q:P>`;2;5@[K+IRZ?9B6 M((L;,S,6$1&)X3\KD_O!QPVW>TWPGX+U+3K6^LO#>A2VMU$D\+_V;$NY&`*G M!7(R".M8^C:5JNBZC;ZG#HU_+81_;(H-.^TQ27<*SFVD+2.\NULRPSN3YC-^ M]3W"]?X2TV;1_"NC:9@I)=T.3MLRC_P@OA/ M_H5]"_\`!?#_`/$T?\(+X3_Z%?0O_!?#_P#$U>U;2KR^N%DMM>U/3D"!3%:Q MV[*3D_,?,B<\)6&L:QX5T;4[GQ;K2SWME#BR[!=_P`WYB?\(+X3_P"A M7T+_`,%\/_Q-'_""^$_^A7T+_P`%\/\`\365X2L-8UCPKHVIW/BW6EGO;*&Y MD6."R"AG0,0,VY.,GU-:W_"/:G_T-^O?]^;+_P"1Z-.P.ZTYOS$_X07PG_T* M^A?^"^'_`.)H_P"$%\)_]"OH7_@OA_\`B:7_`(1[4_\`H;]>_P"_-E_\CT?\ M(]J?_0WZ]_WYLO\`Y'HLNP7?\WYB?\(+X3_Z%?0O_!?#_P#$T?\`""^$_P#H M5]"_\%\/_P`32_\`"/:G_P!#?KW_`'YLO_D>C_A'M3_Z&_7O^_-E_P#(]%EV M"[_F_,3_`(07PG_T*^A?^"^'_P")H_X07PG_`-"OH7_@OA_^)K*\)6&L:QX5 MT;4[GQ;K2SWME#C_`(1[4_\`H;]>_P"_-E_\CT678+O^;\Q/^$%\)_\`0KZ%_P"" M^'_XFC_A!?"?_0KZ%_X+X?\`XFE_X1[4_P#H;]>_[\V7_P`CT?\`"/:G_P!# M?KW_`'YLO_D>BR[!=_S?F)_P@OA/_H5]"_\`!?#_`/$T?\(+X3_Z%?0O_!?# M_P#$UE>$K#6-8\*Z-J=SXMUI9[VRAN9%C@L@H9T#$#-N3C)]36M_PCVI_P#0 MWZ]_WYLO_D>C3L#NM.;\Q/\`A!?"?_0KZ%_X+X?_`(FC_A!?"?\`T*^A?^"^ M'_XFE_X1[4_^AOU[_OS9?_(]'_"/:G_T-^O?]^;+_P"1Z++L%W_-^8G_``@O MA/\`Z%?0O_!?#_\`$T?\(+X3_P"A7T+_`,%\/_Q-+_PCVI_]#?KW_?FR_P#D M>C_A'M3_`.AOU[_OS9?_`"/19=@N_P";\Q/^$%\)_P#0KZ%_X+X?_B:/^$%\ M)_\`0KZ%_P""^'_XFLKPE8:QK'A71M3N?%NM+/>V4-S(L<%D%#.@8@9MR<9/ MJ:UO^$>U/_H;]>_[\V7_`,CT:=@=UIS?F)_P@OA/_H5]"_\`!?#_`/$T?\(+ MX3_Z%?0O_!?#_P#$TO\`PCVI_P#0WZ]_WYLO_D>C_A'M3_Z&_7O^_-E_\CT6 M78+O^;\Q/^$%\)_]"OH7_@OA_P#B:/\`A!?"?_0KZ%_X+X?_`(FE_P"$>U/_ M`*&_7O\`OS9?_(]'_"/:G_T-^O?]^;+_`.1Z++L%W_-^8G_""^$_^A7T+_P7 MP_\`Q-'_``@OA/\`Z%?0O_!?#_\`$UE>$K#6-8\*Z-J=SXMUI9[VRAN9%C@L M@H9T#$#-N3C)]36M_P`(]J?_`$-^O?\`?FR_^1Z-.P.ZTYOS$_X07PG_`-"O MH7_@OA_^)H_X07PG_P!"OH7_`(+X?_B:7_A'M3_Z&_7O^_-E_P#(]'_"/:G_ M`-#?KW_?FR_^1Z++L%W_`#?F)_P@OA/_`*%?0O\`P7P__$T?\(+X3_Z%?0O_ M``7P_P#Q-+_PCVI_]#?KW_?FR_\`D>C_`(1[4_\`H;]>_P"_-E_\CT678+O^ M;\Q/^$%\)_\`0KZ%_P""^'_XFC_A!?"?_0KZ%_X+X?\`XFLKPE8:QK'A71M3 MN?%NM+/>V4-S(L<%D%#.@8@9MR<9/J:UO^$>U/\`Z&_7O^_-E_\`(]&G8'=: MC_A'M3_Z&_7O^_-E_P#(]%EV"[_F_,3_`(07PG_T*^A?^"^' M_P")H_X07PG_`-"OH7_@OA_^)I?^$>U/_H;]>_[\V7_R/1_PCVI_]#?KW_?F MR_\`D>BR[!=_S?F)_P`(+X3_`.A7T+_P7P__`!-'_""^$_\`H5]"_P#!?#_\ M365X2L-8UCPKHVIW/BW6EGO;*&YD6."R"AG0,0,VY.,GU-:W_"/:G_T-^O?] M^;+_`.1Z-.P.ZTYOS$_X07PG_P!"OH7_`(+X?_B:/^$%\)_]"OH7_@OA_P#B M:7_A'M3_`.AOU[_OS9?_`"/1_P`(]J?_`$-^O?\`?FR_^1Z++L%W_-^8G_"" M^$_^A7T+_P`%\/\`\31_P@OA/_H5]"_\%\/_`,32_P#"/:G_`-#?KW_?FR_^ M1Z/^$>U/_H;]>_[\V7_R/19=@N_YOS$_X07PG_T*^A?^"^'_`.)H_P"$%\)_ M]"OH7_@OA_\`B:RO"5AK&L>%=&U.Y\6ZTL][90W,BQP604,Z!B!FW)QD^IK6 M_P"$>U/_`*&_7O\`OS9?_(]&G8'=:U/\`Z&_7O^_-E_\` M(]%EV"[_`)OS$_X07PG_`-"OH7_@OA_^)H_X07PG_P!"OH7_`(+X?_B:7_A' MM3_Z&_7O^_-E_P#(]'_"/:G_`-#?KW_?FR_^1Z++L%W_`#?F)_P@OA/_`*%? M0O\`P7P__$T?\(+X3_Z%?0O_``7P_P#Q-97AFPUC5-.FN+CQ;K2NE[=VP"06 M0&V*XDB4\VYYVH"??/3I6M_PCVI_]#?KW_?FR_\`D>C3L#NM.;\Q/^$%\)_] M"OH7_@OA_P#B:/\`A!?"?_0KZ%_X+X?_`(FE_P"$>U/_`*&_7O\`OS9?_(]' M_"/:G_T-^O?]^;+_`.1Z++L%W_-^8G_""^$_^A7T+_P7P_\`Q-'_``@OA/\` MZ%?0O_!?#_\`$TO_``CVI_\`0WZ]_P!^;+_Y'H_X1[4_^AOU[_OS9?\`R/19 M=@N_YOS$_P"$%\)_]"OH7_@OA_\`B:/^$%\)_P#0KZ%_X+X?_B:RO#-AK&J: M=-<7'BW6E=+V[M@$@L@-L5Q)$IYMSSM0$^^>G2M;_A'M3_Z&_7O^_-E_\CT: M=@=UIS?F)_P@OA/_`*%?0O\`P7P__$T?\(+X3_Z%?0O_``7P_P#Q-+_PCVI_ M]#?KW_?FR_\`D>I/!-S=76A,U_=27<\5[>6WGR*BLZQ7,L:DA%5<[47H!19= M@N[7N1?\(+X3_P"A7T+_`,%\/_Q-?-/[2VDZ=H_CNPM])L+2Q@;38Y&CM85B M4L991N(4`9P`,^PKZYKY3_:M_P"2AZ=_V"H__1TU9UDN4VPS;GJSZ+^&_P#R M3OPM_P!@JU_]$K71XKGOAO\`\D[\+?\`8*M?_1*UT>*U6QA+=C<48IV*,4R1 MN*YSX;_\D[\+?]@JU_\`1*UTN*YSX;_\D[\+?]@JU_\`1*TNI70Z'%&*=BC% M,D;BC%.Q1B@!N*,4[%&*`&XHQ3L48H`;BC%.Q1B@!N*,4[%&*`&XHQ535EU% M[94TA[2*=G`:6Z1I%C7!.0BE2Y)`&-RXR3DXVMR<_B'7#X7_`+<@&F>1;I(? M+\J1VU-EE9(Q!A@(Q,%0QG][GSE`!V@NF[%*-SM\48K"UV^U'^VM/TG2);2V MGN;>>Z:XNH&G4+$T2[`BNAR3,#NW<;2,'.1SFE>--1U2Q@UB*"T@TW[1I]K+ M9LK/*S726[;UFW`*%^U+\IC.?+/(W?*G*P*#9Z!BC%<9;>*-3.G>7J5C!IFJ M2^=(IN6Q#!!&$,LTA)&5B:3R^"/-*AUV1ON3M<4T[@XV&XHQ3L48IDC<48IV M*,4`-Q1BG8HQ0`W%&*=BC%`#<48IV*,4`-Q1BG8HQ0`W%&*=BC%`#<48IV*, M4`-Q1BG8HQ0`W%&*=BC%`#<48IV*,4`-Q1BG8HQ0`W%&*=BC%`#<48IV*,4` M-Q1BG8HQ0!!(;FWLM'N+N[L9[^.WVS"VM[8W$KNK M`IL0#E@P4@\8(R2`,CB].OK4VNHW]U%KUAJM_=,3=6NB3R/%^ZMPRQ!X&81[ M8XD+2(N]D=@JX`66[%QC<[O4;ZTTVSDN]1NH+2UCQOFGD$:+D@#+$X&20/QJ MM-KFDP_V?YVJ6$?]H8^Q[KA!]ISC'E\_/G$*FW>TFV1E4A2[`$,W!W5BZA.MGX9O=-FT75FDUG[?+<3 MVNES2R_8Y+F=XXP53B9EF.U)"HC+,SX(V.N8:@CU"*>*:29(I8W>%_+E56!, M;;0VUAV.UE.#V(/>BVGBNK:*XMI8YH)4$D6E^V)94LT)'^K:6=Y']=)%O^P5:_\`HE:Z.N=^ M&P_XMUX6_P"P5:_^B5K:U&&XGLY(K.Z^R3/@"<1AR@R-Q4'C=C."00#@E6`* MFUL926K+%%>?6-]J]_XA;0!K5VEM$]VT>IQ10&>X$(M`5),9B($EQ,AVH"#$ MHSD/NZSPCJ,VL^%-%U.Z6-+B]LH;F18P0H9XU8@`DG&3ZFA.X.-C5KG/AM_R M3KPM_P!@JU_]$K5[5O$FA:-%LG_F%6G_HE:+ZA;0Z*BEXSC/-'!SSTIBL)11D8!R,'O2\9QGF@+"4 M4O!SSTI,C`.1@]Z`L%%+QG&>:.#GGI0%A**,C`.1@]Z7C.,\T!82BEX.>>E) MD8!R,'O0%CF/'[Z/+I4=AKGB./0H;E]V3<01&X5<;HR)E8,ARNY<D4\%_9DQQ M.(]\0#JRE2T2/D@L".&"_+1H.G>$;Z\BL_#GB"WGM(?(N'TJSO89D=H!&D4K M'#2C;Y4`X<*=BY!W-NBU'O6?X-_Y*3:_]@J[_P#1UK3G3Y.HJ.)]H^5*W]>A MW%UX2=KFZE28W18>;&T;[X0O&T+&P!52"I.2P8LY;1TVQM],TZUL M+*/RK2UB2"%-Q;:B@*HR:.#GGI0% MA**,C`.1@]Z7C.,\T!82BEX.>>E)D8!R,'O0%@HI>,XSS1P<\]*`L)11D8!R M,'O2\9QGF@+"44O!SSTI,C`.1@]Z`L%%+QG&>:.#GGI0%A**,C`.1@]Z7C., M\T!82BEX.>>E)D8!R,'O0%B.YF2VMI9Y!(4B0NPCC:1B`,\*H)8^P!)[5DS> M)]*CT[3[U99YX;^(3VRVUI+/+)&0#O\`+12X4!ER2``64'!(!UKF1H;>62.& M2>1$++#&5#2$#[HW$#)Z;.Y32[R&"^C ME$:(NV7S`AA.TN5W$EE@)4@,*EMK8J,4]SO;W6]/M-.@OGN/-MKC;]G-LC7# M3[AN'EK&&9_E!;Y0?E!/0$U2E\7:)%'"[74A21/,=DMY6%NH8J6G(7]P`RN" M9-N"C@XV-C-U2POF\/Z1:Q::\>J620-!/I4D,-M;3&-XVV"7=B)5+*-H*NI;H&1USE&`NVTR7-M M%/&)`DJ!U$D;1L`1GE6`*GV(!'>N4U#P[+-J%]/I5E:6C0N;F+SR62]NPC-& M9%4G;`DDADV@!C*6D`4C=+O>'3?_`-C6YU@C[8=V2=N[9N.S?M^7S-FW=L^7 M=NV_+BFFR7%=#1HI>,XSS1P<\]*8K"449&`@+'.>-_$4_ARTT][2QBO9[R[^RJDMP857]U)(6+!&/2,C&.]8D/C#Q#- M]WP_I(^NKR?_`"-3_BSCRO#(SS_:I_\`22YJCIW:KIQYGJ<^(JNG:Q>F\6>( MXA\WA_2#]-7D_P#D:F:1XXU.Y\1:7IFH:)9V\=]*\0F@U!I2A6*23[IA7(/E MD=>]-O\`I6#I_P#R/?A7_K]E_P#2.XIU(*.Q%"O*I*S1Z]12\'//2DR,`Y&# MWK,Z[!12\9QGFC@YYZ4!82BC(P#D8/>EXSC/-`6*.M6^G7&E7*:W%:2Z:$\R M=;M5:$*OS;F#<8&,Y/3&:P/A?]C_`.$1']F?9_L']H:A]G^SX\KR_MDVW9MX MVXQC'&*V]7UW1]%\K^V=5L-/\W/E_:KE(M^,9QN(SC(_,5E?#B>&Z\-2W%K+ M'-!+J6HR1RQL&5U-[.0P(X((YS4]2K/E.FKY0_:P_P"2BZ=_V"H__1TU?6&* M^4/VL/\`DHNG?]@J/_T=-45?A-<-\9]&_#8?\6Z\+?\`8*M?_1*UK:U8-J>E M7-DE[>6!G39]ILV59D!Z[68$`XR,XR,Y&#@C+^&H_P"+<^%?^P5:_P#HE:Z3 M%6MC)[G(VG@I;2*$VVNZO'=P;DAN5%OF*%EB4P)'Y/E+'^YC.`@((.#\S9Z/ M3;&WTS3K6PL8_*M+6)((4W%MJ*`JC)R3@`=:MXHQ35D#;8W%:?$W_`)&[PY_UY7W_`*,M M:33^U.^)_P#R-WAO_KROO_1EK3=/[5M1.#&;HEU'O6?X,_Y*3:_]@J[_`/1U MK6AJ/>J'@O\`Y*5:_P#8*N__`$=:TZ^Q.#^-?/\`(]4Q1BG8HQ6!Z(W%&*=B MC%`#<48IV*,4`-Q1BG8HQ0`W%&*Y3XM"T_X5EXG_`+0^S^3_`&?-M\_&WS-I M\O&>-V_;M[[L8YQ6!\2[W4+B31;FQL[N^T)+C3[F*:QN(?+N)GO8=H.9%)`0 M87[R,9PQV^6&J7*Q487/2L48KB_B#JGA2"*"/Q"=(O;D2M;V]GJ%PBPB8JKE MI`^53:A4ERI95?"@F0*_'Z6;%A;,;^/4O$)O=).F7LR[;ZYL?+L_-DB#?O!$ MP^U,X'',V[^.ARL-0NKGLF*,5YB;3^R=&OK9)[C5=!M96^VO.^R.>8M'$(W? MG]RN'ENGQ@N9"<@RQ#T?3+K[?IUK=^1<6WVB))?)N$V2Q[@#M=>S#.".QH3N M)QL3XHQ3L48JB1N*,4[%&*`&XHQ3L48H`X;Q_P"(=7TC5](L=&:PC^UPW$TC MW=N\V/+:$`*%D3&?-.H=#5#P9_P`E*M?^P5=_ M^CK6JJP4=A8:O.I*TG^"/4\48IV*,5D=@W%&*=BC%`#<48IV*,4`-Q1BG8HQ M0!P'Q:'[GPS_`-A8_P#I)GZEF_Z5@Z?_P`CWX5_Z_9?_2.XK>O^E8.G?\CYX5_Z_9?_`$CN*JOL983X MT>PXHQ3L48K`],;BC%.Q1B@!N*,4[%&*`*FHWD6GV,K;P/.YR0. M$0%CU[#CKT%8'PXE6Y\-2SQB0)+J>HNHDC:-@#>SGE6`*GV(!'>NEN9'AMI9 M8X9)W1"RQ1E0TA`^Z-Q`R>G)`]2*YSX;R/-X9EEDAD@=]3U%FBD*EHR;V?*G M:2,CIP2/0FIZE?9.FQ7R=^UC_P`E%T[_`+!4?_HZ:OK/%?)O[6?_`"4;3O\` ML%1_^CIJBK\)KA_C/H_X:_\`).?"O_8*M/\`T2M=)7.?#3_DG/A7_L$VG_HE M:Z3%6MC.6[$HK.O==TBPTV#4+[5;"VL+C;Y-S-[;4!.!U)QP`2>`:KZMXBTS2;E8+Z>1'V"1RD$ MDBP(20))652(DX;YG*K\K<_*<5_B!:W=]X'UZRTZUDN[R[LIK:*&-D4LTB%` M*]+U;4/[<^RZ5<-_P`)!HD>FKF6$?8I!]HR9\O]T?:% MYC\P_(_'W=TMLM13W.KUC6K+2/)%X;AI9LE(;:VEN)6`QN;9&K-M&5!;&`64 M$Y(S')XBTQ;FR@BGDNGNT22(V<$EPNQSA)':-6"(W.&8A3M;!^4XI^*M0UN& M);?1=&OYVDE\N2Z@>VS%'M!,D:RR*&8D[%W<`JS$,`JR8EOIUT/[`BTWPK<: M1?V<5G#]N,\$D<-LNQI;4N)#+(NWS$`*$%]K\8#@;8**MJ=-%XCTF;2IM2AO M8Y;.)_+9XP6)8XVJJ@98ON0H`#O#H5W!ESKUPTWAN[MH[BZT2RCL#:.ZV5HA M1G;4F:[,"H(S$.T;Y)\T>G2LR M'QGXBF^[X>TD?75Y/_D:JWQ0_P"1N\-_]>5]_P"C+6F:=VK6G!2W./$5Y4W9 M%Z;Q?XCB^]X?T@_35Y/_`)&JQX5\97^K>)5TG4=(M;,O:2W22P7S3YV/&I4@ MQ)C/F@YR>E9^H=#5#P5_R4JU_P"P3=_^CK6G5IJ.Q.'Q$JDK2/5J*7%&*R.P M2BEQ1B@!**7%&*`$HI<48H`\S^*'_(W>&_\`KROO_1EK3-.[5)\4?^1N\-_] M>5]_Z,M:CT[M6U`\_&;HGU#H:H>#/^2E6O\`V"KO_P!'6M7]0Z&J/@O_`)*5 M:_\`8*N__1UK55]B<'\:^?Y'JM%+BC%%/^OV7_P!([BMV_P"E86F?\C[X4_Z_9O\`TCN*JOL8X3XT>QT4 MN*,5SGJ"44N*,4`)12XHQ0!#;PS++)#)`[ZGJ+-%(5+1DWL^5.TD9'3@D>A-=!J+7D=G(VFP6]Q=C&R M.XF,*-R,Y<(Y'&3]T\\<=:P/AL9F\,RM=1QQW!U/43(D;EU5OML^0&(!(SWP M,^@I=2OLG3U\F?M9_P#)1M._[!4?_HZ:OK3%?)G[6G_)1M._[!,?_HZ:LZOP MFN'^,^D?AH/^+<>%?^P3:?\`HE:V]3%G_9MW_:GV?[!Y3_:/M&/*\O!W;]W& MW&%/^P3:?\`HE*Z7%6MC-[GD_A#5M-L=*^'>J7VH6=MIB>' M);1KN:94A6?_`$/]T7)QO_=2_+G/[MO[IQV_P]MYK7P#X:M[J*2&XBTRVCDB MD4JR,(E!4@\@@\8KH<48H2L#=S'U>WUV6Y5M'U+3+6WV`,EUI\EPQ;)R0RS( M`,8XQV///%'X:C_BW'A3'_0*M/\`T2E=-BN:^&?_`"3CPI_V";3_`-$I1U#H M='CGVH`ZY_"G8HQ3)&8.!R,]^*7'/M3L48H`:!US^%)@X'(SWXI^*,4`-QS[ M4`=<_A3L48H`9@X'(SWXI<<^U.Q1B@!H'7/X4F#@J7@C_D MI=K_`-@F[_\`1UK5W4>]4O`__)2[7_L$W?\`Z.M:=?8G!?&OG^1ZP!US^%)@ MX'(SWXI^*,5S'IGG?Q,U75K/7="LM*U2?3HKBWNI93#%"[.4:`+_`*Q&P!YC M=,5EVDWB";&[Q;JP^EO9?_&*M_%/_D;O#7_7E??^C+6HM.[5M2BI;G%BJLX. MT6,NG\019V^+=7/UM[+_`.,5+X&U?6I/'$>GZCK5UJ%I)I]Q/LGA@7:Z20*I M!CC4])&X.13]0[U2\$?\E+MO^P3=_P#HZUHK04=A86M.5]_Z,M:CT[M4OQ3_`.1N\-?]>5]_Z,M: MBT[M6]`\_&?$B;4.AJCX)_Y*7:_]@F[_`/1UK5[4.AJEX(_Y*7:_]@F[_P#1 MUK55]B,%\:^?Y'JX'7/X4F#@F-QS[4`=<_A3L48H`9@X'(SW MXI<<^U.Q1B@!H'7/X4F#@& M/3^UC_Z27-9FG=JU/B__`,>_AC_L+?\`MI@<&-W7I^I9O^E8>F?\ MC[X4_P"OV;_TCN*W+_I6'I?_`"/WA3_K]F_]([BJK[&.$^-'LH'7/X4F#@J-QS[4`=<_A3+F>&TMI;BZECAMX4,DDLC!510,EB3P`!SFH].O M[/4[*.\TV[M[RTDSLGMY!(C8)!PP)!P01]11<=B;!P.1GOQ2XY]JIZ1JVFZS M;-<:/J%G?VZN8VEM9EE4,`"5)4D9P0<>XHT_5M-U&.W?3]0L[I+A'DA:"99! M*J,%=E(/(5F`)'0D`]:+A8AUB#6)?*_L:_T^TQGS/M=D]QNZ8QMECQCG/7.1 MTQSD_#99E\,RK=21R7`U/41(\:%%9OML^2%))`SVR<>IKH9'CO(KRWM;SRYD MS"\D!5G@%/\`L$VG_HE*Z;%5]_P"C+6HM/[5-\5/^1N\-?]>5]_Z,M:AT M_M6]`\[&_$2ZCWJGX'_Y*7:_]@F[_P#1UK5S4>]4_`W_`"4RV_[!-W_Z.M:> M(V(P7QKY_D>M8HQ2XHQ7.>H>8?%/_D;O#7_7E??^C+6HM.[5-\5/^1N\-?\` M7E??^C+6H=.[5O0/.QOQ$NH=ZI^!_P#DIEM_V";O_P!'6M7-0[U3\#?\E,MO M^P3>?^CK6G7V(P7QKY_D>M8HQ2XHQ7.>H>8?%/\`Y&[PU_UY7W_HRUJ+3NU3 M?%3_`)&[PU_UY7W_`*,M:AT[M6]`\[&_$3:AT-4O`_\`R4RU_P"P3=_^CK6K MNH=#5/P/_P`E,M?^P3=_^CK6JK[$8+^(OG^1ZSBC%+BC%5--=VEH)0H)C$UQ'"SJ#D;@)"1D$9`R",@U?#EQJ,R>(=.>^^T7.G M7?V6WO+J%2S;K:&8-(L>Q6PTQ&%"950.N6*N.VESI,48KS*_U?7=/N;S2OM^ MJ3.MQ;*@:.T.I3)(9UW6X51;E"85;]X`ZHEPS!<(:LV'B#7X=/T_6KQH[C1D MMY#-&J*+J1P\BI"Z*9+5CS#XJ?\C=X:_Z\K[_ M`-&6M0Z=VJ;XJ_\`(W>&O^O*^_\`1EK4.G=JZ*!YN-^(GU#H:I>"/^2F6O\` MV";S_P!'6M7=0Z&J?@?_`)*9;?\`8)O/_1UK58C8C!?&OG^1ZSBC%+BC%?CMUZ?J6;_I6'I7_`"/WA3_K]F_]([BMR_Z5 MB:5_R/\`X4_Z_9O_`$CN*NOL983XT>SXHQ2XHQ7,>J4-:EM+?3WGU"WDN+>) MTDV1VKW+;@X*,(T5F)#!3D#C&>,9KEO#(BATK7)-6M]0O;+4+MR);O3Y#/>Q MBUC#--`L8V_ZMXP/+0,$3AF<%[7Q(U[4M!LM*.CFS%Q>WWV9FNH6E55\F60D M*KJW`C MU2?0+JXM%O9[O2',XBC-S)Y*6QC5G2.1K\8:\_BC2].UAM+N+>_D>!3:VLD#1LL3RAB6E<,,1E<8'W@<\8( MZI*TL@4-(1?3C<=H"Y/7@`>@%=#J5C%J M-E):W#W"128RUO<20.,$'AXV##IV/(XZ&N?^&L"VWAB6",R%(M3U)%,DC2,0 M+Z<#+,2S'W))/>IMJ:WNCJ,5\D_M;_\`)1]-_P"P3'_Z.FKZWQ7R1^UQ_P`E M(TW_`+!,?_HZ:IJ_"70^,^E/AD/^+;^%/^P3:?\`HE*Z7%$_P#L M$VG_`*)2NFJEL0]SBM/\1ZE/JUC),+/^S+_4[O2HK=8F$T+0?:/WK2[RKAOL MS?*$7'F#YCM^;L\5R]CX5FM]6MI'OXWTRSOKC4K:W%N5F$\_F[]\N\JR?Z1+ MA0BD?)ECM.[JJ%?J#MT&XKFOAD/^+;^%/^P3:?\`HE*OZOX8T'6KE;C6-$TO M4+A4$:RW5I'*P4$D*"P)QDDX]S7(_#SP3X5N_`'AFXNO#.ASW$VF6LDDLEA$ MS.QB4EB2N22>,_$;PCX;M/%?AZ&U\/Z/!%+9WK2)'91JKE M7M@I("\D;FQZ9/K5G2O!_AE]N_P[HS?6QB/_`++7FXG,XX>I[-QN>QA,FEBJ M*K*=EZ'KN*,5Y+JO@[PRF=GAW1E^EC$/_9:R/"/A3P[/\1;>VGT#29;8Z7=2 M&)[.-D+"6V`;!&,@,P!]SZU.'S2->HJ:C:Y6)R26'H2KN::7EYV/<<48KG/^ M$!\'_P#0I^'_`/P6P_\`Q-'_``@/@_\`Z%/P_P#^"V'_`.)KU+L\6R.CQ1BO M&?B-X1\-VGBOP]#:^'](@BEL[UI$CLHU5RKVP4D!>2-S8],GUJQI7@_PT^-_ MAW1F^MC$?_9:\W$YG'#U/9N-SV,)DTL51593LO0]>Q1BO)=5\'>&4W;/#NC+ M]+&(?^RUD>$?"GAV?XB6]M/H&DR6YTRZD,3V<;(6$ML`V",9`9@#[GUJ:&:1 MK5%34;7*Q.22P]"5=S32\O.Q[CBC%+9')_%7_D;O#7_7E??^C+6H-/[5V?_"`^#_\`H4_# M_P#X+8?_`(FC_A`?!_\`T*?A_P#\%L/_`,36E.HX=#EKX957>]OE_P`$Y'4> M]5/`O_)3+;_L$W?_`*.M:[G_`(0'P?\`]"GX?_\`!;#_`/$T?\(#X/\`^A3\ M/_\`@MA_^)IU*KGT%0PJI2YN:_R_X)T>*,5SG_"`^#_^A3\/_P#@MA_^)H_X M0'P?_P!"GX?_`/!;#_\`$UE=G79')_%7_D;O#7_7E??^C+6H-.[5V?\`P@/@ M_P#Z%/P__P""V'_XFC_A`?!__0I^'_\`P6P__$UI3J.'0Y:^&55WO;Y?\$Y' M4.]5/`O_`"4RV_[!-Y_Z.M:[G_A`?!__`$*?A_\`\%L/_P`31_P@/@__`*%/ MP_\`^"V'_P")IU*KGT%0PJI2YN:_R_X)T>*,5SG_``@/@_\`Z%/P_P#^"V'_ M`.)H_P"$!\'_`/0I^'__``6P_P#Q-979UV1R?Q5_Y&[PU_UY7W_HRUJ#3NU= MG_P@/@__`*%/P_\`^"V'_P")H_X0'P?_`-"GX?\`_!;#_P#$UI3J.'0Y:V&5 M5WO;Y?\`!.2U#H:I^!O^2F6W_8)N_P#T=:UW/_"`^#_^A3\/_P#@MA_^)H_X M0'P?_P!"GX?_`/!;#_\`$TZE5SZ"H854I(E1G:1Y%L]3\Z5 MF0QEGEV;W(4@`LQV[4QC8N.D_P"$!\'_`/0I^'__``6P_P#Q-'_"`^#_`/H4 M_#__`(+8?_B:`]&6,,UQ!'H:')?%;_`)&[PU_UY7W_`*,M:@T[M7:?\(#X M/_Z%/P__`."V'_XFC_A`?!__`$*?A_\`\%L/_P`36E.HX=#EKX957>]OE_P3 MDM0Z&J?@;_DIEM_V";S_`-'6M=S_`,(#X/\`^A3\/_\`@MA_^)H_X0'P?_T* M?A__`,%L/_Q-.I5'](@ MBEM+UI$BLHU5RKVP4D!>2-S8],GUJ;2O"'AI\;_#VCM];*(_^RUYN)S..'J> MS<;GLX3)98JBJRG9>A[%BC%>4:IX.\,(IV>'-&7CM8Q#_P!EK'\)^$_#L_Q$ MMK:;0-)DMSIEU(8GLXRA82VP#8(QD!F`/N?6IH9I&M45-1W'B=CV_%&*YS_`(0'P?\`]"GX?_\`!;#_`/$T?\(#X/\`^A3\/_\`@MA_^)KU M+L\6R,'XP_\`'MX8_P"PM_[:7-9&G=J[7_A`?!__`$*?A_\`\%L/_P`31_P@ M/@__`*%/P_\`^"V'_P")K2G4<.AS5\.JS3O;Y?\`!.3O^E8FD_\`(_\`A/\` MZ_9O_2.XKT?_`(0'P?\`]"GX?_\`!;#_`/$T?\(#X/\`^A3\/_\`@MA_^)IU M*KGT(HX14I)\WX?\$Z/%&*YS_A`?!_\`T*?A_P#\%L/_`,31_P`(#X/_`.A3 M\/\`_@MA_P#B:RNSLLC`^,7_`![>&/\`L+?^VES61IW:NV_X0'P?_P!"GX?_ M`/!;#_\`$T?\(#X/_P"A3\/_`/@MA_\`B:TIU'#H"".,&N:^&MO#:>&);>UBCAMX=3U*..*-0JHHOIP%`'``'&!3-2\(^`]+LI+ MS4_#WA>SM(\;Y[BR@C1$_^P3:?^B4KIJYKX8_\DV\)_\` M8)M/_1*4=2N@GC./PS)]C'B?2[?4Y?G-O"VFM?2J/EWLL:H[!?N`MC&2H)R1 M69?>'OA[9Z;;W[^'/#\UM<[?LYM=*CN&N-R[AY:QHS/\H+?*#\H+=`35K6;G MQ78Z;#;Q6_\`:UW<3$27>EV\5O\`9(0HY$=Q.0\A.0ISM&#-+N=3N=$L]#T^:Q1 MDO)[>WC@\N,$EMS@#*!HV!.=H:-P?F1@.1;PQKD.CZ[9)IDDIU[2Y-/B*S1? MZ%NGO'0W+,X+$)=1[G3S69DD)+$AGZ;4O#@W;N=;:SI5_\`^C+6K.C_`,-5_BE_R.7AG_KRO_\`T9:U8T?^&OEL MT_WE_(^WR;_<5ZLEUC^*L3P5_P`E.M?^P3>?^CK6MO6/XJQ?!/\`R4^U_P"P M3>?^CK6L\N_WJ'S_`"9KFG_(OJ?+\T>LT4M%?6GP0E%+10`E%+10`E%+10`E M%+10`E%+10`E%+10`E%+10`E%+10`E%+10`E%+10`E%+10`E%+10`E%+10`E M%+10`E%+10!Y?\5/^1P\,_\`7E?_`/HRUJ;1^U1?%7_D9_P"X5/E^:/5Z*6BOK#X,2BEHH`2BEHH` M2BEHH`2BEHH`2BEHH`ANITMK:6>02,D2%V$<;2,0!DX5068^P!)[5S7PTG2Y M\,2SQB14EU34G421M&P!OIR,JP#*?8@$=ZZ:ZG2VMIIY!(R1(781QM(Q`&3A M5!9CZ``D]JYKX9SI<^&)9XQ(J2ZIJ3J)(VC8`WTY&Y6`93Z@@$=Z.I5M#J:^ M1?VN_P#DI.F_]@F+_P!'35]=U\B?M>?\E)TW_L$Q?^CIJBI\)I1^(^E_AB/^ M+:^$_P#L$6G_`*)2NFQ7-_#`?\6U\)_]@BT_]$I6OJ&IV]AY=Q1BO,+^!(;;QE;J9&AN/%>G13+)(TG MF1S#3Q)&VXG*,KLI3[NT[<;>*Z;P-;PV-]XJT^RBCM["TU18[>VA4)'"K6=L MY5%'"@N[L0.[,>I-%PY3J<5S/PQ'_%M?"?\`V"+3_P!$I6AK$^OQ7*KHVF:7 M=V^P%GN]1DMV#9.0%6"0$8QSGN>.,FA\,L_\*T\)8Y/]DVG4_P#3%*+ZA;0Z M7%&*7G(]/K0,Y.>G;FF(3%&*/FVC@;N,C/'O2\Y'I]:`$Q1BE&/>@#S#XI_\CEX9_Z\K_\`]&6E6-'_`(:@^*G_`".7AC_KRO\`_P!& M6E3Z/_#7RV:?[R_D?;9-_N*]62ZQ_%6+X(_Y*?;?]@B\_P#1UK6UK'\58W@? M_DJ%M_V"+S_T=:UGEW^]0^?Y,US/_<*GR_-'K>*,4HSDYZ=N:3YMHX&[C(SQ M[U]:?"!BC%+SD>GUH&/>EYR/3ZT`)BC%*,Y.>G M;FD^;:.!NXR,\>]`!BC%+SD>GUH&/>EYR/3ZT` M)BC%*,Y.>G;FD^;:.!NXR,\>]`!BC%+SD>GUH& M/>EYR/3ZT`)BC%*,Y.>G;FD^;:.!NXR,\>]`!BC%+SD>GUH&/>EYR/3ZT`)BC%*,Y.>G;FD^;:.!NXR,\>]`!BC%+SD>GUH&/>EYR/3ZT`)BC%*,Y.>G;FD^;:.!NXR,\>]`'E_Q M6_Y'#PQ_UY7_`/Z,M:DT?M3/BO\`\CAX8_Z\K_\`]&6E/T?M7RV:?[R_1'W& M3?[BO5EW5ONGZ5B>"O\`DI]K_P!@B\_]'6M;>K?=/TK%\$_\E0M?^P1>?^CK M6HR[_>H?/\F5F?\`N%3Y?FCUG%&*49R<].W-)\VT<#=QD9X]Z^L/A0Q1BEYR M/3ZT#.3GIVYH`3%&*/FVC@;N,C/'O2\Y'I]:`$Q1BE& M/>@`Q1BEYR/3ZT#.3GIVYH`3%&*/FVC@;N,C/'O2\Y'I]:`*FI7$MI923V]E M<7TJ8Q;V[1AWR0.#(RKQG/+#@=SQ7/?#.1YO"\LLD$EN[ZIJ3-#(5+1DWT^5 M;:2N1TX)'H36SK,VLPF+^Q;#3KL'/F?:[Y[?;TQC;#)G/S9Z8P.N>,CX9F9O M"\K74<<=P=4U(R)&Y=5;[=/D*Q`+#/0D#/H.E+J.VAU.*^0_VO?^2E:;_P!@ MB+_T=-7U]BOD+]K[_DI6F_\`8(B_]'35-3X32C\1],?#`?\`%M?"7_8(M/\` MT2E=-BN:^&`_XMIX2_[!%I_Z)2NFQ5+8A[F7#X?T:#^T?)TG3X_[2S]MV6R# M[5G=GS<#Y\[F^]G[Q]:LZ;I]GI=E'9Z9:6]G:1YV06\:QHF22<*H`&22?J:M MXHQ0(3%K)=8_BK&\#?\`)4+;_L$7 MG_HZUK9UC^*L?P+_`,E0MO\`L$7G_HZUK/+O]ZA\_P`F:YG_`+A4^7YH]=Q1 MBEQ1BOK#X03%&*7%&*`$Q1BEQ1B@!,48I<48H`3%&*7%&*`$Q1BEQ1B@!,48 MI<48H`3%&*7%&*`$Q1BEQ1B@!,48I<48H`3%&*7%&*`$Q1BEQ1B@!,48I<48 MH`3%&*7%&*`$Q1BEQ1B@!,48I<48H`\L^+'_`".'AC_KRO\`_P!&6E/T?M3? MBS_R.'AC_KRO_P#T9:4[1^U?+9I_O+]$?;Y-_N*]67=6^Z?I6+X)_P"2H6O_ M`&"+S_T=:UM:M]T_2L;P1_R5"U_[!%Y_Z.M:C+_]ZA\_R9>9_P"X5/E^:/6\ M48I<48KZP^%$Q1BEQ1B@!,48I<48H`3%&*7%&*`$Q1BEQ1B@!,48I<48H`AN MC,MM,UK'')264BZ9<6]O=G&R6X@::->1G**Z$\9'WASSS MT/._#)9E\+RK=21R7`U34A(\:%%9OMT^2JDDJ">@)./4]:.H^AU6*^0?VOO^ M2E:;_P!@B+_T=-7U_BOD']K_`/Y*7IG_`&"(O_1TU14V+I?$?37PO_Y)IX2_ M[!%I_P"B4KIJYKX7_P#)-/"7_8(M/_1*5TU4MB7N)17%W_C*_P!+GC@U;18[ M>XO4#:?$E[YA8F>"`+<$)B(A[F'.PRC`?!.U=^[X;U>;4UU"&]M8[6_T^Y^R MW,<,QFBW&*.4%'*J6&R5,Y5<'<.0`2[A9FO7,_"__DFGA+_L$6G_`*)2NGKF M?A?_`,DT\)?]@BT_]$I2ZAT.EHI:*8A**6B@!**6B@#RWXK_`/(Y>&/^O*__ M`/1EI4FC_P`-1_%C_DH?/\F:Y MG_N%3Y?FCU^BEHKZP^%$HI:*`$HI:*`$HI:*`$HI:*`$HI:*`$HI:*`$HI:* M`$HI:*`$HI:*`$HI:*`$HI:*`$HI:*`$HI:*`$HI:*`$HI:*`/*_BU_R.'A? M_KRO_P#T9:4NC]J/BW_R.'A?_KRO_P#T9:4:/VKY;-/]Y?HC[;)O]Q7JR[JW MW3]*Q_`W_)4;7_L$7G_HZTK8U;[I^E8_@;_DJ-K_`-@B\_\`1UI49?\`[U#Y M_DR\S_W"I\OS1Z[12T5]8?#"44M%`"44M%`"44M%`"44M%`"44M%`$-U$\UM M-%'-);NZ%5FC"EXR1@,NX%@%=1=1/-;311SR6[NA59HPI>,D8#+N!7(ZC((]0:YCX8Q/#X M6EBDGDN'35-35II`H>0B^G!9MH"Y/4X`'H!2ZCZ'55\?_M@_\E+TS_L$1?\` MHZ:OL&OC_P#;!_Y*7IG_`&"(O_1TU34V+I?$?3?PO_Y)GX2_[!%I_P"B4K8U M"QN+JYLY8-4O+)('W20P+"4N!D':^^-F`X(^0J?F//3&1\+O^29^$?\`L$6G M_HE*Z?%-;$O<\UN/#OBS5[V>ZUF#0HY5>.>W:*\EEV^3=0SQ0+F%1$C"(B23 M#LS%6QM1(QUGA;3;RS;5KS4UMX[S4[P7;P6\C2QPXABA"AV52V1"&SM7!;'. M,G>Q1BBP7,76/#MEJ]RL]W-JL;J@0"TU2YM4QDGE8I%4GGJ1GISP*H?#``_# M/PCG/_((LSP<#'5_\`^C+2GZ/_``UTGC[2O"ETEC?^,;J*R2W+PV]Q M)J4ED`9,%DW*Z9SY8.#G[OUK,?PAX*M=7@TI]0O(=4G3S(K,^(KM9I%Y^94\ M_<1\K<@?PGTKR,7ETJ]5U%)(][`YM##8=47%MZE/6/XJR?`7_)4;;_L$7G_H MZUKH]3\(^"K"YL[;5-1O;:XO7\NVBN?$=VCSMD#:@:?+'+*,#/4>M:.C^&/" MOA?Q#;26LC0ZQ>0RP6Z7>IS322H-KR"-)9&SC8A)49``[5.&RV=&LJCDM"\7 MG$*^&E146F[?FF=8``2>>>>M)L&T+S@8[G/'O4"ZA9-907BW=N;.?R_)G$J^ M7)YA`CVMG!W%E`QU)&.M6L5[)\]8;@;@>>>>M.Q1B@!FP;0O.!C MN<\>]+@;@>>>>M)L&T+S@8[G/'O3\48H`;@;@>>>>M.Q1B@!FP;0O.!CN<\>]+@;@>>>>M)L&T+S@8[G/ M'O3\48H`;@;@>>>>M.Q1B@!FP;0O.!CN<\>]+@;@>>>>M)L&T+S@8[G/'O3\48H`;@;@>>>>M.Q1B@!FP;0O.!C MN<\>]+@;@>>>>M)L&T+S@8[G/'O3\48H`;@;@>>>>M.Q1B@!FP;0O.!CN<\>]+@;@>>>>M)L&T+S@8[G/ M'O3\48H`\I^+G_(X>%_^O*__`/1EI1H_:E^+O_(X>%_^O*__`/1EI2:/VKY? M-/\`>7Z(^UR?_<5ZLNZM]T_2LCP+_P`E1M?^P1>?^CK2M?5ONGZ5D>!/^2I6 MW_8(O/\`T=:5&7_[U#Y_DR\R_P!PJ?+\T>O``$GGGGK2;!M"\X&.YSQ[T_%& M*^K/AQN!N!YR..M``!)YYYZT[%&*`&;!M"\X&.YSQ[TN!N!YR..M.Q1B@!H` M!)YYYZTFP;0O.!CN<\>]/Q1B@!N!N!YR..M``!)YYYZT[%&*`&;!M"\X&.YS MQ[TN!N!YR..M.Q1B@#)UG0K36#$;N748_+R5^R:C<6N*^/?VP_^2F:9_V" M(O\`T=-4SV+I?$?3GPN'_%L_"/\`V"+3_P!$I748KF?A:/\`BV7A'_L#V?\` MZ)2NGQ5(E[B8HQ2XHQ3$)BN7^%P_XMGX1_[!%I_Z)2NIQ7,?"T?\6R\(_P#8 M'L__`$2E+J/H=-BC%+BC%,0F*,4N*,4`)BC%+BC%`'$:[KFI:5:VL^HZ#&NM MS/);6\VGP7.IQ6L)",\DC1PJX&57]V`-Y5/F`W,G.V\]C#9>'/#=AH/B&WL4 M_LNXGFDTF7SI'0P^2DDBH(@R"*(S.S854V*"Q/E^LXHQ2L.YY]\19K?4-(U* MQT^UU4ZM>VTEN$BTF;R[T+YL:VT\YBPD3.S?-OC(5MZNJMN./I.CWL_BG6[7 M4[>XG.MWEU!K$36#0P'3]DJ6[BY`&^39Y"!4DX61LQB0225ZSBC%%@N>8&TU M;2K&WU72=)N-02.8_8K2\XF#R&:2:[D0!0DEQ(ZQ#(Q`LAHF*,4N*,4Q"8HQ2XHQ0`F*,4N*,4`)BC%+BC%`"8HQ2XHQ0`F*,4N*,4`) MBC%+BC%`"8HQ2XHQ0`F*,4N*,4`)BC%+BC%`"8HQ2XHQ0`F*,4N*,4`)BC%+ MBC%`"8HQ2XHQ0`F*,4N*,4`>4?%[_D,\NUL>7$%9F8+O/RJ2%#'H":YBXTKX8P6-I\.M]K MWBWMX]'22YE*'$BK`L9E+(>'4+E,'"S?ZM05 M'DOYW_X!7U;[I^E9/@/_`)*E;?\`8(O/_1UI73ZWX:^'VC>2+WPGHSRS;C'# M:Z&+F5@N-S>7%&S;1N4%L8!903EAF719/`FC:O%_8%AI5I<7*)$+W3M."PD2 M[62-KF-/+4OF,JC,"V^/`.YWE_P2L3G'MZ$J/):_6_G?L=KB MC%9$/B;1Y](GU2"_CELH7$;/&"Q+'&Q54#&[\+2W-I+'/;S:IJ*/&5M[>2>0Y('"1JS'KV!P.>@KG?AA,MUX5EN M(Q(J2ZKJ;J)8VC<`W\Y&Y6`93Z@@$=Q2ZCZ'5XKX[_;$_P"2F:9_V"(O_1T] M?8N*^._VQ?\`DINF?]@>+_T=/4SV*I_$?3WPM_Y)EX1_[`]G_P"B4K9U'6-, MTVZL[;4=1LK2XO7\NVBGG6-YVR!M0$Y8Y91@9ZCUK'^%H_XMCX0_[`]G_P"B M4KJ,4UL)[GDOB)KW1-M,VH^9?6T4\D6&_T7RTGV801 M;C<910(E-=CX),D-UXETWS[B:UT[4EM[;[1,\TBHUK;RD&1R7;YY7.6)(!P. M``)H?!>BQQSK)%>W1E0)YEYJ%Q,BCG,BGXHQ0`SG,BCG,BGXHQ0`SG,BCG4RW` M$NU<<+Y>XC'RAMR\(?#/B'S/MEGINM6=X]I+#8C^T+?_`$2\:YGD:[NMC@%9 M"\,C11;T.UE:-O+BKV7%&*5AIG*^+-3UZ*!+?0]"U*9Y9?+ENH'M=T$6Q6,D M:RRJ&8EBB[N`59B&4*LG)V'A'4I[[0[:RT^]\/:'"UE>:G9O>03Q2RP0Q&)( MFVO*Q1X8$=BT:E8B5#%RU>K8HQ18+GGLOAF]MDNKO0M/33OL3NEA:(4=W#,B M2W*[B8Q*(4:*W5OEC0A6PC&./M=*-]_9-D=62#^TC#']I6VSY8EP-^S=SMSG M&><5=Q1BF(9SN`P<8ZT#))X(P?SI^*,4`,R=H.QLG'R\9%'.X#!QCK3\48H` M8,DG@C!_.C)V@[&R",'\Z?BC%`#,G:#L;)Q\ MO&11SN`P<8ZT_%&*`,G6M3N]/,7V30M2U3>3N^R/;KLQC&?-E3KDXQG[ISCC M./\`"^1Y_"LLLD$EN[ZKJ;-#*5+QDW\Y*MM)7(Z'!(]":Z34[F:SL9)[>QN+ M^5,8M[=HUD?)`X,C*O&<\L.!W/%OL?%?'/[8__)3M,_[`\7_H MZ>E/8JGN?3_PL_Y)CX0_[`]G_P"B4KJ,5S/PL_Y)CX0_[`]G_P"B4KJ,4T2] MQN*,4[%&*`&XKE_A9_R3'PA_V![/_P!$I758KE_A9_R3'PA_V![/_P!$I0'0 MZ;%&*=BC%`#<48IV*,4`-Q1BG8HQ0`W%&*=BC%`#<48IV*,4`-Q1BG8HQ0`W M%&*=BC%`#<48IV*,4`-Q1BG8HQ0`W%&*=BC%`#<48IV*,4`-Q1BG8HQ0`W%& M*=BC%`#<48IV*,4`-Q1BG8HQ0`W%&*=BC%`#<48IV*,4`-Q1BG8HQ0`W%&*= MBC%`#<48IV*,4`-Q1BG8HQ0`W%&*=BC%`#<48IV*,4`-Q1BG8HQ0`W%&*=BC M%`#<48IV*,4`-Q1BG8HQ0`W%&*=BC%`#<48IV*,4`4]3>]CL9'TNWMKF\&/+ MBN)VAC;D9RZHY'&3]TY/''4A(&?0=*ZJZ69K69;22.*Y*$1/*AD16QP64%2P!Z@$9]1UKE_A)#&C-]ON,E5)8J">@)./4]:.H^AU>*^./VQ_P#DIVF?]@>+_P!' M3U]DXKXW_;)_Y*=IG_8'B_\`1T]3/8J&Y]0_"S_DF'A#_L#V?_HA*ZC%5-](TG66TJ07-Q?+#YFR"/*[S)!&D.\D*)':YAPI(`#AG*JRDZF@ M:Q'K$-S_`*+31V1MY[N1;NQF*EGN&!D=;;"G"QH(PGR*4*>A>#K.\CFU[4 M+^SDL3JE^+J.UF=&EB5;:"'#[&9,DPLPVLWRLN<'(!<+(Z'%"/RK!MB(H51DVQ)P`.2-6(4&V)QD\9)K9_X1C5O^AX\1?]^-/_\`D6BX6.FQ M1BN9_P"$8U;_`*'CQ%_WXT__`.1:/^$8U;_H>/$7_?C3_P#Y%HN%CIL48KF? M^$8U;_H>/$7_`'XT_P#^1:/^$8U;_H>/$7_?C3__`)%HN%CIL48K@/!6F:YK MG@W0=6N_&NO)(O\`OQI__P`BT7"QTV*, M5P'@K3--6(4&V)QD\9)K9_X1C5O^AX\ M1?\`?C3_`/Y%HN%CIL48KF?^$8U;_H>/$7_?C3__`)%H_P"$8U;_`*'CQ%_W MXT__`.1:+A8Z;%&*YG_A&-6_Z'CQ%_WXT_\`^1:/^$8U;_H>/$7_`'XT_P#^ M1:+A8Z;%&*X#P5IFN:YX-T'5KOQKKR7-_8074JQ6]@$#/&K$*#;$XR>,DUL_ M\(QJW_0\>(O^_&G_`/R+1<+'38HQ7,_\(QJW_0\>(O\`OQI__P`BT?\`",:M M_P!#QXB_[\:?_P#(M%PL=-BC%(O^_&G_P#R+1_PC&K?]#QX MB_[\:?\`_(M%PL=-BC%P"!GC5B%!M MB<9/&2:V?^$8U;_H>/$7_?C3_P#Y%HN%CIL48KF?^$8U;_H>/$7_`'XT_P#^ M1:/^$8U;_H>/$7_?C3__`)%HN%CIL48KF?\`A&-6_P"AX\1?]^-/_P#D6C_A M&-6_Z'CQ%_WXT_\`^1:+A8Z;%&*X#P5IFN:YX-T'5KOQKKR7-_8074JQ6]@$ M#/&K$*#;$XR>,DUL_P#",:M_T/'B+_OQI_\`\BT7"QTV*,5S/_",:M_T/'B+ M_OQI_P#\BT?\(QJW_0\>(O\`OQI__P`BT7"QTV*,5S/_``C&K?\`0\>(O^_& MG_\`R+1_PC&K?]#QXB_[\:?_`/(M%PL=-BC%P"!GC5B%!MB<9/&2:V?\`A&-6_P"AX\1?]^-/_P#D6BX6.FQ1BN9_ MX1C5O^AX\1?]^-/_`/D6C_A&-6_Z'CQ%_P!^-/\`_D6BX6.FQ1BN9_X1C5O^ MAX\1?]^-/_\`D6C_`(1C5O\`H>/$7_?C3_\`Y%HN%CIL48K@/!6F:YKG@W0= M6N_&NO)(O^_&G_\`R+1<+'38HQ7` M>$M,US6-*GN;GQKKRR1W][:@1V]@!MANI85/-L>2L8)]\].E;/\`PC&K?]#Q MXB_[\:?_`/(M%PL=-BC%(O^_&G_P#R M+1<+'38HQ7`>$M,US6-*GN;GQKKRR1W][:@1V]@!MANI85/-L>2L8)]\].E; M/_",:M_T/'B+_OQI_P#\BT7"QT-TLS6LRVDD<5R4(B>5#(BMC@LH*E@#U`(S MZCK7+_"Y9E\*RK=R1RW(U74Q*\2&-&;[?<9*J2Q4$]`2<>IZU/\`\(QJW_0\ M>(O^_&G_`/R+6IX:T6/0=)6QBN;F[_?37#SW.SS)'EE>5R=BJOWG;@*!C%`& MEBOC?]LK_DI^E_\`8'B_]'SU]E8KXU_;+_Y*?I?_`&!XO_1\]*6Q4-SZC^%8 M_P"+7^#_`/L#V?\`Z(2NIQ7+_"K_`))?X/\`^P/9_P#HA*ZG%-"8F*,4N*,4 M"$Q1BEQ1B@!,5S=QXUT"!L/>2,%>5)7CM9G2W\N5XG>9E4B%`\<@WR%5/EN0 M2%)'2XKR[QWIDEM-XQL['2[D_P#"0:"MA8BSM'>.2[+WA<2,BE8LM@)"$XZXP<8(S?Q7) M:9*3\5-?4VUZL9TJQC6=[2587:.6Y9U64KL8@3Q\`GJ?[K8Z[%%P$Q1BEQ1B M@0F*YNX\:Z!`V'O)&"O*DKQVLSI;^7*\3O,RJ1"@>.0;Y"JGRW()"DCI<5Y= MX[TR2VF\8V=CI=R?^$@T%;"Q%G:.\&(+C1V MUMXFTJYU@Z9#<2&YWO$KFWD6&21,[XTF*^6[KM?**Q8;'R!L;&UBN#N=9&L_ M$'2[%M,UJ*WTJ\D:*1E("HNZ3O<47`3%&* M7%&*!"8KF[CQKH$#8>\D8*\J2O':S.EOY\+B1D4K%EKF-B\A5278YX8@ MN-';6WB;2KG6#ID-Q(;G>\2N;>189)$SOC28KY;NNU\HK%AL?(&QL;6*XB[N M#J?Q"T>2Q35IA8O-!GRPVD"^7(#8N(XP5=OW2,%>5)7CM9G2W\N5XG>9E4B%`\<@WR%5/EN02 M%)'2XKR[QWIDEM-XQL['2[D_\)!H*V%B+.T=XY+LO>%Q(R*5BRUS&Q>0JI+L M<\,07&CT&^U?3[#4M-T^[NXHK[4G>.T@)R\Q1"[X`[!5))/`R!G)`-_%>7ZC MI'BA?B#HNIW.EZ=\D8*\J2O':S.EOY\+B1D4K%EKF-B\A5278 MYX8@N-'>?V[8'7/[(C:YEO!PYBM99(HCMW[9)54QQMMP=K,#AEX^9.0;Y"JGRW()"D MCI<5Y=X[TR2VF\8V=CI=R?\`A(-!6PL19VCO')=E[PN)&12L66N8V+R%5)=C MGAB"XT>@S:M9Q:Q!I9>1[Z9#)LBA>01KSAI&4%8PVU@I7^& M+'4;+QA@'6CJ,VL7T^IF=)!:?8&$WV?:Y40R-_QYX(+3*OR9"(47U'%%P8F* M,4N*,4"$Q6!J'BW1[&XN+>2:YFNH)C!);VMG-($BT7QMIFNM87)LVL[R"YEL;*2XD:>1K3RRZ1*SG*6[#>1@!%! M(RH)<9>G\:Z!#=6T(O))Q=Y_EA+B&*22V!D`,:M.JF)6<,A568%O,3`.]< M[^*\:\,:5J.E/X;TZ^T:Y2ZM8=,BEL5ADDMKHQP(KWQN+BWDFN9KJ"8P26]K9S7,H81QR$[( MT9BH6:++@;09%!()`KH,5QGB!(M%\;:9KK6%R;-K.\@N9;&RDN)&GD:T\LND M2LYRENPWD8`102,J"7&::^+M#>^@M8K[SO/\L)<0Q226P,@!C5IU4Q*SAD*J MS`MYB8!WKG?Q7C7A?PIK<5GHF@V[?98(O[*OM<6[L'/E3VL-MB.WN`ZI)N-M M&I"JX7$I9P=B'V;%"8-"8HQ2XHQ0(3%8MYXGT:RDDCN[^*&2._ATLJX8%KJ5 M4:.)1CYB5E0\9`&22-K8V\5QGQ)2*ST".6WL+F66?6-.N)A8V4D\C^5RJO7:*+C-BY\3:5;:P-,FN)!<[TB9Q;R-#'(^-D;S!?+1VW)A& M8,=Z8!WKG:Q7FFL6MW_;&MZ8MC>M8S3`>6A'V:; MY68,=HP#N7/IF*+A83%&*7%&*!"8KXT_;,_Y*AI?_8'B_P#1\]?9F*^,_P!L MS_DJ&E_]@>+_`-'SU,MBH[GU)\*O^27^#_\`L#6?_HA*ZFOB3P_^TAXOT+0= M-TFTT[0'MK"VBM8FE@F+E(U"@L1*!G`&<`5?_P"&I?&W_0+\.?\`@//_`/'J M+CL?9E%?&?\`PU+XV_Z!?AS_`,!Y_P#X]1_PU+XV_P"@7X<_\!Y__CU.XK'V M917QG_PU+XV_Z!?AS_P'G_\`CU'_``U+XV_Z!?AS_P`!Y_\`X]1<+'V917QG M_P`-2^-O^@7X<_\``>?_`./4?\-2^-O^@7X<_P#`>?\`^/47"Q]F45\9_P## M4OC;_H%^'/\`P'G_`/CU'_#4OC;_`*!?AS_P'G_^/47"Q]F45\9_\-2^-O\` MH%^'/_`>?_X]1_PU+XV_Z!?AS_P'G_\`CU%PL?9E%?&?_#4OC;_H%^'/_`>? M_P"/4?\`#4OC;_H%^'/_``'G_P#CU%PL?9E%?&?_``U+XV_Z!?AS_P`!Y_\` MX]1_PU+XV_Z!?AS_`,!Y_P#X]1<+'V917QG_`,-2^-O^@7X<_P#`>?\`^/4? M\-2^-O\`H%^'/_`>?_X]1<+'V917QG_PU+XV_P"@7X<_\!Y__CU'_#4OC;_H M%^'/_`>?_P"/47"Q]F45\9_\-2^-O^@7X<_\!Y__`(]1_P`-2^-O^@7X<_\` M`>?_`./47"Q]F45\9_\`#4OC;_H%^'/_``'G_P#CU'_#4OC;_H%^'/\`P'G_ M`/CU%PL?9E%?&?\`PU+XV_Z!?AS_`,!Y_P#X]1_PU+XV_P"@7X<_\!Y__CU% MPL?9E%?&?_#4OC;_`*!?AS_P'G_^/4?\-2^-O^@7X<_\!Y__`(]1<+'V917Q MG_PU+XV_Z!?AS_P'G_\`CU'_``U+XV_Z!?AS_P`!Y_\`X]1<+'V917QG_P`- M2^-O^@7X<_\``>?_`./4?\-2^-O^@7X<_P#`>?\`^/47"Q]F45\9_P##4OC; M_H%^'/\`P'G_`/CU'_#4OC;_`*!?AS_P'G_^/47"Q]F45\9_\-2^-O\`H%^' M/_`>?_X]1_PU+XV_Z!?AS_P'G_\`CU%PL?9E%?&?_#4OC;_H%^'/_`>?_P"/ M4?\`#4OC;_H%^'/_``'G_P#CU%PL?9E%?&?_``U+XV_Z!?AS_P`!Y_\`X]1_ MPU+XV_Z!?AS_`,!Y_P#X]1<+'V917QG_`,-2^-O^@7X<_P#`>?\`^/4?\-2^ M-O\`H%^'/_`>?_X]1<+'V917QG_PU+XV_P"@7X<_\!Y__CU'_#4OC;_H%^'/ M_`>?_P"/47"Q]F45\9_\-2^-O^@7X<_\!Y__`(]1_P`-2^-O^@7X<_\``>?_ M`./47"Q]F45\9_\`#4OC;_H%^'/_``'G_P#CU'_#4OC;_H%^'/\`P'G_`/CU M%PL?9E%?&?\`PU+XV_Z!?AS_`,!Y_P#X]1_PU+XV_P"@7X<_\!Y__CU%PL?9 ME%?&?_#4OC;_`*!?AS_P'G_^/4?\-2^-O^@7X<_\!Y__`(]1<+'V917QG_PU M+XV_Z!?AS_P'G_\`CU'_``U+XV_Z!?AS_P`!Y_\`X]1<+'V917QG_P`-2^-O M^@7X<_\``>?_`./4?\-2^-O^@7X<_P#`>?\`^/47"Q]F45\9_P##4OC;_H%^ M'/\`P'G_`/CU'_#4OC;_`*!?AS_P'G_^/47"Q]F45\9_\-2^-O\`H%^'/_`> M?_X]1_PU+XV_Z!?AS_P'G_\`CU%PL?9E%?&?_#4OC;_H%^'/_`>?_P"/4?\` M#4OC;_H%^'/_``'G_P#CU%PL?9E%?&?_``U+XV_Z!?AS_P`!Y_\`X]1_PU+X MV_Z!?AS_`,!Y_P#X]1<+'V917QG_`,-2^-O^@7X<_P#`>?\`^/4?\-2^-O\` MH%^'/_`>?_X]1<+'V97QG^V;_P`E0TO_`+`T7_H^>C_AJ7QM_P!`OPY_X#S_ M`/QZO,OB;X^U3XBZ]!JVMP64%S#;+:JMHC*A0,[`D,S'.7/?TJ9/0J*U/__9 ` end XML 11 R1.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Label Element Value
Risk/Return: rr_RiskReturnAbstract  
Document Type dei_DocumentType 485BPOS
Document Period End Date dei_DocumentPeriodEndDate Apr. 30, 2011
Registrant Name dei_EntityRegistrantName BLACKROCK HEALTHCARE FUND, INC.
Central Index Key dei_EntityCentralIndexKey 0000709140
Amendment Flag dei_AmendmentFlag false
Document Creation Date dei_DocumentCreationDate Aug. 26, 2011
Document Effective Date dei_DocumentEffectiveDate Aug. 29, 2011
Prospectus Date rr_ProspectusDate Aug. 29, 2011
XML 12 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 13 R9.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Label Element Value
Risk/Return: rr_RiskReturnAbstract  
Registrant Name dei_EntityRegistrantName BLACKROCK HEALTHCARE FUND, INC.
Prospectus Date rr_ProspectusDate Aug. 29, 2011
BLACKROCK HEALTHCARE FUND, INC. | Investor A Shares
 
Risk/Return: rr_RiskReturnAbstract  
Maximum Sales Charge (Load) Imposed on Purchases (as a percentage of offering price) rr_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice 5.25%
Maximum Deferred Sales Charge (Load) (as a percentage of offering price or redemption proceeds, whichever is lower) rr_MaximumDeferredSalesChargeOverOther none [1]
Management Fee rr_ManagementFeesOverAssets 1.00%
Distribution and/or Service (12b-1) Fees rr_DistributionAndService12b1FeesOverAssets 0.25%
Other Expenses rr_OtherExpensesOverAssets 0.33%
Total Annual Fund Operating Expenses rr_ExpensesOverAssets 1.58%
1 Year rr_ExpenseExampleYear01 677
3 Years rr_ExpenseExampleYear03 998
5 Years rr_ExpenseExampleYear05 1,340
10 Years rr_ExpenseExampleYear10 2,305
Annual Return 2001 rr_AnnualReturn2001 (2.30%)
Annual Return 2002 rr_AnnualReturn2002 (22.36%)
Annual Return 2003 rr_AnnualReturn2003 22.00%
Annual Return 2004 rr_AnnualReturn2004 10.25%
Annual Return 2005 rr_AnnualReturn2005 14.20%
Annual Return 2006 rr_AnnualReturn2006 0.38%
Annual Return 2007 rr_AnnualReturn2007 18.90%
Annual Return 2008 rr_AnnualReturn2008 (26.29%)
Annual Return 2009 rr_AnnualReturn2009 23.02%
Annual Return 2010 rr_AnnualReturn2010 3.36%
Year to Date Return, Label rr_YearToDateReturnLabel year-to-date return
Bar Chart, Year to Date Return, Date rr_BarChartYearToDateReturnDate Jun. 30, 2011
Bar Chart, Year to Date Return rr_BarChartYearToDateReturn 16.99%
Highest Quarterly Return, Label rr_HighestQuarterlyReturnLabel highest return
Highest Quarterly Return, Date rr_BarChartHighestQuarterlyReturnDate Jun. 30, 2003
Highest Quarterly Return rr_BarChartHighestQuarterlyReturn 13.87%
Lowest Quarterly Return, Label rr_LowestQuarterlyReturnLabel lowest return
Lowest Quarterly Return, Date rr_BarChartLowestQuarterlyReturnDate Mar. 31, 2008
Lowest Quarterly Return rr_BarChartLowestQuarterlyReturn (17.14%)
1 Year rr_AverageAnnualReturnYear01 (2.07%)
5 Years rr_AverageAnnualReturnYear05 1.17%
10 Years rr_AverageAnnualReturnYear10 2.13%
BLACKROCK HEALTHCARE FUND, INC. | Investor A Shares | Return After Taxes on Distributions
 
Risk/Return: rr_RiskReturnAbstract  
1 Year rr_AverageAnnualReturnYear01 (2.33%)
5 Years rr_AverageAnnualReturnYear05 0.05%
10 Years rr_AverageAnnualReturnYear10 1.27%
BLACKROCK HEALTHCARE FUND, INC. | Investor A Shares | Return After Taxes on Distributions and Sale of Fund Shares
 
Risk/Return: rr_RiskReturnAbstract  
1 Year rr_AverageAnnualReturnYear01 (1.35%)
5 Years rr_AverageAnnualReturnYear05 0.70%
10 Years rr_AverageAnnualReturnYear10 1.60%
BLACKROCK HEALTHCARE FUND, INC. | Investor B Shares
 
Risk/Return: rr_RiskReturnAbstract  
Maximum Sales Charge (Load) Imposed on Purchases (as a percentage of offering price) rr_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice none
Maximum Deferred Sales Charge (Load) (as a percentage of offering price or redemption proceeds, whichever is lower) rr_MaximumDeferredSalesChargeOverOther 4.50% [2]
Management Fee rr_ManagementFeesOverAssets 1.00%
Distribution and/or Service (12b-1) Fees rr_DistributionAndService12b1FeesOverAssets 1.00%
Other Expenses rr_OtherExpensesOverAssets 0.47%
Total Annual Fund Operating Expenses rr_ExpensesOverAssets 2.47%
1 Year rr_ExpenseExampleYear01 700
3 Years rr_ExpenseExampleYear03 1,120
5 Years rr_ExpenseExampleYear05 1,516
10 Years rr_ExpenseExampleYear10 2,587
1 Year rr_ExpenseExampleNoRedemptionYear01 250
3 Years rr_ExpenseExampleNoRedemptionYear03 770
5 Years rr_ExpenseExampleNoRedemptionYear05 1,316
10 Years rr_ExpenseExampleNoRedemptionYear10 2,587
1 Year rr_AverageAnnualReturnYear01 (2.08%)
5 Years rr_AverageAnnualReturnYear05 1.12%
10 Years rr_AverageAnnualReturnYear10 2.03%
BLACKROCK HEALTHCARE FUND, INC. | Investor C Shares
 
Risk/Return: rr_RiskReturnAbstract  
Maximum Sales Charge (Load) Imposed on Purchases (as a percentage of offering price) rr_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice none
Maximum Deferred Sales Charge (Load) (as a percentage of offering price or redemption proceeds, whichever is lower) rr_MaximumDeferredSalesChargeOverOther 1.00% [3]
Management Fee rr_ManagementFeesOverAssets 1.00%
Distribution and/or Service (12b-1) Fees rr_DistributionAndService12b1FeesOverAssets 1.00%
Other Expenses rr_OtherExpensesOverAssets 0.40%
Total Annual Fund Operating Expenses rr_ExpensesOverAssets 2.40%
1 Year rr_ExpenseExampleYear01 343
3 Years rr_ExpenseExampleYear03 748
5 Years rr_ExpenseExampleYear05 1,280
10 Years rr_ExpenseExampleYear10 2,736
1 Year rr_ExpenseExampleNoRedemptionYear01 243
3 Years rr_ExpenseExampleNoRedemptionYear03 748
5 Years rr_ExpenseExampleNoRedemptionYear05 1,280
10 Years rr_ExpenseExampleNoRedemptionYear10 2,736
1 Year rr_AverageAnnualReturnYear01 1.57%
5 Years rr_AverageAnnualReturnYear05 1.47%
10 Years rr_AverageAnnualReturnYear10 1.88%
BLACKROCK HEALTHCARE FUND, INC. | Institutional Shares
 
Risk/Return: rr_RiskReturnAbstract  
Maximum Sales Charge (Load) Imposed on Purchases (as a percentage of offering price) rr_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice none
Maximum Deferred Sales Charge (Load) (as a percentage of offering price or redemption proceeds, whichever is lower) rr_MaximumDeferredSalesChargeOverOther none
Management Fee rr_ManagementFeesOverAssets 1.00%
Distribution and/or Service (12b-1) Fees rr_DistributionAndService12b1FeesOverAssets none
Other Expenses rr_OtherExpensesOverAssets 0.32%
Total Annual Fund Operating Expenses rr_ExpensesOverAssets 1.32%
1 Year rr_ExpenseExampleYear01 134
3 Years rr_ExpenseExampleYear03 418
5 Years rr_ExpenseExampleYear05 723
10 Years rr_ExpenseExampleYear10 1,590
1 Year rr_AverageAnnualReturnYear01 3.61%
5 Years rr_AverageAnnualReturnYear05 2.50%
10 Years rr_AverageAnnualReturnYear10 2.94%
BLACKROCK HEALTHCARE FUND, INC. | Class R Shares
 
Risk/Return: rr_RiskReturnAbstract  
Maximum Sales Charge (Load) Imposed on Purchases (as a percentage of offering price) rr_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice none
Maximum Deferred Sales Charge (Load) (as a percentage of offering price or redemption proceeds, whichever is lower) rr_MaximumDeferredSalesChargeOverOther none
Management Fee rr_ManagementFeesOverAssets 1.00%
Distribution and/or Service (12b-1) Fees rr_DistributionAndService12b1FeesOverAssets 0.50%
Other Expenses rr_OtherExpensesOverAssets 0.69%
Total Annual Fund Operating Expenses rr_ExpensesOverAssets 2.19%
1 Year rr_ExpenseExampleYear01 222
3 Years rr_ExpenseExampleYear03 685
5 Years rr_ExpenseExampleYear05 1,175
10 Years rr_ExpenseExampleYear10 2,524
1 Year rr_AverageAnnualReturnYear01 2.63%
5 Years rr_AverageAnnualReturnYear05 1.74%
10 Years rr_AverageAnnualReturnYear10 2.35%
BLACKROCK HEALTHCARE FUND, INC.
 
Risk/Return: rr_RiskReturnAbstract  
Risk/Return [Heading] rr_RiskReturnHeading
Objective [Heading] rr_ObjectiveHeading
Objective, Primary [Text Block] rr_ObjectivePrimaryTextBlock
Expense [Heading] rr_ExpenseHeading
Expense Narrative [Text Block] rr_ExpenseNarrativeTextBlock
Shareholder Fees Caption [Text] rr_ShareholderFeesCaption
Operating Expenses Caption [Text] rr_OperatingExpensesCaption
Portfolio Turnover [Heading] rr_PortfolioTurnoverHeading
Portfolio Turnover [Text Block] rr_PortfolioTurnoverTextBlock
Portfolio Turnover, Rate rr_PortfolioTurnoverRate 138.00%
Expense Breakpoint Discounts [Text] rr_ExpenseBreakpointDiscounts You may qualify for sales charge discounts if you and your family invest, or agree to invest in the future, at least $25,000 in the fund complex advised by BlackRock Advisors, LLC ("BlackRock").
Expense Breakpoint, Minimum Investment Required [Amount] rr_ExpenseBreakpointMinimumInvestmentRequiredAmount 25,000
Expense Example [Heading] rr_ExpenseExampleHeading
Expense Example Narrative [Text Block] rr_ExpenseExampleNarrativeTextBlock
Expense Example, No Redemption, By Year, Caption [Text] rr_ExpenseExampleNoRedemptionByYearCaption
Strategy [Heading] rr_StrategyHeading
Strategy Narrative [Text Block] rr_StrategyNarrativeTextBlock
Risk [Heading] rr_RiskHeading
Risk Narrative [Text Block] rr_RiskNarrativeTextBlock
Risk Lose Money [Text] rr_RiskLoseMoney You may lose part or all of your investment in the Fund or your investment may not perform as well as other similar investments.
Risk Nondiversified Status [Text] rr_RiskNondiversifiedStatus Non-Diversification Risk — The Fund is a non-diversified fund. Because the Fund may invest in securities of a smaller number of issuers, it may be more exposed to the risks associated with and developments affecting an individual issuer than a fund that invests more widely.
Bar Chart and Performance Table [Heading] rr_BarChartAndPerformanceTableHeading
Performance Narrative [Text Block] rr_PerformanceNarrativeTextBlock
Performance Information Illustrates Variability of Returns [Text] rr_PerformanceInformationIllustratesVariabilityOfReturns The information below shows you how Healthcare Fund's performance has varied year by year and provides some indication of the risks of investing in the Fund.
Performance Availability Phone [Text] rr_PerformanceAvailabilityPhone (800) 882-0052
Performance Availability Website Address [Text] rr_PerformanceAvailabilityWebSiteAddress www.blackrock.com/funds
Performance Past Does Not Indicate Future [Text] rr_PerformancePastDoesNotIndicateFuture As with all such investments, past performance (before and after taxes) is not an indication of future results.
Bar Chart [Heading] rr_BarChartHeading
Bar Chart Does Not Reflect Sales Loads [Text] rr_BarChartDoesNotReflectSalesLoads Sales charges are not reflected in the bar chart. If they were, returns would be less than those shown.
Bar Chart Closing [Text Block] rr_BarChartClosingTextBlock
Performance Table Heading rr_PerformanceTableHeading
Performance Table Does Reflect Sales Loads rr_PerformanceTableDoesReflectSalesLoads However, the table includes all applicable fees and sales charges.
Performance Table Uses Highest Federal Rate rr_PerformanceTableUsesHighestFederalRate After-tax returns are calculated using the historical highest individual Federal marginal income tax rates and do not reflect the impact of state and local taxes. 
Performance Table Not Relevant to Tax Deferred rr_PerformanceTableNotRelevantToTaxDeferred Actual after-tax returns depend on an investor's tax situation and may differ from those shown, and the after-tax returns shown are not relevant to investors who hold their Fund shares through tax-deferred arrangements, such as 401(k) plans or individual retirement accounts or through tax-advantaged education savings accounts.
Performance Table One Class of after Tax Shown [Text] rr_PerformanceTableOneClassOfAfterTaxShown After-tax returns are shown for Investor A Shares only, and the after-tax returns for Investor B, Investor C, Institutional and Class R Shares will vary.
Performance Table Narrative rr_PerformanceTableNarrativeTextBlock
BLACKROCK HEALTHCARE FUND, INC. | S&P 500 Index (reflects no deduction for fees, expenses or taxes)
 
Risk/Return: rr_RiskReturnAbstract  
1 Year rr_AverageAnnualReturnYear01 15.06%
5 Years rr_AverageAnnualReturnYear05 2.29%
10 Years rr_AverageAnnualReturnYear10 1.41%
BLACKROCK HEALTHCARE FUND, INC. | Russell 3000 Health Care Index (reflects no deduction for fees, expenses or taxes)
 
Risk/Return: rr_RiskReturnAbstract  
1 Year rr_AverageAnnualReturnYear01 5.88%
5 Years rr_AverageAnnualReturnYear05 2.31%
10 Years rr_AverageAnnualReturnYear10 0.21%
[1] A contingent deferred sales charge ("CDSC") of 1.00% is assessed on certain redemptions of Investor A Shares made within 18 months after purchase where no initial sales charge was paid at time of purchase as part of an investment of $1,000,000 or more.
[2] The CDSC is 4.50% if shares are redeemed in less than one year. The CDSC for Investor B Shares decreases for redemptions made in subsequent years. After six years, there is no CDSC on Investor B Shares. (See the section "Details About the Share Classes — Investor B Shares" for a complete schedule of CDSCs.)
[3] There is no CDSC on Investor C Shares after one year.
XML 14 R10.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Label Element Value
Risk/Return: rr_RiskReturnAbstract  
Prospectus Date rr_ProspectusDate Aug. 29, 2011
XML 15 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } ZIP 16 0001193125-11-244540-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-11-244540-xbrl.zip M4$L#!!0````(`-.!*3^IUZLH5"0``)X^`0`:`!P`8VEK,#`P,#2&Q`T9#YI`)#X?D./"%&/"`D?Z47/([%I(K?Q!.*#S1#9)6PVQ8YD'#(,,P M'!_N[T\FDT:`984NVK#]4;VN6_M,!=0.[\EFK8:9_'*L6_:]0]+=MWK[EF&: MQ#0/6YU#RR)'WU3)^W[@$D#LB8^U5(OXN.$'-_"6T=SG'J*U64V5/+3YK0'_ M'1@]LV5DWNN[U+X-?/L6>RF;K!O=NM6)WW083\K+-B*Q#\^PF5[=,.M-,R[) MA=\"0BSKE2H1O^!R[W9):?RY#]2*BP=!MB."V8T;_VX_"+#;1MVPZE8W+HPE MG+F>ZYH[^^K'=%&^!BWO%_H]:_UH!1A'S`CX?"'K(1O60#(G\Z M'`9L\+&684@=R6YTK4[C7C@U72ZL1OJ?O%"'DZ/[KGX MF>G3SRO\;%A6J_.-C?HL^!D$/R]8,/"#$5+C&Z,B"IA\$7XY&H0LN*;W3)Q[ M)UR$`>]'V+Y(O0R#:0P]CL35$$;%L4N%R&GW6+;;/NBUU:N*E@"/R9[J;_"= M._ADP%E`)(U9AB>Q=!R?_E[[-*O^P_[LM5E5@MW@X$\>P",E(X?L?NQRFX>J M+\3A4$[I&:#@X1P%:Y\R4`[G2?AA/[?6M9H-@L-\+M0^P4\KV/!4'2C@Y#S^ M>5:N:O[#?I81'_8S//\P9@'WG13;0AJ$)Z`T/R5ZJP=U)$^3@LQS%HK%S^*F M4I5_V-=#:8/'U9'G7%&7[<;79HRO+#MVXZQ2XVSNQ8NV8>S&QGIC8Z[Q&0EW MLO@86;R,A&"NVX0GOS'JAL-CT`.GGL/N=P+Z&`%=1=>=U!9)[9I&1F\GIT\T MM_=VDOFDDMG=2>83269W)YE/*ID'.\E\(LD\V$GFDTIF9R>93R29)9O?2>;. MF;7S(6V,9+XB\:H^?Y^=69M!DC@H^,/C"Q'!")\AJ?!'TTHH,E*>D4\Z('OX MX^KDPW[\4#6!K^95LE"'#)\>CN%C815Q%Z^CLCL^K?CH\LOY.N/[R=[Y/3[<2/=BVPSJA,8>/*\B+I?(\\Y M!TT`K7DW7^['H/^9N*9]EUU#7SZ[OGV[3L<>-`/^XH;O'7[WRTWXGOQ"1^/W MZCL1X=0%3>IP,7;I]-#S/?:^IDI`T7^1PIR3P'?9_A4H8B=RV1*_BLFTS[231.$_!(_@"\?]M=A\9Q07+(P"CS+,,QGYOUC[')@@0UT<<7' M6JM&<&:0G=132MUH&!8JEQQ016BM*J.UK&8G#ZU5A+996;0(ULAE;;,(;*O" M8$W#:N>!;16!;5<9;,O*Y6R["&RGPF!!8+MY8#M%8`\J#-;L]G(Y>U`$MEM9 ML*B..VA+YX`J0MNK+%H`VS2L/+"]`K"F46&P1C-WHC6-&=@[,+9N6/KW?S`: M5-V:,@X4[")TE<3?60-_=POQ'Y25>K.]C>SOEA[T'7,+X??*PK3B"_CT7FL&JKRVAAZM'P. M;E<2?CD33,*WMA!^>0NLM8W<+VV!66UC"^&7ML#,@U85X+^,!68UEUOC%2+& M.A88U-^K+NY-L,#0YWI0"3VR>088TLY8;KRNI%VU/7^6N=3\7.T"W$CXI>TO MR]A&^.7MK^7+_HK"+V]_]98:(!6%7]X#MGS=OBGP7\;^`DVX+<18R_XR6Q7& MO2'VE]E9:G]5EX8O03MKJ0L@1;O/-#B&MD-@;`J*S/J",8\'6;U46A^Q$?[' MVC<6TA,:TAJFIV&.+OX^CI/\1C2XX5X]],>'Q!C?OR?Z0=\/0W^DGLDW\:T! M]#Q^$3_7!W3$W>DA.;H\/3I[7XN;_#D*:T3P_X-BS>3E_B])KEP_\PP_\/@# M)1[%-.[0M\V>V6O^[-1F[U'\F"(K.?7D1Z2@*I'4,VMC'WN:?!DGG]()>ZNY MML#@8]<7\/P/RM;<)!9;\F6`C,(=#EFP0S MS]X1ZCFR-M>?+*U,YFO^I6N9YGOSH&&V%NK]1@-[2)JFK+C[KD&NH=8IC&^@ M7=W!5&M=-U3F#V0W9)U>7XS?J_Z8INIWI]'KO6F0$O*WF#U:)&$+(GCB,_'= M1XES0>G)>>3,IXYX=E&434EVWL!?/$+/\Y'PLA]`R'F>-\CI`)],R80%P'M% M1D$F?N0ZI`^L8T)``8KO^8(IT6EDJ%$$=H$JU56SA+K\QOM8LQGT/'C\D$PT M[*EW!R,#!L01D1.C("M5Y(8A./K^_Y4F5L;N)0M MG8C9[!YDD>@OW0EW[8;QJ7+(%*B;`JIU0B[N3<,_2(_9' MX>OE-D>5W`:5S\H%3N,*^MI'(:CX$(<1WNGU,M#GL:T$O_GC&O>/+JCU/!@) MUK2W!AU>++CC-C.MOOF5,7%^QX(C(5CXW.N6YXW0Z;U"9;%N`W'*)Q#I76.O MB3CEPUNOD#@YP2\K?UB].M*4#HP9[0<21V]%_APP>COVN1="#;8?><].CMJG M?_@1+%&GZ)9S^6`JG70BY4PB3M(5/B!3*(W./?@;$+4Z)5RZ,O8(>O=N`L9( MZ.MGL==I$,$$Q/8(#8G+J`AG+KIDU9M:V:*Q\E>KO0<=S2Q<9[5YRO9RV3VA MSAW'.Q_Z4S);RQ_A0S\0>^3L[)B\K26_U-XI#U8QO8M9\HU[?!2-E.,&3TZX M9/^,>,"_5%KJ\WCP/40%C>:.@0^@A2K>`"HEB%SQU(/R<5/P*1. ML'W0-OY`ZQV46ZTL<`6GKILI+.;#+P$9@8ZBKE0N`L,,J0Y`'Z,1D][P4+:L MM=M?30.55*8I5)_X)>2C..J"W7>X+:^?T8$1C\#P8VQ$J.MB?Z0Z%AFJ)J"I2?2#*DJY"32UP&D`"<##/X$ M>Z0?W\D#M0A-S+&,$JM*U-MQW.'P80&:50.J:.3YE\`'U9W/4UPQ'5/YY36J M/;0$%!O&P$HYT_HN,#$C$=H&<+BC`TQ2C%/R6XJ!>3PK8D4)UFV58VH)S(!Z M8@SZP"EV5:E3:V>E60%#F+ M\EQ2M)I/2HI-//*GI%0<')22BF:525%2*@Y:W2>.A2(]*215F-8TBS(5>E(W%_#B/6C4Q M/\YS5DW,91>1[5Z1VJX>YK*KR+95M')>Q/PJ4\0>O7N^.;]['G-"94).?"&- MROO1"46/V4.?Y=,\^W9I9[EI9R%Z?F&8"#O@?9E9Q<@@9E&2!Y/D@F':$^;+ MZ,28?C25!8>^Z\097<#.N=VEC=49L*\M+S=;Y3L0?>Z=@*"QUU!CN(6 MU(9L(E4J$R`AZM(\3&$;4R"\V4D/T%\%5JUU<:;BBR@`5D%_H;3:X[U8U^EI MO=W%`A>XO>ST=*YF$=)0W=P'SZGC\%#U/T69!YYH4*@#YK7$9J?FES\NIIWQ MJ"Q)PM]LP.5/J&L=;`7@TIMVK*PSI;*`2Y]"9S:MK0!<_MPYL[<*]C/: M9^X&(D^V<&9/W9$@ER!)T.9NW=YXL)E#@2368AP)U&_4@_E2WC"[Z=O%RL]) M.A9=A*V*X-?>@+I-X-?>8+I-X,O/6UL(OOS9]>7!W^.NO1,V8$'`U)&4QW+E MAX7/Y?)G\^B0H_M.OW^MR1O.3V$I4X=B9@YA-$U60JXX>7*TXP)Y\G==M]JO MA$0Y.G2!1,W\H?5**)2C:"6%7NN@RM&]3TN/5)G3D<#J(Q[ M-Q08MU&3W]YA."[TB6#LEKB^=U,/63`B-AWS$*-OXW$` M8U8%]L)A(`^4F/B!ZTRXD^D5]PB>51-.,7`6!3SD*IPJM_IX7,=A]^*0FS_F MGHRN#53L?)0LLO=`2P0272`/Q\8XKCP7&WJI?Z%$1'T14N`PA@O](-150^H&S%92T#V ML:+X))G9"'KW`%5:(&$S$<0U4B4B2^6/BM27Z19`JR#TTGYX0\>)MP=Z:2^\ MH2/&VP.]M`_>T+'C[8%>_I#&3J\4]-2M,T\]]W*H]NEMUS#> MS=*QNEVK#B@5SY9U;%7O_\[Z5SQD1XX3X/T>SPUC<=.Y/%]M&8QL#_/PI&X8 M.G7=2(30;R;^FP9<5W$^T"=ZOXA1]$@+?);BUF>N/Y'WK,B3T0A\F+>_,=DL M==<2GN]V![C!CI5V0G\Z.]T-C-0[L*8%$?Z(Q2?0S2Q:$G!Q*PJ/S)NS7^<9 M5IX%>0RL4N+I&+/N8`&3MES)RYFW>3F8KT7H,E^PWRHS5Q_[*#(9F*G^P8I. MFM&ZR2M8T3DT<%*YK?@)_Y$+WP]^%0^DIYDP0T0S2.6>=!2\*'J!5+`\OLJP7`!B^VV M81!Y9V5R[Y:^UI+@O9:5@Z?$C^!-G`J6.O92KNY`7#F[T\S?+I2SP4,]Z2+Q MQZ!.0Y81;B7\7,B1:]-(P"A+KOD2\55O27$8`W+"52>@YKE[8*AR(!*,7SEN M2J>G'^DZ\0!3$=GIRL4>+%]%F.G(VSX;8$HW"BC%6R-A,-\S(1U%>(XD]>:T MA4I-!V0B$DUPC.3J+=2[>]D*))>)35&L03BQ%VKSP!W'L>C=K*9N@:V9)1G@S6ED+&UZF#.*ZBXPQS-U M/]#EM]0NRK.>+F!LZ9OW3O6YPE_58'EN(^J%Q_P\>0J!YU%)GM^$I2]?_"K& MQP_S>>3%8`JA;U2@*IECP\"'H9RQ8;5MFIV;\^9PF`S=]_'<$U]RMV\::0>H MO@R8:(>PO-V)Z)7(XNC,=J?`';KJ\MGYWZNTN*GP.D9>/5T'A9+,/CC+@T5F M1ZZ<;2(1WWT[Y'C1)EIKR>VVJ'?`UI)!`^:`S+@:NMQ;9>/B158MITP2*'=IR6+`;JA!JKDY&RI_55-H7:F#U>D"2(>-Y<'PGM*>Z@[1 M7X7L+4R4D=XL)V-?4^)PC&:KH%7*;ME+U@F+#:@;@F<6D\ON*/0OV3KH!S`) M#'VUOU%%QJ2UH+CZ@W)Q$J*0F"H/N3ZKB+3%M'^)L;'\;D2ST>SF=WZYU.P6BJG8E+2GQG0* MUA3.(-36R6TB;3V!)AAQ>98'/)S@=5H\Q)-7XHP\UQ7IA,&W,,?7E#9">M>D M3W0>(&VUR5"'8#'@R9`CXCS_-54N#GGH2L[-7=*FE`I1'^&TAU[@ M6$DNALT:Y"1Q\Y*1+_=G8[H9&7"!RA-#?!FG;T(@U,9D0L5J#ZW9[+Z9<\,YOG6Y6[=4-DFVJJ2%2RYN7^6L M\.B<\?9\SO@%B*?-Q^C0BZ/(I[FW_3TFCSS%KPP/S\"2_08F\O3%[F-UY;U_ M>"H0IBRGK@G,IDH-/@OY<=O)&1((&<( ML7-OSL]:2!5U1R605',%^96D.*CP=:+;DWP&X\/8`;S0G>J'"(.WO#GRS_R-"U4Y'AEY1H' MD_U1`IJ=0:XSUQ3B*6!@)8SDXE$=X3:.HTMQ<'/]')2')8G7.POB591_,-=F M=H62:5V%DW0/^GX`BY(ZK%5=.A;LD,2?0%K5;_*01QOM(5@4`=+DNTYKDM\G MW`F'T!7#>*/'D6PIB+L>.BB\($.HG<>S\F]J1#]VV>`)7/I+7[[F>,OI=S8A MESX8+`^MYN^GW__C!/Y=92O`][P2;OJ'P%J2U"2_A$Z*Z(6DSA&,92_.,V8F MO4_.LNQW- M=E4L:3H28'>C'H7_BP;8(,G!?'MY+W!M\HM(IMS$:3:HA68W\,)B)@)U)YV, MJ!#[H/.Q#B@LSY:,^^KCD8>8)"1S>G!1X40L\7GR($L^5*_V$+W/LTMXU7<1 MJSS5,)CS=L`<+HF!"E'OYE*UJ86"S<;I3+ZY%R=@;`^YQP10Y(IC]!\J4QNK MY-Z5V6XJ-.U5][1G7B8UC="!':(U`5A]O>[A87RIL*8KPZDQGRNH^?$^Y#DR MXZW%))R.U;8Q31V9%J,H+MF`VVO&8W<:OP33`!Y#I6SV6=>6KT/4:%0?@]E' M9.-N^MA-'[OIH]3T<<)D\B6:;Y=HWX[#->8.-:;E2(\P^.`)'R-PSJS.(*XS M=JGX?V[;.,+OG>G_@#)-QYXA M:5NRFS2U'UPY[GB:],&,'_J4`<$3B1&(PQQ`2"`^9 M<43@?N#NOOUQN]_"N5PRXI>$Q^B'7C`(4F%]WW'L$TL49SR,<11AB]6VIJPE MP16[51-GIW.IL5T;\<*!^G42G,J1H-45XNTT)BMH7N_"ND(5?^OY*O/HS<"G M6IL8+>69U6U/,#"BU8A6(UH=%ZU^%"J0N[H5 M%FQ7B@XD8')IH3EE1CRSA6/^#D*A0ZZ1QHG:9T''BCU[LH.;2@.DP8@_H':M MPCL:V)Z&GK#;-&F>+$?X&.%CA(_CPL=;M4SNBA_^O>`2@L"B,OP7FUW2IB\, MGWPQA/A&PY$*(Q<@'^:+>>M=-H<2#F%-G$&!$-:?-KB&;XPET9S8(\@ZS197 M<5XWDHXTJ^2'$3M^)W;H(R??WFX^-T7TW^*HG'YR5&HVZ=T&]$E'44?M-$X" MQ$>7[.GM\09``B9Q"4]%_?,RSB]\\$[]H'HH+.GK=2B,6A`2FT(]6;H<-D76S9M8.6K-XD4.][%N%E MNM[T*OGC^1K/UU'/UUFC;S:[VCFR86'.ZOV.7&)!J`117BU_GP_YNBFJ:MS+ MXUX^NJQ0ZT>)'#4HP^]L;Z5Y7[>2?43G\:5UM/![R4"NZG;V?G^W_/+R%.E@ MA0*\N,;A4V=']=K9*WJ`7J5_D53(8\W\4-:*%(MZ+?N?I(\83-IZP+W+"UE!8,`XRA3$G-2FJH&S@-*/@HC.X%#77 M%:=PHA_E*VJ+*&^)8`S,F9+%5]P$GL\,;4*]0TO,:N?$/+E)F6L2 M8U8F0WI/FGN-"<]SE6+Z):7C"95N&NYKG)!J7R!5D!1`&J(%>;A9B997#@V. MSF;7]S8*H-&Y/CK7C^%<;U(89N^-I/K>U<\>9$&T[_Z%IP='GWT;PMG5U`LH MDY3.-A(<.&[5))O<9G;-F<5!7$')SO/P>I]QB537509_(*<7VV5I,U.9><1J MPV9H2-U8TR#%(M`QO#81TE(@>BN81G";V+S']0>R-!E0F4?G_HA=(W8=`[N` M66`$>71F<]PP2#+;X]OAUVM./I(&."U70D0E@+(+@(^7(F5NMQEN([Q6012Q$G!AC2C@['LNWL$3^E MR6KH[!3RDBXY0\MC6S`@D:8U<1OS=IC2I[,-]""IQ@%/]F'6<P?7!@>[`%O@[T_:_-9V^\;JK,B;=. M,/-J>ASEU$RHXHIN>Z#$"7G0I7";=6H8DJVPC;.,H"??,4$=DF-]UE>3^LI8 M;JZ92N]FNX`)T0)-6#505OCRD%M-&D9]'9#T M'J&%=TAS/8_3##SY!`;FVK@DU:O[FNS$28,P^[6T<3O%7NHT-#"/@"-"\>/H-YR-D`?E6.L]'^E>:?&5WJ;"U.:)TRW1FGNX*RM067 M7!D@N\(5D2.[G+X<(53F\[BT;H2_>Y6>1I`:06H$J>."U`*Z2G06%ZQF_+@U M.!/KZ-\22'?GE"QN+:'6"#.,;TRC\AH?'/!`0B,T-%N=>A%*+;%9IW8?XU"= M0LYI]G4^5J:>32,*3X82&VZJ>E6)@Y>6FS"--&@L8!SW&:@RD,`@I5'OBK!M MGE?0VCW`B?]OD.&PGX^M3=>&#+-:347DR>[X!5"&=.Q1G]XW]'I]*]-:.B'2 M?I#DD=_QRU+.^Q+!620>!D[1)QC;_:7WEV+5_`_!U-L8EQROEW9714RU_AXJ MW@&CX+L\F3=@?!,D=1&FM0_K'ZM&:O0LXAL/DF$;_+1S_W%Z\YS M^:DB3@GG4D?0YMDA[U]$OG][#.V>/U1)A,[<;BA_H$4&#BH@?.9:!_T%%VY9 MUN#&E6S66YSD^PY-A?P\$$<=*N1WS47$HKZ("&WX>[$A=Y;M8#E',N`N MMG;D+JFHYH(],7&R0>%:3HKMNU?"152+D/:`BV(:A`*$[IQI;S@'6QX?<$U& MNK7;@I8B=OWTV@2 M*.4T+R81FH33[@TQT81[),Q/H^6NJBG@O$E7V6F=)LRA&IS;7]>*#3J=>CO4 M1WR0Q*AH;!M-`[)(#>V7:720Q:!'#`H+H?(<`'YC%3"JJ$S"^V2D] MRI^7.4P*&3#V9%%'6I<[%+(T97ACO$KC=6YI$R?-P\)AUS,8#J_1JL?AF_Y3 M8&12VL!''2$H"5?1/D9I0QL,F4?\J&_):?QIO-JF>,Q66)%1SWF5A#F^G#0Z,[V'DNP54]PCE M07RN(?Q_M&=^L:A5(/K]3S$=X".C]Z\WZ".=5\_XU1??_>.%!WX4H"#TGJ&6 ML-*@\UQ[)\+3A`AX^9?9[*VU%1UT">ZC"S4)E+WKIBK*'AZ5>9[8RF]LR_G6&\KR;UWW_-EEF[950OJJR;/&FU[`?^VB$@CGW"=9L$!Q^9 MA#[Q!!@P\TWYUX'#0R.RKR;^>\Z:2G?S(P_9.O;OHGP],_^=W3 M/QV8_NE7-_W3X>F??FSZON7V7'NVSVU.7'>8TJG/QJ:_;C/J`5C1Y.S-XFSRF$L*SY^2WI.*SE-ZOB]?-\"LS+;0 MA-CSGOJ#VWAE&._IX6??(^BGVI1:^;J^B+OBJ,TO7S26H4[+Q4!;I`$(FSY_7991[\8*R/<2J)[AFO'RP3O\6Y9 MDHZ"#X@62=9R\3I2YZ_E#T&(+:T7]T7;X:"K>?1H88P/,&,5M37B\0BR'$.6H5+<"5AEC*.>/[[6RIY]C98>_ MVIE?(#D7S7KVS:GS-\AH[N'E$XR5_OE_4$L#!!0````(`-.!*3]-#ITXT`(` M``H*```>`!P`8VEK,#`P,#&UL550)``.N M4:%`411;&@* M"F;FH*^DUE.F*)@\@#%;40-NY-04V*Y4^4$#L"UQ/%`ZEF-A(VPAKH;9"MM69[Z*)18U%X-QSDF%IKK',5DH2187%',S)]9WA[L4 M!'G`2;@=7^Y5.JD#W'B$#A&^EB;<%$PP)SDO>SNPY55%.H:W%K#;8KHV5*0T MW:XRXP38#B/8`#ZHN>SIA@ZX/&!+"&I&"_C1&W3[5^-1_PI9.?TWWJ?0E:JT1%JQO9(DF:RHWIGMKIJOP"L2,UB3_\:M_U]6R%" MG6=9FV M[!O31K%)7O94I#=4K1BA*)J@0Q8^-_+=6_JJ0BN+H_]H\`L``00E#@``!#D!``#M75MO([N1?@^0_]"KO"1`9%TL6=)@G,"7 M&8P1WU;VV218+`:T1$D=M[J=9LLCX^#\]R5;+>O":U,2R7%X7HY'*C:_^HHJ MLEC5Y.>_SJ=1\`I3%";Q::5Q5*\$,!XDPS`>GU9FJ`K0(`PK?_W+[W_W^;^J MU7^<]Z^#83*836&O,`L>DE'V`^!/ MBN<'K:/&4;/1.:H'DRQ[^52K_?CQXR@ELJ@0/1HDTVJUZ.T<(/QTW"[OMGG4 M>/_FHN@YB3\%W5JS5VO6&XV@T?C4.OG4;`5G-^^2-UB542@7C<+X^0GW%V`^ M8G1:60,X?TJCHR0=XY;UX]I2L+*0_#1'X8;TC^.E;*/VCYOKA\$$3D$UC%$& MXL&J%7D,JUVCU^O5\F_?17'WP^Q==AU-N[;X$HNB\!/*N[I.!B#+C2E5(>!* MD']5EV)5\E&UT:P>-X[F:%C!=`7!YS2)8!^.@ASKI^SM!9Y64#A]B8B.^6>3 M%(Y.*X/PN8[_Z]1[C5:]2LBO=YLGY$%_N"P&4C]$SWV8S=+X83:=@O3MES@" M3S""P_,(#)[39/#\#8(HFPSP"/DZBX=7\:`2$`"_]*\V]'Q:RI-Q5",2M=TZ MJ>U-63(0AK,(/DSP\R=)-(3I5PC1'C34>/+^U3J+XQF(2`=W+S#%(S`>?YF_ MP!B)@#1*ZZC;S?X5+KK],@>D^6,*8O22H+T,V5VZ.+2BMTD?#N'TA;@8`TJ7 M[^Y00_LQR4"T<"""H78.T@O\,\PT!W;93@Z@+)ZKP9@!YR#&WK&W_:E_&:)! ME*!9"E?SQ"7,0!A=@@Q\B2"90O;AK'?OJ*32Z\L&!`='X^2UEJ9D%53'_R7KXM5X5DW=;.L4[P(]+![`E6AR$>7V0M7@F*CBBL MY"EAG-6P:*V0J3$?<$#`[[U4A\D4A"71TJW-0(4C,(LR;:S+Y@<$"Z*H'+R\ MP2'9RPU4G<+I$TQ+,K?9M`")60SCD"P7KC&<`A21/VR6?@ZO;BZ,_+<(QK'F4##9@1"003-)=?%R:?K_'8?T+'&0S M]`B>5F;.$9Y66`(U'4`9F"=Q,L53R6+`S%!MAJIC`%[(N.G58OP#R?\UA"$9 M/;UJO5'$HW_`'WV_AF,0?8DQU6]G\Q!MP61*O.-<#9FS=!,Q'FK+)Q6C3M-5 M)BD.RDXKC>731FDR9;-7=)]P0+^D89+B?YU6>I5@AC">)%\;@\@2\0MPEX6? MI5C?_/I`E-/^GLVW8*`L"=_$^S.S_?WDN-6N-QOM1K?5K+=ZO6[/A`&6D]A> M+,#487]&$<0#&U]]?R!_UYO-ULE-,=ML4"\3/A3KFQ,@GW'6J"%TRW#O8\3K MS#3Y1E:^AF?X+./3A>#W[FW4N5]!8?H6IH1E9ZXP8@K&:>@_%=-. M.G)]]MWSZ3FX>XPRSDJY=T8[FYY>,+A$SIZAQ98!%C';IQDBWNRT,@(1*KW, M5S;+10ZLW>FU%6Q!"]LT0.GQ19N%5LC,C^&]7Y4%#BULE/7FX5C?S\JG/.N= M,JQWK+!^?#C6.Y98[Y9AO6N%]=;A6.]:8KU7AO6>%=;;AV.]9R>V6FUJGCVA M+`6#C%YWLF0.1'N^J\Q=Q?#!4B%4$6")EH_%ZF60Q!F<9T6"[;2"X)C\L?H^ M(LG&TTJ6SG3W,'7,\0T"4FHELL:[B,U95L4L#,@KPS1,#_F[IW_A(1*^0B[% MM(3-&56%81JQ"P3?IR%)7#SBG][0WO[> MYO2IPO(V7OO4WH*4E)>]0L&P%H@:)?Q$FW`6=(O<;U4P7H"\8\X6&4/.*.N= M\JSS<+M#>;Z@$@QYB;A1`W1W-L`V?)NSZ78Y*W?P\R6-LM_3F$NYR"T2+Z@H MEOT82C0UNR]9+V^;$KK8GYR+XF#9\F=;S*P1-`);#FYG""^Q*!*T,&L&C4!6 MKH(S%OE[F$W6*N0E#JM,6[-6T@B&RRCCC+W6WV84I=QG`ES1K"8WXG`_= M)>8%OPJ1K%GV->)T$7B;L3K&FL'Q&W?`4P)FF=8)R+<1.T"ORBI7)&N6=(TX M7`3>(O\$MS`?9BD3IA%-;Z"U3*G*<.;)F25:(V+F`;?(^?+MW+-XN/::7[Z` MXHYNE39F;:$1-JLH87/ULL*D\I.0B)NUAD9X+,'OP`]$^FNP-/0U(EP*L0/T MRN)6GIQ9LC6B5!YP!SB_B!*$[:_`.BUIEG>-F)0/W0VO+IYB'9E7=:)1MR=3 MF9\1B)JE7B,\%6!WB/R2RQEN&[/FT`A<5920V^5S;?.0@!T/#M`X?FN=4=%I M`?_8O/=?_BLW_QV;_X[%]\]B\^?[P7G[)+B`&E<+B&/,>932@?J-K(\NO9I0PFUL3: M)K7N_0FJ.];'FSO6B^X"\IS@O<-@V:/?O_;[UW[_VN]?^_UKOW_M]Z_]_G59 M%^+WK_W^M=^_KOO]:[]_[?>O_?ZUW[_^>/O7U"X-?P=;(&IE#UL*_>/L8L=@ MG`,AVX)DE^\,(9@QPBV^I.6]:%5;\16PN.%\&6*LX=,L)RT>/L#T-1S`1O.I M(;.'>DO+6\^J]E%7R.919V0/?*F(R#Q<0'G6'AR5A(L8M`?);NR MJ24Y+KK>D!EF*64YJZ)D(#9R^SO$ZX".E0@_MIXFT27\V#7"VTJ$MZUG0G0) M;SM&^.K&%!'A1,IR'D23<(+TV)M(4ID3\'MTFPZMIG2'R&Q&=( M?(;$9TA\AL1G2-SP&SY#XC,D/D/B,R0^0^(S)#Y#XC,D/D,B4LB5^Q%5LR7L M-@YD3D3*?,PLRKK&:AD55@NGLBL*1I1KY,R>-`5.FH%AM7`J&[.[@5S*TE#@ MI!D;5@NGLC>[&\BEK,XV.'F&A]7"J6S/S@:RF@5:'`7VF&0@6MSQ(3AP;'G3 MD'KNYX1Y[EC>6U!TIY+D^5_<WR^Q^=[?+['YWM\OL?G>WR^Q^=[#KJH((7^41,YB9VNQ MI=6LLQ(WM(3E1(V*76C0%G>2M\`TI1PWK>=:-#ANNL0Q([]%2UA.EVAP;#=E MM06F)>6X93WCH<%QRR6.&6E`6L(HQR?[X-AN9F\+S(F4XQ/#''?VP?&)2QQW MI!QW#'/67),IX#W>(BGH;$6\SS)1U8U`O'#I?]_2_M+?#_ M_>2XU:XW&^U&M]4\;O5ZW0-NT:],`D=@%F6'L@E3*8MF.AME,'T$C-$-N?(02CZ!A_LDAG7>!%WE4\A',%MN6-+9>.E3>!7"6; M^=_UY.0B/<@O$18*6RD45H#_8/T3/"S"7,`-A=`DR4#A* MP7$@ZN4LW:`:K'K#_R`=UA8]!HLN`])G\.NR5U+)\D=))O9/&5++Z2Q5>R'&(+U5>R^$J6W5CWE2R^DL57LHB$?27+;JS[2A9? MR>(K6:2\.[2H_VDK67R)A"^1\"42&J&Q+Y'P)1+_\242JTP7OS*")6.E(((/ MUNTZB/TD5OIP3%PHB+-;,-W.OO'%+,\48IOQ85O\3:Q&T27(A&G.Q?>6)X42 MOXH%7B?<#7:%PS`>B[S-NXAEER\EF`'9(L=W3__"Q@Y?(9=B6L+R<6I2AFG$ M+A!\GX93D+X]XNGC'#_Z6<`T+6KY=#5URFGH]F]/X@[M[>\MGZ\F97D;KWUJ M;T&:`F)WP;`6B%H^;$V5,2 M;HN4WX!Y.)U-\VT(- MQX7WY3LXOJ19(Y0-9(70K?XH8C#.=S:(WR6CX0PAF#&R8GQ)L\QK!+A\Z!:9 M7]_O)MO=,'W%'K+1?&K(+*'>TJQE-")C=55L>B?B'Y<_6I%AN()F[:`3/_.0 MVX\WA(S;)ULC8%X34(EFS M[&L$U2+P+O'?9^_GL\7,LJX15'-PVW?IYRD$SR\)UIR\Y);,8H%K9\J:S5EI M1,(R!F MPW:+;<8E9VPILVQKA+ULV&ZQS3A=@RUEEFW]N'<+ME-LLX[18$N995L_<[P% MVQFV;Y,^',)IWOGY&X''W?-7;FC6)OK)9;DF3II);:IEM3!K&(U06:Z"NQ:1 M3L>L%F9K$O4C:($*[EI$.F6S6IBUB'Z<+%#!68O(IW56"[,6V3E:9JE@LV0) M(\[@^(V[1T$)F.5;(RRF$#M`K\J.A$C6+.D:$;$(O.5*=6&-NJ5AK1$%;Z"U M3*G*<.;)F25:(P#F`;?,^76"X$T2PS$H MA,.'#&0S1J*++VF6;HUXE@_=(O/+&W+/XN':RYCY"W]O((P*C:!7#-\]*_P=/CV$ M&3P;#E.(Q#\C43.S=M%YBUA-#S<,=`]0=IE`=)MD5WCY@I\.O\ZP&4=)F&58(\:C(3L095]$"<(1OR"]P9';I%Y4O'TF)`# M#!?8KPG3-.T<,;.<:T1]'-P.#/5M9.PS,<729NG?(;7*AN^@%=0M8/JD08UP MD0_=(O/?PO$$HNR_9Q@83*,WH=L1"IOE7R.8%*)W8/"S\8D=D:B-68-HQ)XJ M2CAKE[(V,6T/C4A5IH!%6UPG/Y2]E$C6K`TT8ED1>`=^"TQX8A.HU/1PR$"_((B*Q<57B/4&$>>H*L5V9DVDG['$_]-UH>0'9PR3Y(;Z14-S0K)UV*VH6 M:^*0F4J^)0?%:9 M"E_4+/DZF6@^=O?(9V9.^:)FR==)4O.QR\G_7%NI=8T?NOAP\[.B.UJO-2OD M.CW`-(2K:W5S;K`/A/%PM8[*PHP\IMZN8WL%U>`R&+^+[)6OXCW_:YYE=MX*6&SQS33]+*&`^,>7@KW MX9UM'@`H^]KFEJ]=M/X0KE8'4'YC5M<1ZKPSK/2NLMP_'>L]&B3H/^!S0+% M#!`GMO.PG<[LPGD,)MADDB;9[A:#8J#8=*Q&EEQ1SN/?E]3#MD1>DG(VO!HL ML+%U+GGH>W3)2Y'BIU]>9@%YHC'SH_#S5F>GO45H.(K&?OCP>6O!6AX;^?[6 M+S__]2^?_M9J_7%\/MG?Z>QT.[V=-IDFR?QH=_?Y^7DG%EB60W=&T:S5RFL[]A@O MG=NEU79W.LLK)WG-47A$^KO=P6ZWW>F03N=H__"HNT^&ETOD)6_*Q#=#`S]\ MO.?U$?Y[A.SSUAK!E_LXV(GB!V[9WMLM@%L9\NB%^27T\UZ![>S^<7EQ.YK2 MF=?R0Y9XX6AE)8I1V74&@\%N>I5#F7_$4ON+:.0EJ8>,O`B($)]:!:PEOFIU MNJV]SLX+&V_QWX"03X%W3X,+#B$IA:/D=4X_;]&7A(9C.M[*OXVC@&J8B,LI MG:Q046PT*A48B.9$<5'>-*:397EI68R.=AZBI]TX%NYJ\_^WQ/];[6ZKVQ=\ M?XKC'S<^>[RAR2(.A_AJ3EB M=Q1QW\Z35EIB83Z)HQE((J\R`@`_@ON@RK1$,Z8L6L2IH.Q]LLY.]QMEM7.E MHC":^91E)!=LEP>:!\^;"ZZ#W3`* MLT]CZ@N9#EKM3B[3G_A7/T[S^'/':ZJT1K[LUMD0/>'GZC5G+E97+'FW@!"! M:8![KVGL1^.S<'S*0[VF214+X%0)*!@`&LA`Q..)@*.*(NS,/&3 MUQOZX(L8%2;?O)E*%6J8>U'HZ!::4&&<2@(F(,?^)8@(%+H03K@Z8R\XY^.2 MEU_I*]@X"80HDL((QR'J8<@#U5@$JR^!]Z!H5^6Z M>_\K"19^+UUTZF]%S9*?EQ@B0`T8%*2)'T^$#&.",@QO2*"B6QT1K&-0!@0R M`7@\4&"Q1P,%H;/)A(X2_XD:!%'!X2E"2;@JB1((11,*!K`HEN"WJL(^][^. M(S;GE2Z8PO&*Z\YS?C7!/-\O7W29ZZMJEAR[`FWLT)'_V.;_>NU!9[\M_-=I M][N'J?=*EWXF>(:AF^U<0A`GA"LTI?G@_#K.='"I0]W< MMU?W_\W&&Z"3981S'T,D9%/VI: M(D/Q'`[1KGJ^BD.1@)H$K(5MDEN0[\*&I$9N=''V,J MONC2UZJ:)0?G(,>W>E[K-R^./:$NS:VN@6(Y&J9=]KF,0W`_1`)4PM+`_9U^ M.^6)P30*QC3^0BD[\>9BSDEN&H1S+@@]X5P-:I!+*>@82#I8`Q.!)CD\DP.* M$-)40Q,C#'!L6:CIJ]51QB**1$7$K)7OJ9FC\>*(',,P7'B!F):2Z)NB2`U3Y[*IW:Q<1]9V+H55 MDY3\=#*U)Z(`HE"=RQB45WKVXLWF@3%%J<*P!K!JNN7!:QF#,'!5$0`'K3D8 M)XW)*Z^1S6@LD#5AF]N`<#REU,YT"M$@9CSE%OSN)],;.J:SM-LT]5=U;)%5 M9=,PI;YTAGA*,[,R:6Z;B#+(JA#$7NM;M*)Q_/IOZL7@0-K:$#N*F9JD#F:0 M%6),TU,RR^Q;M":R;7+\2D0AVQA#<[AE]2*=SK)!NJL1Y6"S9BAOLPA7DI[3 M^'8=QFF*%2AO.'#@D?_-.'5S!&2`#W\\EJBL4,+*FWN;`B'XE;C':T&N7:V]9V<^AWQ+C[F^?#4BY-A.+ZF\22* M9^)E"VFF`=[<-C;.Q6'?D%PH9@.7HK%E(Z\,]V*26A(O'),U6Y(:N\X35O7; MA!8#W'VV8$._2!AT6*W`.PT!%.)* M=L/F].H:=C<[EB^]%W^VF-UZ`65B?/-`SV?SB-'Q57C-?X:IQRB[>J+QU61" M8][#7)Q<#3A_V45D;FHZ:-+89]27G5,QVL_1MKT9$IC M\)?3&V&)UJ8I98GJ+!`$::8#RJ\P5>K0+#D2Q21>K0&:Q]&(TC';)L]3?S2E MXGF_ST@0/=/8C3JE#0=PQZN!XN\:`CI?$(>Z;\C0`EE(%+#W$8?'0=%R"G@8ACF1`&GXM6F_OU"!*=A.+ZE M\1,/6IWN?<>D"'M+YPJIVZA<,;9F+A54CY/\HKHU<_%\<9?W1GD9Y`,OI=7Y MF([XW?0\HKZ[3UXJT$?HT2A-7E=8^7NY<50VH,TMI=/SGR)3&C`(RM69_)[1.]'MR MG=]D[\K>P>X8."V!<,@[7X"$1`W"V]5B2$4J>UC!0O9Z MF:S2YQD$S^/K]9OW+#V7=V5NDTZZ7PXK^MJT0V:E[B$K M=6]CI>ZE.GBGKK:>5*%&`!1=:?7`BOQ!,[1Z8-;J`;)6#S;6ZD%SM`HU`J#H M2*N=M@UY@6J`5E=D0:UVVKA:+>K?9`30;HQ8P59`'!WOX[?-6M0V#=J[;Y7- MJ`R:L5^_7I93V:F/D?2LD[=+@%06#1*016(DPYLAGGH)4^7](HU(EZQ;@Y8Z M20R-:93*HFEZUZ=7,KQ!>K=.NRIZ;T;29=T`U3%-,Q)`Z_8X309+ M._K@_`^`X>Z3!+(\)09MEZ3I:+7E_K@4[29YRQZ79F=`\=8HDC49@?3*;)ED MZ[6)X5Y%XR@AL M[U83R^IE1.]"F9;DW3T,[^X;^>_C>W=?[]U]1._NVWIW'\.[BA1:1F![MYHB M5R\C>A?*&27O'F!X]]#(_Q#?NX=Z[QXB>O?0UKN'&-[M&?GW\+W;TWNWA^C= MGJUW>QC>[1OY]_&]V]=[MX_HW;ZM=_L8WAT8^0_PO3O0>W>`Z-V!K7<'"-Y5 M3=/*"&3O2M.PU[;3=>/>)QMX#72<)3U-JP>Y];J9>N!]&.E6" MB88LBLR"E,3A:!)3)@LM/=%`FR`*Y6(3$(HGC#$@##/PIFG2YT"HS` MH!X`LR)@"4;B MG&RC(;U^MHT"YOQT&Y`#<+Y-"4\R`Y>B6'M7[7F8_B76`)X'P8*E)VFQ?WFQ M[]W[@9^\7DVR<;9",1L6@_E*XOK-E=]2;%\&THN+ZQ+4OLMXK3"R5AI9*TZ\ M528O$$G%PR?/#W(VUU,>8[6_CP*-J4F0O"P]"8JD,("'5DCK-B0U:H!8?J?W MMWY"A^,Q_Z'T(4YGUA3YJ)NCUU'9I@&"4A&R5Q:W9MR:Y.9(&KOV6'(:4?8M M2LYY9\]+IU\6/$+J`Y/&"E-AQL;(`@--D/1EX*.5E[`EPI@/W!)2F)/,WJ6^ MBF7\>4-NZ"2@HR1]D;)X?[(B?)DMT#9,F!I1V3L!P3&V4>BY:'94+$64F^8O MP4Z-70I)S(G?1:=BX-#=*E.HPT)('D%F1I MHN]?_A3RNBW']5O@OA]4<]3WACH;O$-YC0VIGM,+&J`Z M;6V<=FKIICF:J:D7)TJYB)ZMNTT=UKE"S,1S=:Y+$7.J:Q M%P!KMBWMT`6F;Q"@,+41IL1TC"PT)LQ),=C/"W"W%%PZ0EP\*@KHDQ#=:*!0,&57 MX?K9J.R2SNY5Q[(;#=QO?[1K0K$)4H]VNA72AHJ\_CQ[6<*PB!M\G!2%I&2/ MJQQQ*J]("FHKJ&K8'"6IFV125-FJ$+HY#3U$UU8>D3F[=2+WW0L M9N*]1&$T\RG+&KI@NPO6>O"\N6CO8#>,PNS3F/HM\4VKW6GM=5(Y\J]^7-`' M+S@+$S]Y571C2H1;@6E("B4I+CN3#%BWI(U;&G,/O;V'>JNW,Z*GTO^;4PW+%@'LW\>O(?VSS?[WVH+/?%MU%I]WO'J;^*EWZ<2O^ M;G>[^X?*#L($=NM+.^K"LWJD,S_;T)"]OH21#.?VB=E&G(\OAB>_WER=_$J^ MG@TO[KZ>#&_.R)??OIUND_-O)SMN$J@X8G,Z2A8L[?W2G`Y(H4"D^R3*0+I( MHP"8TT1*RT&6L0#EF;7#%&K%3=D=*1'.O0Z1S+U=O>S2R^JZ==YUUD.EM5WS M>L.D5F>EL&M&OP4V2->%24;HO1G`J&XGD<>*K*!WE=1)2OV@-SBPT)$,QA0/ M1%U63!6))!,U#4D;*U@#!CV6G+/7BT0Q&;XAWZXO6IN1N@QNA&B-(_4J$ENT M^E'O"M8DT>HY+T5[[%2TO3JB[35*M#UKT?::(=J>G6A[31*MGO-2M"=.1=NO M(]I^HT3;MQ9MOQFB[=N)MM\DT>HYGXW@T;I=F"MVT$S M=#NPT^V@2;HU<$[3L)NW/T-ZR]H':/(&1C9@_8-R,@>"X:Z!T$[N'%..IMG# MQO>=V[D^:+=MYG+6<:AS-S)AQ5S-"H0U-U-E(,_?$0%I0%"RH/IW;S;_QS41 M?,_#,7TA'^)LN3,C843&=+P8I6]3XZ(E$TK9-J'92T$9X=\D0L4?WU7&-PO& M:!#L\6^^4B](IB<\' M5F-D9D38DQU=OC"+YWQ><-?_,/_$_ M[CU&^8?_`U!+`P04````"`#3@2D_U0[K<8X6``"GY0$`'@`<`&-I:S`P,#`W M,#DQ-#`M,C`Q,3`X,C9?<')E+GAM;%54"0`#KG-J3JYS:DYU>`L``00E#@`` M!#D!``#MG6UOX[J5Q]\OL-]!F[YI@3JV;,>Q!S-;.`^#"6XRR2:9;1>+Q05C MTXX:64HE.>-@<+_[DK*86#))D8X=/H1]T[GQH7C^_)$2>7A$??[;8A9Z3S!) M@SCZLN?OM_8\&(WB<1!-O^S-TP9(1T&P][?__/=_^_P?C<8_CJ[/O7$\FL]@ ME'FC!((,CKV?07;O'2=QFDZ"!'IWS]YU\`0S[R:>9#\!^DMQ?:^[[^^W_?98^?FLV?/W_N)]@V+4SW1_<2AJ.P(INCHJEU?;WO=??CDN:HZC3UZ_ MV1XTVRW?]WS_4[?WJ=WUAA>A]HC2+WLK#B[NDG`_ M3J:H9*O3)(9[2\M/BS0H6?_L$%N_^8^+\YO1/9R!1A"E&8A&KZ7P96CE_,%@ MT,Q_1:9I\"G-RY_'(Y#EA&K]\I@6^+\:Q*R!_]3PVXV.O[](QWNH#3SOFDZ!WD_X?1^#3*@NSY+)K$R2R7<1I"_%.ZY^$*?UR?E73=A6#TD,2C!]P9 MFMBB*7?1YM;%7`?IPS7,YDET,Y_-0/+\(PK!'0SA^(@X^PV",+L?H3[\=1Z- MSZ*1M+C-*MF>6-Q5Q_,0WMRCZ]_'X1@F7R%,MZ!P@RMO7]8PBN8@Q!5KIXA%'*<\27UKAI-=L77%1[N@"X^&T"HO0Q3K?29=]2Q:Z%?H^OX1C. M'O$]X1U$RU>WJZY]&V<@7-Y`.%WM""3':!AF&W9LV4IV(!;-)L"4XLY.8+^Q MMBT^BH)T%,;I/(&OSXD3F($@/`$9(`^_;3R.WER1I.C"G7RRDL+1_C1^:B8) MGJ>UT/_C5F@U6NU&NY^W0]6I=5W5"^6JUHOMU,LKF.03$S3ENX``-^9E%#X+ M^KI>^)W;%(/>L%V710MO'Q.8HLZ23\_.D7.%B[C@=F=\J\T!%QF,QG#\\M<@ MP]7A<=7RO89'KKCZ3Q"-O>7EO97K>[](#7\LY\=(4AB/2K6%>&8>)V]I_23Y M_;45AW=IEH!11BZ8SP"_[%%M?N]UN@>M=JO3&O3]5J?7[;5)TTMZFH%%',6S M`*;+-<,\;:*UWQ2`1[QTC.%K^UQ@&>.4P:+3\8N7P)_2GWTE#WJ*:*IY7 M?RZ<]@_\?K=]V!T,^H,5IU=[S#`I"P#)B%P;_7.M$Y47.X5%\Q'=F**L,;H/ MPI<>,4GBF4R3%D[$@F+B!,UOT5IZSYNGR,4XGQH`=,=Y3((X07WLR]Y`,2=T MAPEB-*#&:+CR@)7LK"%7KZI`V-80X?(V=0VG`=8=9=_!C$:09F8\0&%1!;^. MMOR.4K9L:#$Q95\.MIS.]T,H&C+'B"-0!+=M80K%=5 M(#S<`4+Q5/R-%Y2J&T]KO1=,34%%3Z(E0^-ZNKY:VMH3?;6!!;4_O5 M-36NK+FLS2NJ\WZ]5/@'LOCST?GP^+?KR^/?O&^GP_/;;\?#ZU/OZX_O)W_U MSKX?[_]%;K'-B9F5?OJ=+9:QZ)8M_MIG>GY[,&@?;+P>WV3,W8*[D#OH<@-M M1MU6&I+@(4LI#KF*A#4K!MB\_VT3$:$QKZ?E) M/`-!Q%R]+7_6AI-HL].6;!PINZ`D?%._R>.Z[7:W=P%G=S#AWL*KQ@:3V4`8 M)Z@%)S!)X/A\V6A,(;F*#"8IS"W?\>&69PXO\F:0&I!KY?0D)P"B?HR*:67>5G?$\#CW[^!P<"``KFIL'2TA@V@[7)Y`SNZ"KG#[,G#[ML/E">3L1^@* M=R`#=V`[7)Y`SF:%IJN8UQ:AA@LH%A:0%54EL'&Q^R#JF]*O-*,DN+84E".0 M2/&>>+Y!@-],XM$I3'2"(]C6##X\03M,-1/'E2R9+;&?,.*\MUPU!X:*F4WV; MT`+S0(%F[`$LK):C5QES8YT,7&$H=KX"NF`M6/0L@$G,KK4QD6(IW51$+J=+9S$ M(QQMM1$.XO!Q&*>H8PD`JUK:@DQ(%X&F.,(A.A.Q=/JQR9Q#;6"CZK'8?,.N M>Z.<,,)-\7%&%9\E)XR,,K:1E)PZJCH+:8-/$*RV/>\`I+;7\,CE\3]?:_!P M%>A/OVI./)(\7EC/$X^ZK4'7'[3[./'HI7'+8]&=>&3(&U?NQ"-#SM5Q M)Q[I2L:=>,1XRKD3C]R)1YJ\]>U./#*7ECOQR)UXY$X\,AJN._'(8KCNQ".+ MX;H3CXPG*ZI*BQ./*F%P]K%'#$,]>0FN,F4T:7$`T@58!+/Y[`:$,,7[U5-X M-LL_/7H97OX[U4 MZ)$:/\3>I=_I^H/>H'_0=7N76]^[7&UI`TJW=^GV+MW>I=N[='N7;N_2 M[5VZO4L;:+F]2[=WZ?8NC8;K]BXMANOV+BV&Z_8NC2=KU-[E6ER!*4TZ5)CN8$9A"_(EXO)F#-V*&:0HS2FR`9:D3,3D`E=TI"7E:;#:>!$A; M<#?/FS8:W\#D*1A!OWWGUZ$4+6D)VC?)U>-K,7ASE`CGD6486@)21IU.GXOA M(K.6EARH-Z\AXPR$Q4ST?1,#RD>JWB8@2O,4EFV\PMPM)P4457E%7=ZOU]K^ M^!`I`?B-V_[@H'.H>4I`W\24@-7&%4X)Z(M/B"`FVSP5^][[+U6_2%S#P[\P4$??SG0Y1YL/_?@ MI7%=[H$.*%WN@^!R#VR@Y7(/7.Z!RSTP&J[+/;`8 MKLL]L!BNRSTPGJS!N0>K87/1/`1:&3TI;I23("Q/P_R$5=_%IH[U614]ZG<=\MJ\HCJ1](G_135[ M>=7_9T4FQ<&@U_4U_RB]L9D4I'%=)H4.*%TFA$R M*6R@Y3(I7":%RZ0P&J[+I+`8KLNDL!BNRZ0PGJQ1F10DZ)VOR]C)$U0S/5D) MKC#%%6F1(K'<6UAN*J!6H:1$5"UTHB/>V"5&0I*T^&!#Q=-V+9ZV?7CHDK3X MR$+%4TKJ2-7"/CS<;!"UWU*H>-JMQ=.U#P]=$F>QI@P/)<6F:F$?'F[6#&VY MI0Q/KQ9/SSX\=$FU>`[MPT.7)+``>G<\_5H\??OPT"45>/HZX1G4 MXAG8AXY+J_K$'%LM0*EWCKUU![Y_B< M_,;A!-UQ;\$"II?129!F27`WQWZDU`=??0$;*&XBD;GD5,5O&(UO0`CE.98+ M6LU30"KSYKJKB-W50:LE$J%[M3,>D9PRHZ8[B\9P M(0"XKK!EU#>2JWQ!*7^[7LT"6>9AL%_VX1B7FF-@V-Q65I=`\O4[3)36G68= MBLHTU8F:+(0Z@AR%>KP9Q'"9ED7/,K6>'UVA'J\.T5VFICJR3&WGQU`H\V[1 M#C(@T91[%,9X5G`=I`]+;T]@!H+P!&3@-(0S=&'.>9#BR8]]K^&]UH;^`U?8 M7-;H+:OT<)W>+U(KSGO\XU]LR'L<]%KM3D?SPR!5#LFM-&XY&"2@5.-, MNK?E/6H\)UV_HXJ*T9C6IGF/*CF)-GL95*T42_(>S2*S@3#E63JJ\QZ-ND?* MBK(Z[U$;<@(@ZL>HF%9S\QYMH"4D4/D=54'>HU5P!1Z7'RKOT2JX/('F;&IM M+^_1*K@\@8_:T!)=8XI+LC'O434N\=:O MH?;.\3F]\AX-I;B)Q`^1]V@;3P&IIN4]FHA(3IDY2\3WRWLTG_I&PPN7$[>\K7<(J?'2#*OH-9-: :83.4$0M%UF M`5%:)#>^=LX3D'&3;O#O1L,14Z-%RN*K-G1K'P?1E'?/*TQ,9R,F2(O3SB_O M_HDZ4?`$F72J%J;#$=*CQ5'G+YY>)<$,),^W<)$=H4L_<"!53:VA)21,BR/0 MBX_;,P=4^7?3`0FHT>+D\\+/[R!)`.Y/G,'$-+6$E:`P+4Y$S_5P-'V8]A6>S_&CER^AJGHSN00K3 MRR>87$[0"AW=+M!-?429J6]T&=-9;T^T%H>Q%W).BEC,BJQ<1'9/BTL+%+($ ML[1$J2/<=SG0I'01:&KC)JM[57BK"B9/Z'[OM^_\.HBB)4V'^B:=!++BZ`N^ MW9,;"8\IP]!TA#*R"#&U,1D16/9QDD2TS3VY=]U!B)-L$H=!?(M:)T9:F3$< MEJ7IH*5T$=QJ`SMK+G,B.VQ;Z\`)Q79\M<&=-:>OZ1MW-#/K@#%%$59J0SO% M(^`H@>#A,0ZB#)\Q$<\CS@.08FLZ-4EE!)W:4,R:TQ=!A&,09]$33#.\*KJ& M_YH'Z.D\G&$M`D!KKF`=YDWTDNUWM1&;0LKI`LP>P]I-J;*9)1@%1!%6:@,U M97\EMJJ8)>PB*+=QU58;P"F[SCHFCV9E%[3Z,_':VWR=5S'BCA#BCH6(Z9H( MXFUF;"M&3#DLD69E(6+^R8BF1GW6A=+.4Z19V8>8?WAB>YLO^"J<6,77<`QG MN8:C9RR;N8LI6-"NCB`GD_0-M:$DM@*QF==Z"7N9"LS(:+$FLP>ZV.QLO83E MW8`_:Z/%K2SH!K4SN/42J\W4:5G7#>CZR!L*M`B6^=V@?I:W7L+N;L#01[H! M+3AF0C>X08V3P>DS,_A9,3`=LH@4=Z)XFB,NE"2!I,`CF]0L\XIZ0TL2QM(">LBT-2&?8Y`@E^>R(;1>.4< MDOQP"N;#J;Z,Z2`W5$B0JDTT6O%8Y(G&-3<=I+PXPE!MQM&*WV=1_B_LQ5D8 MSM-\KIO^-T@"$R)_+R;)5^$<[BE_&(N9O%$T.,5";@+2B9_@$@K!P_>H> MS0>XR->L+2(KIHT`5'RN#MWMO\.[FR"#P_$8-3Q_\+*+68I40"1AJS8`L^+_ M%4BSDQBFW^/L#,T!T=7AUSEJ#?X@99:RB*R<1@)6;7B&3`%K9\&637D%YK== MM:$:XFG1HZ[A)(2C+'\/_#P&8\J=M*Z$+>RD]!&8:@,YJQ\?18U$^PYRQ<)T M6$)Z"!RU$9V*J^U:.&W+X-#U$#AJ(S<55RF9&54+R^#0]1`X:F,P%5>[M7"Z MEL&AZR%PU`97*J[2OMU>L;`,#C=9Y4!MM*/B:J\63L\R.'0]!([:2$;%U<-: M.(>6P:'K(7#4AB(JKO9KX?0M@T/70^"H#2=47!W4PAE8!H>NA\!1&U$HNTI+ M:ZQ:V`6'G[9XH#9"0((;QV&K>"XT-0&(;X% MTWN89O\U1V[#)'SFWBL^_<[++F,YR0X4$J=K8 M!M]Y69QVH^1B5!L%.8]_"M]6V;:FXY-41M#ID7)!=9Y_3V46,1WD9@()3ST2 M-:B^2[*TFB.7H=KHB_!+`9:^";!!^G]/\7&^%8]Q4I!`CI10,=MHBHLD;!6? M]UOQ_T<*TV*&]A4B!T'(.`!8J)QM="54$KS:O+F3"\AS^4+X!*+L-KX%"_+- MFWK`K)*V(9;222!K\VI/+N$R@LAD,_GYJK\(FU+ML3W>!A-'Z=MV9!AB_8ZK30_[R&=Q*/YOB; M`.B?^$+-Y96\Y:6\7S^BG#8<_[$GU>M&P0.NX+`U\+LMW,G\5K_=R[M8Z:?? MCT(P>DC0$PBM[L/L?H1(?IU'X[-H1&A5NIU\\5U/.9(X?42KV'F:/ULI\XNR M@39C8U,09%(A((M\0X0S,-H[&Q@KLYX+"-*5MT'Y0^,`-5]E:*QK>) M;%'AK].P_RCLZGDDW^CLZO*\[-*#Z09O-LSG;[W6?Z]U$<.%79\=E.N/;.9?A=] MN[6?OYVU8?_^W,2UWH$4HO_X?U!+`P04````"`#3@2D_+(Q.LH,%``">(P`` M&@`<`&-I:S`P,#`W,#DQ-#`M,C`Q,3`X,C8N>'-D550)``.NX%*.J"!H^(0&]!M1Z(Z/U".&D=P^.K17(G+50P_::MN>X+G+=UN%QRSM$W:N9Y!6X M,J*;1:4_(1%&$`TF.\8"O<<#BXLQ:#FN_>6J?Y?*&9E@:SH4(2V)ZY%"X<"F M3"K,?%+(AY0]K!'7CX?@],S\"_F=AND=%P`^?7#@[\1INH=.+4TH#?44DWFL4D\2:1W,*"STA(\)/<0!J0O/@\NU\162]BZK((D)%W&`/$B8<%-3`0`L?'Y-"9, M$GE::'TD.%03'[I%RUTR'V)!@XZQI8V9!X4/`1E11E-?H49`7T' MB=\W%,$?^R*HG`SN)I":"0\#(B[(NN8M]__KU3:FVRNW_()EI$WOFWRK_.9S MY?D41S%8$)C)F,O-+;Z%_L:,'Y8SGD.@'`,]SU&^[[/_$[-_S0"*0K*85Z3^;\`$:60?^^+H+H(8/^,QRLR67^BV,[4QK(X62J+#&UU M>>QGB>UW"U3Z(9>)(//5_AE1F(9G6.'S;,N[<=VXM96-9='0NX89RM*^(8-" M&@L]%VC[K<-V^\?BM\N"KID(RZBU(1KRA\WUM_ZW]AHJOZ_=RD[R1^[<+,&\=!>C> MNE%8:O@W"D)OCK(R!FU[\9P8[LKGR&T(`1<*L96G^%7?%+)O%GWNIX;6J.@[ ML]`S]9#I>N:!:TUE4'"L0V$>A'H4"KW:%-:=[%=06*4"O^9-"FR% MIYSQ".K%6E`?8QRGVC8)U=R@.3=8C]'R]Y`?),,XR^[`7A67_.M)NF`HM>;7 MN_2U[WF'QUEU]"5E`?WJ:4@$:GCM4CW0BSE+:QEF:KB MOTID=USII3R/3II'9?XKQG>0]'$%Z5TLFAFYDPK2)[M,NE%!NK'+I)L5I)L[ M2/KN]LAQEN:0TM#N4*W>RG\!^TL6D&DY2Z^0^T]3U[:S%SE<_@M02P$"'@,4````"`#3@2D_ MJ=>K*%0D``">/@$`&@`8```````!````I($`````8VEK,#`P,#`L``00E#@``!#D!``!02P$"'@,4```` M"`#3@2D_30Z=.-`"```*"@``'@`8```````!````I(&H)```8VEK,#`P,#

&UL550%``.N`Q0````(`-.!*3]D2Y8>,1(``+S]```>`!@````` M``$```"D@?(\``!C:6LP,#`P-S`Y,30P+3(P,3$P.#(V7VQA8BYX;6Q55`4` M`ZYS:DYU>`L``00E#@``!#D!``!02P$"'@,4````"`#3@2D_U0[K<8X6``"G MY0$`'@`8```````!````I(%[3P``8VEK,#`P,#&UL550%``.N'-D550%``.N XML 17 R2.htm IDEA: XBRL DOCUMENT  v2.3.0.11
BLACKROCK HEALTHCARE FUND, INC.
Shareholder Fees - BLACKROCK HEALTHCARE FUND, INC.
Investor A Shares
Investor B Shares
Investor C Shares
Institutional Shares
Class R Shares
Maximum Sales Charge (Load) Imposed on Purchases (as a percentage of offering price) 5.25% none none none none
Maximum Deferred Sales Charge (Load) (as a percentage of offering price or redemption proceeds, whichever is lower) none [1] 4.50% [2] 1.00% [3] none none
[1] A contingent deferred sales charge ("CDSC") of 1.00% is assessed on certain redemptions of Investor A Shares made within 18 months after purchase where no initial sales charge was paid at time of purchase as part of an investment of $1,000,000 or more.
[2] The CDSC is 4.50% if shares are redeemed in less than one year. The CDSC for Investor B Shares decreases for redemptions made in subsequent years. After six years, there is no CDSC on Investor B Shares. (See the section "Details About the Share Classes — Investor B Shares" for a complete schedule of CDSCs.)
[3] There is no CDSC on Investor C Shares after one year.
Annual Fund Operating Expenses - BLACKROCK HEALTHCARE FUND, INC.
Investor A Shares
Investor B Shares
Investor C Shares
Institutional Shares
Class R Shares
Management Fee 1.00% 1.00% 1.00% 1.00% 1.00%
Distribution and/or Service (12b-1) Fees 0.25% 1.00% 1.00% none 0.50%
Other Expenses 0.33% 0.47% 0.40% 0.32% 0.69%
Total Annual Fund Operating Expenses 1.58% 2.47% 2.40% 1.32% 2.19%
Expense Example - BLACKROCK HEALTHCARE FUND, INC. (USD $)
1 Year
3 Years
5 Years
10 Years
Investor A Shares
677 998 1,340 2,305
Investor B Shares
700 1,120 1,516 2,587
Investor C Shares
343 748 1,280 2,736
Institutional Shares
134 418 723 1,590
Class R Shares
222 685 1,175 2,524
Expense Example, No Redemption - BLACKROCK HEALTHCARE FUND, INC. (USD $)
1 Year
3 Years
5 Years
10 Years
Investor B Shares
250 770 1,316 2,587
Investor C Shares
243 748 1,280 2,736
Bar Chart
Average Annual Total Returns - BLACKROCK HEALTHCARE FUND, INC.
1 Year
5 Years
10 Years
Investor A Shares
(2.07%) 1.17% 2.13%
Investor A Shares Return After Taxes on Distributions
(2.33%) 0.05% 1.27%
Investor A Shares Return After Taxes on Distributions and Sale of Fund Shares
(1.35%) 0.70% 1.60%
Investor B Shares
(2.08%) 1.12% 2.03%
Investor C Shares
1.57% 1.47% 1.88%
Institutional Shares
3.61% 2.50% 2.94%
Class R Shares
2.63% 1.74% 2.35%
S&P 500 Index (reflects no deduction for fees, expenses or taxes)
15.06% 2.29% 1.41%
Russell 3000 Health Care Index (reflects no deduction for fees, expenses or taxes)
5.88% 2.31% 0.21%

XML 18 FilingSummary.xml IDEA: XBRL DOCUMENT 2.3.0.11 Html 11 86 1 true 10 0 false 2 true false R1.htm 000001 - Document - Document and Entity Information {Elements} Sheet http://www.blackrock.com/role/DocumentDocumentAndEntityInformationElements Document and Entity Information false true R2.htm 000101 - Document - Risk/Return Summary {Unlabeled} - (BLACKROCK HEALTHCARE FUND, INC.) Sheet http://www.blackrock.com/role/DocumentRiskReturnSummaryUnlabeledBlackrockHealthcareFundInc Risk/Return Summary - (BLACKROCK HEALTHCARE FUND, INC.) false false R9.htm 000108 - Disclosure - Risk/Return Detail Data {Elements} - (BLACKROCK HEALTHCARE FUND, INC.) Sheet http://www.blackrock.com/role/DisclosureRiskReturnDetailDataElementsBlackrockHealthcareFundInc Risk/Return Detail Data - (BLACKROCK HEALTHCARE FUND, INC.) false false R10.htm 040000 - Disclosure - Risk/Return Detail Data {Elements} Sheet http://xbrl.sec.gov/rr/role/RiskReturnDetailData Risk/Return Detail Data false false All Reports Book All Reports cik0000709140-20110826.xml cik0000709140-20110826.xsd cik0000709140-20110826_cal.xml cik0000709140-20110826_def.xml cik0000709140-20110826_lab.xml cik0000709140-20110826_pre.xml BarChart1.jpg true true EXCEL 19 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]A,S$S9F$T-U]D,38R7S0S-35?8C!E-5\Q-SDX M-S4S,F-E,#DB#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O6QE#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O M=&5C=%-T#I0#I0#I0&UL/CPA6V5N9&EF72TM/@T*/"]H96%D M/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D M('=I=&@@36EC'1087)T7V$S,3-F830W7V0Q M-C)?-#,U-5]B,&4U7S$W.3@W-3,R8V4P.0T*0V]N=&5N="U,;V-A=&EO;CH@ M9FEL93HO+R]#.B]A,S$S9F$T-U]D,38R7S0S-35?8C!E-5\Q-SDX-S4S,F-E M,#DO5V]R:W-H965T'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA7!E/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#XT.#5"4$]3/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^0DQ!0TM23T-+($A%04Q42$-! M4D4@1E5.1"P@24Y#+CQS<&%N/CPO'0^075G(#(V+`T*"0DR,#$Q/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`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`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`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`\ M+V9O;G0^)FYB3H@05))04P[)R!C;&%S3H@5&EM97,@3F5W(%)O;6%N.R<@ M8VQA6QE/3-$)V9O;G0M9F%M:6QY.B!!4DE!3#LG(&-L87-S/3-$7VUT M('-I>F4],T0R/B`\+V9O;G0^/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$ M=&]P('=I9'1H/3-$,24^)FYB2!B92!L97-S(&EN9F]R;6%T M:6]N(&%V86EL86)L92!R96=A2!N;W0@8F4@82!C;W)R96QA=&EO;B!B971W965N('-U8V@@:6YF M;W)M871I;VX@86YD('1H92!M87)K970@=F%L=64@;V8@=&AE(&1E<&]S:71A M2!S=6)J96-T('1O('1H92!S86UE(')I2!M87D@8F4@8V]N=F5R=&5D+B`\+V9O;G0^/"]P/CPO=&0^/"]T6QE/3-$)V)OF4],T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.B!724Y'1$E.1U,[)R!C;&%S3H@05))04P[)R!C;&%S6QE/3-$ M)V9O;G0M9F%M:6QY.B!!4DE!3#LG(&-L87-S/3-$7VUT('-I>F4],T0R/CQB M/CQI/D1E=F5L;W!M96YT(%-T86=E($-O;7!A;GD@4FES:SPO:3X\+V(^("8C M.#(Q,CL@4V]M92!O9B!T:&4@8V]M<&%N:65S(&EN('=H:6-H('1H92!&=6YD M(&EN=F5S=',@;6%Y(&)E(&EN(&5A6QE/3-$)V)OF4] M,T0R/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!724Y'1$E.1U,[)R!C M;&%S3H@05))04P[)R!C;&%S6QE/3-$)V9O;G0M9F%M:6QY.B!! M4DE!3#LG(&-L87-S/3-$7VUT('-I>F4],T0R/CQB/CQI/D5Q=6ET>2!396-U M2!S96-U2=S(&9I;F%N M8VEA;"!C;VYD:71I;VX@86YD(&]V97)A;&P@;6%R:V5T(&%N9"!E8V]N;VUI M8R!C;VYD:71I;VYS+B`\+V9O;G0^/"]P/CPO=&0^/"]T6QE/3-$)V)O3H@05))04P[)R!C;&%S6QE/3-$)V9O;G0M M9F%M:6QY.B!!4DE!3#LG(&-L87-S/3-$7VUT('-I>F4],T0R/CQB/CQI/D9O M6QE/3-$)V)OF4],T0Q/B9N8G-P.SPO9F]N=#X\ M+W1D/@T*/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS1#,E(&%L:6=N/3-$;&5F M=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3H@05))04P[)R!C;&%S3H@05))04P[)R!C;&%S2!B=7-I;F5S2!L:6UI=&5D(&]R(&YO(')E9W5L871O6QE/3-$)VUA#L@;6%R9VEN+6)O='1O;3H@+39P>#LG/CQF;VYT(&-L87-S M/3-$7VUT('-I>F4],T0Q/B`\+V9O;G0^)FYB6QE/3-$)V9O;G0M9F%M M:6QY.B!!4DE!3#LG(&-L87-S/3-$7VUT('-I>F4],T0R/B8C.#(Q,CL\+V9O M;G0^/"]T9#X-"CQT9"!V86QI9VX],T1T;W`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`\+V9O;G0^)FYB3H@05))04P[)R!C M;&%S3H@5&EM97,@3F5W(%)O;6%N.R<@8VQA6QE/3-$)V9O;G0M9F%M:6QY M.B!!4DE!3#LG(&-L87-S/3-$7VUT('-I>F4],T0R/B`\+V9O;G0^/"]F;VYT M/CPO=&0^#0H\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24^)FYB2!N;W0@86QW87ES(')E86QI>F4@9G5L;"!V86QU92!O;B!T M:&4@6QE/3-$)VUA#L@;6%R9VEN+6)O M='1O;3H@+39P>#LG/CQF;VYT(&-L87-S/3-$7VUT('-I>F4],T0Q/B`\+V9O M;G0^)FYB3H@05))04P[)R!C;&%S3H@5&EM97,@3F5W(%)O;6%N.R<@8VQA M6QE/3-$)V9O;G0M9F%M:6QY.B!!4DE!3#LG(&-L87-S/3-$7VUT('-I M>F4],T0R/B`\+V9O;G0^/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$=&]P M('=I9'1H/3-$,24^)FYB2!M87D@8F4@;&5S2!S96-U M2!D97!E;F0@;VX@82!M;W)E(&QI;6ET960@;6%N86=E;65N="!G M6QE/3-$)VUA#L@;6%R9VEN+6)O='1O;3H@ M,'!X.R<^/&9O;G0@6QE/3-$)W!A9&1I;F#L@ M;6%R9VEN+6)O='1O;3H@,'!X.R<^/&9O;G0@3H@05))04P[)R!C;&%S"!P2!W97)E+"!R M971U2!V:7-I=&EN9R9N8G-P.SQF;VYT(&-L87-S/3-$7VUT/G=W M=RYB;&%C:W)O8VLN8V]M+V9U;F1S/"]F;VYT/B!O3H@05))04P[)R!C;&%S3H@05)) M04P[)R!C;&%S3H@05))04P[)R!C;&%S#LG(&%L:6=N/3-$8V5N=&5R/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!!4DE!3#LG(&-L87-S/3-$7VUT('-I M>F4],T0R/CQB/D%S(&]F(#$R+S,Q(#PO8CX\+V9O;G0^/"]P/CPO9&EV/CQS M<&%N/CPO3H@05))04P[)R!C;&%S&5S*3PO=&0^#0H@("`@("`@ M("`@("`@(#QT9"!C;&%S&5S*3PO=&0^#0H@("`@("`@("`@("`@(#QT9"!C M;&%S'0^/&1I M=CX@/&1I=B!C;&%S#LG/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.B!!4DE!3#LG(&-L87-S/3-$7VUT('-I>F4],T0R M/CQF;VYT(&-L87-S/3-$7VUT/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.B!!4DE!3#LG(&-L87-S/3-$7VUT('-I>F4],T0R/D%F=&5R+71A>"!R971U M"!S:71U871I;VX@86YD(&UA>2!D:69F97(@9G)O;2!T M:&]S92!S:&]W;BP@86YD('1H92!A9G1E"UD969E"!R971U7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA5)E9VES=')A;G1.86UE M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y"3$%#2U)/0TL@2$5! M3%1(0T%212!&54Y$+"!)3D,N/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^075G(#(Y+`T*"0DR,#$Q/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S&EM M=6T@4V%L97,@0VAA&EM=6U386QE&EM=6U$969E'!E;G-E&%M<&QE665A&%M<&QE665A'!E;G-E17AA;7!L M95EE87(Q,#PO=&0^#0H@("`@("`@(#QT9"!C;&%S2!2971U5)E='5R;CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^ M;&]W97-T(')E='5R;CQS<&%N/CPO2!2971U5)E='5R M;D1A=&4\+W1D/@T*("`@("`@("`\=&0@8VQA2!2971U5)E='5R;CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S&5S(&]N($1I&EM=6T@4V%L97,@0VAA&EM=6U386QE&EM=6U$969E'!E M;G-E&%M<&QE665A M'!E;G-E17AA;7!L95EE87(P,SPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'!E;G-E17AA;7!L95EE87(P-3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'!E;G-E17AA;7!L94YO4F5D96UP=&EO;EEE87(P,3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S&%M<&QE3F]2961E;7!T:6]N665A'!E;G-E17AA;7!L94YO4F5D96UP=&EO;EEE M87(Q,#PO=&0^#0H@("`@("`@(#QT9"!C;&%S&EM=6T@4V%L97,@0VAA&EM=6U3 M86QE&EM=6U$969E'!E;G-E&%M<&QE665A'!E;G-E17AA;7!L95EE87(P,SPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S&%M<&QE665A&%M<&QE3F]2961E;7!T:6]N665A'!E;G-E17AA;7!L94YO4F5D96UP=&EO;EEE87(P-3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S&EM=6T@4V%L97,@0VAA&EM=6U386QE&EM=6U$969E'!E;G-E'!E;G-E'!E;G-E17AA;7!L95EE87(P,3PO=&0^#0H@("`@("`@(#QT9"!C;&%S&%M<&QE665A M&EM=6T@4V%L97,@0VAA&EM=6U386QE&EM=6U$969E'!E;G-E'!E;G-E'!E;G-E17AA;7!L95EE87(P,3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S&%M<&QE665A'!E M;G-E17AA;7!L95EE87(Q,#PO=&0^#0H@("`@("`@(#QT9"!C;&%S6QE/3-$)VUA#L@;6%R9VEN+6)O='1O;3H@,'!X.R<^ M/&9O;G0@#LG M/CQF;VYT(&-L87-S/3-$7VUT('-I>F4],T0Q/B`\+V9O;G0^)FYB#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!!4DE!3#LG M(&-L87-S/3-$7VUT('-I>F4],T0S/CQB/DME>2!&86-T'0^ M/&1I=B!C;&%S#LG/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.B!!4DE!3#LG(&-L87-S/3-$7VUT('-I>F4],T0S/CQB M/B`\+V(^/&(^/&D^/&$@;F%M93TS1'1O8S$Y,3DS7S(^(#PO83Y);G9E'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&@^51E>'1";&]C:SPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/&1I=CX@/&1I=B!C;&%S#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!!4DE!3#LG(&-L87-S M/3-$7VUT('-I>F4],T0R/E1H92!I;G9E2!S96-U3H@05))04P[ M)R!C;&%S'0@0FQO8VM= M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&@^'1";&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/&1I=CX@/&1I=B!C;&%S#LG/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.B!!4DE!3#LG(&-L87-S/3-$7VUT('-I>F4] M,T0R/E1H:7,@=&%B;&4@9&5S8W)I8F5S('1H92!F965S(&%N9"!E>'!E;G-E M2!I;G9E2!";&%C:U)O8VL@061V:7-O'1=/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&@^'0^/&1I=B!C;&%S M#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.B!!4DE!3#LG(&-L87-S/3-$7VUT('-I>F4],T0R/CQB/E-H87)E:&]L M9&5R($9E97,\+V(^/"]F;VYT/CPO<#X-"@T*/'`@3H@05))04P[)R!C;&%S6]U'1=/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&@^6QE/3-$)VUA#L@;6%R9VEN+6)O='1O;3H@,'!X.R<^/&9O;G0@6QE/3-$)VUA#L@;6%R9VEN+6)O='1O;3H@,7!X M.R<^/&9O;G0@6]U('!A>2!E86-H M('EE87(@87,@82!P97)C96YT86=E(&]F('1H92!V86QU93QB3H@05))04P[)R!C;&%S6QE/3-$)VUA#L@;6%R9VEN+6)O M='1O;3H@,'!X.R<^/&9O;G0@&%B;&4@86-C;W5N="X@5&AE'!E;G-E'!E;G-E0G)E86MP;VEN=$1I'0^66]U(&UA>2!Q=6%L:69Y(&9O6]U'!E M;G-E($5X86UP;&4@6TAE861I;F==/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&@^6QE/3-$)VUA#L@;6%R9VEN+6)O='1O;3H@,'!X M.R<^/&9O;G0@'!E;G-E($5X M86UP;&4@3F%R&%M<&QE3F%R6QE/3-$)VUA#L@;6%R9VEN+6)O='1O;3H@,'!X.R<^/&9O;G0@&%M<&QE M(&%S6]U65A'!E;G-E2!B92!H:6=H97(@ M;W(@;&]W97(L(&)A&%M<&QE+"!.;R!2 M961E;7!T:6]N+"!">2!996%R+"!#87!T:6]N(%M497AT73PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S&%M<&QE3F]2961E;7!T M:6]N0GE996%R0V%P=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/&1I=B!C;&%S#LG/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.B!!4DE!3#LG(&-L87-S/3-$7VUT('-I>F4],T0R M/EEO=2!W;W5L9"!P87D@=&AE(&9O;&QO=VEN9R!E>'!E;G-E4AE861I;F<\+W1D/@T*("`@("`@("`\=&0@8VQA3H@05))04P[)R!C;&%S3H@05))04P[)R!C;&%S2!S96-U2!L87)G92!C;W)P;W)A=&EO;G,@=&\@2!A;F0@;65D:6-A;"!R97-E87)C:"!A;F0@ M9&5V96QO<&UE;G0L(&-O;7!A;FEE2!D97-I9VXL(&UA;G5F M86-T=7)E(&]R(&1I2!A;'-O('!R M;W9I9&4@9&EA9VYO2!R96-E:7!T6QE/3-$)VUA#L@;6%R9VEN+6)O M='1O;3H@,'!X.R<^/&9O;G0@'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&@^'1";&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/&1I=CX@/&1I=B!C;&%S#LG/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!!4DE!3#LG(&-L87-S/3-$7VUT M('-I>F4],T0R/E)I6]U(')E8V5I M=F4@;VX@>6]U2!L;W-E('!A6QE M/3-$)V)OF4],T0R/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.B!724Y'1$E.1U,[)R!C;&%S3H@05))04P[ M)R!C;&%S6QE/3-$)V9O;G0M9F%M:6QY.B!!4DE!3#LG(&-L87-S/3-$ M7VUT('-I>F4],T0R/CQB/CQI/D-O;G9E2!I2!T;R!T:&4@=6YD97)L>6EN M9R!C;VUM;VX@6QE/3-$)VUA#L@;6%R9VEN+6)O='1O M;3H@+39P>#LG/CQF;VYT(&-L87-S/3-$7VUT('-I>F4],T0Q/B`\+V9O;G0^ M)FYB3H@05))04P[)R!C;&%S3H@5&EM97,@3F5W(%)O;6%N.R<@8VQA6QE/3-$)V9O;G0M9F%M:6QY.B!!4DE!3#LG(&-L87-S/3-$7VUT('-I>F4] M,T0R/B`\+V9O;G0^/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$=&]P('=I M9'1H/3-$,24^)FYB2!B92!L97-S(&EN9F]R;6%T:6]N(&%V M86EL86)L92!R96=A2!N;W0@8F4@82!C;W)R96QA=&EO;B!B971W965N('-U8V@@:6YF;W)M871I M;VX@86YD('1H92!M87)K970@=F%L=64@;V8@=&AE(&1E<&]S:71A2!S=6)J M96-T('1O('1H92!S86UE(')I2!M87D@ M8F4@8V]N=F5R=&5D+B`\+V9O;G0^/"]P/CPO=&0^/"]T6QE/3-$)V)O3H@05))04P[)R!C;&%S6QE/3-$)V9O;G0M M9F%M:6QY.B!!4DE!3#LG(&-L87-S/3-$7VUT('-I>F4],T0R/CQB/CQI/D1E M=F5L;W!M96YT(%-T86=E($-O;7!A;GD@4FES:SPO:3X\+V(^("8C.#(Q,CL@ M4V]M92!O9B!T:&4@8V]M<&%N:65S(&EN('=H:6-H('1H92!&=6YD(&EN=F5S M=',@;6%Y(&)E(&EN(&5A2!T:&%N(&1E=F5L;W!E9"!C M;VUP86YI97,@=&\@;&]S92!S=6)S=&%N=&EA;"!V86QU92!I9B!T:&5Y(&5X M<&5R:65N8V4@<')O8FQE;7,@9&5V96QO<&EN9R!T:&5I6QE/3-$)V)OF4],T0R/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!724Y'1$E.1U,[)R!C;&%S3H@05))04P[)R!C;&%S6QE/3-$)V9O;G0M9F%M:6QY.B!!4DE!3#LG M(&-L87-S/3-$7VUT('-I>F4],T0R/CQB/CQI/D5Q=6ET>2!396-U2!S96-U2=S(&9I;F%N8VEA;"!C M;VYD:71I;VX@86YD(&]V97)A;&P@;6%R:V5T(&%N9"!E8V]N;VUI8R!C;VYD M:71I;VYS+B`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`\+V9O;G0^)FYB6QE/3-$)V9O;G0M9F%M:6QY.B!! M4DE!3#LG(&-L87-S/3-$7VUT('-I>F4],T0R/B8C.#(Q,CL\+V9O;G0^/"]T M9#X-"CQT9"!V86QI9VX],T1T;W`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`\+V9O;G0^)FYB3H@05))04P[)R!C;&%S6QE/3-$)V9O;G0M9F%M:6QY.B!!4DE! M3#LG(&-L87-S/3-$7VUT('-I>F4],T0R/B`\+V9O;G0^/"]F;VYT/CPO=&0^ M#0H\=&0@=F%L:6=N/3-$=&]P('=I9'1H/3-$,24^)FYB2!N;W0@86QW87ES(')E86QI>F4@9G5L;"!V86QU92!O;B!T:&4@6QE/3-$)VUA#L@;6%R9VEN+6)O='1O;3H@ M+39P>#LG/CQF;VYT(&-L87-S/3-$7VUT('-I>F4],T0Q/B`\+V9O;G0^)FYB M3H@05))04P[)R!C;&%S3H@5&EM97,@3F5W(%)O;6%N.R<@8VQA6QE M/3-$)V9O;G0M9F%M:6QY.B!!4DE!3#LG(&-L87-S/3-$7VUT('-I>F4],T0R M/B`\+V9O;G0^/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$=&]P('=I9'1H M/3-$,24^)FYB2!M87D@8F4@;&5S2!S96-U2!D97!E;F0@;VX@82!M;W)E(&QI;6ET960@;6%N86=E;65N="!G2!;5&5X=%T\+W1D/@T*("`@("`@ M("`\=&0@8VQA6]U'1=/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&@^2!I;G9E2!B92!M;W)E(&5X<&]S960@=&\@=&AE(')I3H@05))04P[)R!C;&%S6QE/3-$)W!A9&1I;F#L@;6%R9VEN+6)O='1O;3H@,'!X.R<^/&9O;G0@3H@05))04P[)R!C;&%S"!P2!W97)E M+"!R971U2!V:7-I=&EN9R9N8G-P.SQF;VYT(&-L87-S/3-$7VUT M/G=W=RYB;&%C:W)O8VLN8V]M+V9U;F1S/"]F;VYT/B!O4]F4F5T=7)N M'0^/&9O;G0@'1=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&@^'0^*#@P,"DF;F)S<#LX.#(M,#`U,CQS<&%N/CPO5=E8E-I=&5!9&1R97-S M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#YW=W'1= M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&@^&5S*2!I3H@05))04P[)R!C;&%S3H@05))04P[ M)R!C;&%S3H@05))04P[)R!C;&%S#LG(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.B!!4DE!3#LG(&-L87-S/3-$7VUT('-I>F4] M,T0R/CQB/D%S(&]F(#$R+S,Q(#PO8CX\+V9O;G0^/"]P/CPO9&EV/CQS<&%N M/CPO'1=/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&@^2!W97)E+"!R971U'1";&]C:SPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/&1I=CX@/&1I=B!C;&%S#LG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!!4DE!3#LG M(&-L87-S/3-$7VUT('-I>F4],T0R/D1U65A'0^2&]W979E M6QE/3-$)V9O;G0M9F%M:6QY.B!!4DE! M3#LG(&-L87-S/3-$7VUT('-I>F4],T0R/D%F=&5R+71A>"!R971U$1E9F5R"!R971U'0^ M069T97(M=&%X(')E='5R;G,@87)E('-H;W=N(&9O"!R971U6QE/3-$)VUA#L@;6%R9VEN+6)O='1O;3H@,'!X.R<^/&9O;G0@"!R971U2X\+V9O;G0^/"]F;VYT/CPO<#X\+V1I=CX@/"]D M:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S"`H M'!E;G-E65A65A7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A4IX1D1+0FMA M14E),$MX=U)64S!F06M-,DIY9V=K2T9H8UE'4F]L2FEC;TM3;S!.5%DS#0I/ M1&LV43!21E)K9$E357!45D965U8Q:%I7;4YK6E=:;F%';'%C,U(Q9&YD-&58 M<41H25=':#1I2FEP2U1L2E=7;#5I6FUQ2VIP2U=M#0IP-FEP<7)+>G1,5S)T M-VDU=7-,1'A-6$=X.&I*>71,5#%.6%#AV M4#`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`R8E(O0W5J85IC=$&ME9W!*9#!/5'1S>6HO=V=V:%`O;U8Y0R\X04)F1"]!4$4P M#0IF.$E,-%0O-D9F478O0F9$+W=$13%E,6)3#(W2U1K+TUF36EC-35X,7AW3T]U96,X2E='&)R4WHS M=&Q$8WE,2$):0E%Z;T=)1V)C;D=4-FUN<#)%5!2+W=J,G`O=T11,S8Y+S,U3="9"]W03,U:68X24PT M5"]W0VA8,$PO#0I!348X4"]X3D@O0T,K12\K:%@P3"]W048X4#A!.%175C13 M#16,&)5-VYX8G)3>C-T;$1C>4Q(0EI"47IO#0I'24=B M8VY'5#9M=&(O:$AT5"\V1R]8=BLO3FPO.&HP861G9#%P>F9M2B]W9W9H4"]! M2T9F478X07=8=R\O13!F.$E,-%0O-D9F478O#0I!05AW+W=$>$Y,+W=J,G`O M.41F3="9"]Z9FU*+W=G=FA0+V]6.4,O.$%"9D0O05!%,&8X24PT5"\V M1F91=B]"9D0O=T1%,6QE17)$5TY9.$LV3G%D>C1T,7!:-S)Y#0IH=5I&:F=S M9V]:,$1%1$YU5&I*.517="]W:C)P+W=$43,V.2\S-7-V+VME:E1S1'5T3V(X M>%`X06A"9D-F+U%R-D8O-$PT9B]!26UJ#0HO:$)F0V8X03!+*VAF*T,K2"\T M;6PO-%(W52\K:'8Q-R]V>EIF+TDY2"]#4&%N+S!.*W9F.2MB3"]W0U(V3$QS M1C,O3BM9;B]!06=V#0IH4#A!-D9F478O0F9$+SA!13!F.$E,-%0O=T-H6#!, M+T%-1CA0+WA.3"]W:C)P+SE$9G(S+V9M>2]W1&ME:B]H2'14+T%/:'8Q-R]V M#0IZ6F8O04-04EID9W4O=T-B.'A0*T5&.$HO=T11')(:%A2=%1U#0IF1G5T3%!E,E5. M>DES8T9K1D1/9UEG6G1Y8UI0<6$Q=BM%93%0+V]B.64O-S@R6"]!36HP861G M9#%P>F9M2B]W9W9H4"]O5CE#+SA!#0I"9D0O05!%,&8X24PT5"\V1F91=B]" M9D0O=T1%,'8X07=J,G`O=T11,S8Y+S,U6AU6D9J9W-G;UHP1$5$3G54:DHY5%=T+W=!23EQ9B]!14XK=F8X069M M>2\K4C9.3W=/-C`U=GI%+S11#0I8=VXO04Y#=F]8+V=V:"\K2F\O-%%8=VXO M=T)#=F]8+T%)3#1F+VEA6"]H2'14+S9'+UAV*R].;"]W1$DY2"]#4&%N+T%. M1&9R,R]F#0IM>2\K4C9,3'-&,R]!1&9M2B]W9W9H4"]!2T9F478X07=8=R\O M13!F.$E,-%0O-D9F478O04%8=R]W1'A.3"]W:C)P+SE$9G(S+V9M#0IY+SA! M:V5J+T%)4C=5+SA!;V(Y92]W0R].;"\X:C!76%E,=BMB.'A0*T5&.$HO.$%1 MDES8T9K1D1/9UEG6G1Y8UI0<6$Q=BM%93%0.$$V M1R]8=BLO3FPO.$%).4=N#0I92&1A8S,U:68X24PT5"\V1F91=B]"9D0O=T1% M,&8X04-#*T4O=T1O5CE#+SA&.%`O=T%44R\X04-086XO=T)$9G(S+T%(-7-V M+VME#0IJ+VA(=%0O-DD4O-%%8=VXO=T)#=F]8 M+T%)3#1F+VEA4"M%1CA*+SE#=F]8+V=V:"]W1&EA6"]H2'14+T%/:'8Q-R]V M#0IZ6F8O04-04B]W04DY<68O045.*W9F.$%F;7DO*U(V3$QS1C,O3BM9;B]# M0RM%+RMH6#!,+W=!1CA0.$$X5%(O=V=V:%`O;U8Y0R\X#0I&.%`O04U44R]W M1$-086XO04Y$9G(S+V9M>2\K4C90*T5E,5`O;V(Y92\W.#)8+WE04EID9W4O M-79Z12\T45AW;B\P2RMH9BM#*T@O#0I!3TIO+W=#148X2B\Y0W9O6"]G=F@O M.$%I87EV0U9HEIF+TDY1VY92&1A8S,U:68X04-# M*T4O=T1O5CE#+SA&.%`O=T%44B]W9W9H4"]!2T9F478X07=8=R\O13!V#0HO M0U!A;B\P3BMV9CDK8DPO04]2-E`K164Q4#A!-D&)R4W5L-V0R=T-15U%' M,DLT:VE5#0HX,C4U,F]#9F905'!7="]W:C)P+SE$9G(S+V9M>2\X06ME:E1S M1'5T3V(X>%`K148X2B\Y0W9O6"]G=F@O=T1I85`X06A"9D-F+U%R#0HV1B\T M3#1F+T%);6PO=T-%93%0+T%+1R]8=CA!=GI:9B]).4@O0U!A;B\P3BMV9CDK M8DPO04]2-DQ,D4O=T-%1CA*+SE#=F]8+V=V M:"\X06EA4"M%1CA*+W=$47(V1B\T3#1F+VEA>79$3FAR1W%A9$YC6$AI,U=L M9$PR#0HW=&=%9W-G3G-6>$I%<#5T>GIT444K*V5N4W1B+VA(=%0O-D2\X06ME<%!"3GID M6%=H33$O9%-88SA6-V57,VYY2VES-GA8#0I-&=B5%DU1VIT659I#0I5$)H9TEX3491>&XY-VYZ;$%",F=U;3=&2TYZ M=#A567)#,3(K,4@K,G10,&Y32F)3,FYU8F5E-F$T=6]';E5,13!3-T%I#0IU M:'E4341U,V-B4TU(3U)Z;6QE3DY2,5-X9S%I2T,P9S`S-U)P.7),6G-R4$MZ M6%-7-V(Q;3-!2T8K,4PX<&I/9DQ023-F2VY+=TM$#0I:-D)I:D9C6F)E2TY4 M3VYE6'%6:D)P;7%3*V1)<'57>$1"0D=%37,P:$I'5FEA5'DK0U!.2V@Q,E)V M=51T8U4P-V%)I;EEO>%%!,T9' M2V1I:D9!1&-567`R2TU504YX4FEN66]X44$S1D=+9&EJ1D%$8U59<#)+355! M3GA2:6Y9#0IO>%%!,T9'2V1I:D9!1&-567`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`O.$%34S5Q:G`S87)P>#5N<6,K27%U;F%X96TX5V5)-&@X,V@O4T0Y M3EAK#0HO=T1K86UA4C0T,4\U.%)A6'!M;V%*6C(X9#E+.%%M9S%"<%-H5TM3 M5#=P:%A)4&QK9&4Y3G8X07!71'`O=T1Y4&9H6"]R.6PO=T13#0I/-'`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`V8G1&:W1X%)I;EEO M>%%"=TAX84@W;G=Z+T%.:%DO=T1P2F,Q43`W=%=H.%CE/-U9R4C-:=S1Z9&5N-FQM+S969S9F+W=!:C,T5B\V+UIF+U-/ M-')E=BML64]N9CAJ-316+S8O6F8O#0I!16IU2W%V%)I9T)U2TU5-T9'2T%+;6\S:U=N,F-L,4]L=SAC94UR8G=0 M3S5Y44]%449J#0HQ-T1J%)L43!H02LV3GA!#0IY M96Y*03E32S5Z-&)Y4$XT6FQL:VAK9V0Y5#%&;6EK2VQO>6(R9DMN85--:G!W M4U!1;7`V;&9:3VUX6'ED*S%J+W=!;$8P-R]!3$)5#0IF+V\V879R4$9F2G8W M5V8O04-58E1V.$%S1E(O*VIP<6ER.$IR:"]J4&\O-&$O.$%*3V9#=B]92W10 M.$$P4W1D2EA/9D14+VMN4&A8#0HO%)I=6,Y26]A#0HQ<6QR;W5L6$]P86DX:V1N8DHU:W)P13AP4F4W M8E5"3T(Q2GAW05-E06%R-G0T:3!Z4V)L64PV95)(,D-2>6M%:VEW25-12DI7 M5E-)#0IK-&(U;DMR.')C+TMC5B]I0F$S9#DT2#$V>3`V,6MU-WDWDA*-&DP>&)M>6=I;FMU;G4P4U-),F-%;'=U>'IH2DAA3E=#23-/1UEH5'1B M0BM5-'`K2W11,75'#0I*8F929$=V-3)K;#AU4S9G93)Z1DAT0DUK87EY2T=9 M:S=&,V-!<7I%34%Q>5EL=G`Q,%`W06DP,W=R8V%29C)C5FY$.75-.$5K8TYS M#0IU>'!B575*1$Q)=3-Z14%+148YG(Q=S`S:'4W M=&\W:38P4WEJ$M#6'E536-#;C5546A7=W)' M3U!S9$U&-2]:='`O868R9C=F-5-F#0IA4',K9DLX>D$S8DXS3S-/8UHU>%14 M13!U:'I0:F)X6&0K2#E2,'EYD5/,&(U2C@P M96Y3&XT#0II;2LW-&4P:V985C50+VMA<3-X42]W0U)U.$XO.656.2]W M0VI,5VUA9#)R5VY"4S-/4$56-54S6D8V8GAF-&II*SDT9C!G+U16-5`O#0I! M2D=Q>#16.%I8*W)E2E8P;E5D271B379A4S-34W=8>E0U,E!'<%5G>$IJ4&UG M-7EE;%HK;V1$5D1W5B]Y57$Q+W=#=U1D+RMJ$](>$5Q:W)3 M4%9Q2UA&1TMY3W=3:6QX4FEG0DM+6$9'2T%%;W!C55EO03AZ*TM(+TDS9479V+U)L&,O,4AH;B]!3$,S+W1P8S%N860R%%"1&-Y4$1B4WEX=WE4=6E&;&EJ M2VAP0T(Y,&)I0FLY3U-"#0HV:U9Z;G4TU M8TDU#0I(1U0Y,#@X8V1A=U!H'@S0C%0551):V)L,59V=',K M44=)0DEZ,W=-*V=P9%-V'8O9%,O3&Y0-W1V M-W!X,B]W.70U3)J:VEK57%Y34EL0E5G.&=G.%ER M#0IO8U59;U-S1&1Z2#%E,S$R5S56=$@Q3%1,5S,R04UL,7`X;'=X8DIY47EZ M24%-631X,E!04$9(-&%J+VDS2&A42"]12W10.$$P4VQD#0I.:75A*T=F+T%# M5&IW<"\R0V)4+T%.17!2,41O9$AJ;C)O038U+T-N66]X5$I'64]">4TY*TM8 M2%!T5'-566]!84(Q>BM&2FC=5061C+VA4C,T M<"M+359Z2'!N;F9X33%85G)06&1#%=*,TAM4'A3+S5'-W%A-96U.>'HW M54%D8R]H5'-566]!6F%0X55ER;5!41S0U.7%!3W5F=W`R2TU504UW8T1K6C&YZ4'1D:SEX=399>'1L:GAJ M;E!83U(P>'IK#0HO1%I:;#A->7)D4U)Y6$$Q4%5223AA1D9:=G1S*U-&2DI! M>C)Y8V5PGDU:WI#.&M"5FYG8V]'2$)"05E";%E"#0IG M4F=G-$E.8R]W1$1A2F]F1$US56LP;'3(O-T).,R\V M3W1A94DR27=8>'(U+VME=%EO>%,T;WA83V5O95EF1E`O:V)V1%@O6&QF9BMJ M3%=O=$\W5DXX5E`K4G4X#0I.9CA!6&QF9BMJ3%=O9$\W5G914$]X=GA%=6]D M-G`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`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`K3&(K M1E`K=U1A9CA!;VQ+-EA&8S,X378K4V)E12]W1'-%,FXO04M*4W5M<6QS43EZ M#0II=%`X4C9L4'$Q:DI-3%`K>DPO53=V4V]R9%EM13!,469A4#-R4S=YG9R:E5R83-& M=59M13@O;3EA)+T1Z=U0T5G4O04AH;31U=D1/:'HS13)M5W-K M:W-L:$5Z3WAI#0I5;&E3=5-396-M:EE-.96]Q86IA M-5=*>5-72&]3$Y(+T%!9U!G+SA!-D90=R]W1"M#,D@O04]*4]J>%)I=D=F M:4XT4CA.#0HR;FEV=SE$82M(.4EG:6QS-S%P16IS;S%6>7(R=U5K0F533GI9 M.4UN,7%X<%AG+W#=J:6I&8S4O=V=09R]W1#9& M4'2\T2C!E2TU6>FXO0T$K1"\K#0IH5#A0+W=$9W1H+RM*;R\T44AW M9B]W0D-N-&8O05!"8D0O.$%%,6QD;EA:2$HO1E@O:V)V1%@O6&QF9BMJ3%=O M3D\W5C)F.$%W9U!G#0HO=T0V1E!W+R]W0T,R2"\T;6HO:$%F0B\O47`K2"\X M07=7=R\O13%P5'%/2%$U82M'5E8S=F(U9CA%-4A53SE64$%V+T%#57DR+S=" M#0I.-2\V3W1A-VXO:$%F0B\O045+9F@O.$$X1G-0+W=!5%(O=V=09R\O04M& M4'$Y:6%HQ,E)Y9GA6+S5'-W3%Q1%1U,61N+W=G4&75Z4-6&QN;#)B,TE59T%S>#(W M57AJ675/:R]W0T5".$@O05!1<"M(+R]!05=W+W=$>$Y(+T-!*T0O05!O52]$ M+R]!24Q9#0IF+VEA03E'8VXO86YG5DQA4THP.%)S-W5R+V%:8E161W552VAG M=3)D;$UQ04(S1T991$5J:BM.$Y( M+T%!9U!G+SA!-D90=R]W1"M#,D@O04]*EDY36XQ<6)3 M=D-(:'`X8B]$,FIT.6)+22\K>3$U=4IZ3T](<65Z8V)N6Y: M#0IE:#=&:6I&955A<#1/.$U)<#)E2$Y'6&IT67A$+W=";')(.$HK12]$4U(-'E1V8C5F M.$%"3U1V*VQ9;6LO.$%)+SA!:%`X038O6G8O4T\T75ZC=D;3-J8FI'36-9DHY M:DAI9E,W9E4U9FY.=D,R;71F4W%0;#-S#0IS86\W0F9U071J1U-O2GE25UIF M94AV:#=:-F)B,S&]Z4#AO3&9+ M1#AO3&1!5%9R5V)N#0IX6%DV8D1B>%G1'8VQ4=#)V3&)V8V%F-%)S3E!I.$UA;W%,67=7-71, M#0I'.6DS5S1-6E9O,6UA6D=*:C)G8G=15'55<50X,C%$*UIH4S)F=WEI:FAD M=D0K:&Q*13AX,E1247=T,41&4S`U15HX9T)L8T5Y-V-'#0I.=V-B1WAU849B M941.3'5D5'5D17,Y1#`K87A2:W9*-V4S:F')K3VHV-UI*<&MK#0IP,3=3-4Y0:4MZ4F8V1G5N=DA1,TQ- M-$Q%2F12-VY4>E=::VM*3$5H;C9B579$8S`R;S,X*VLR3FY:;4IZ9%$O84-7 M:G9R31R5'%I3$AM4'A2 M+S5(3'=Z+W="958O.$$K:DQ778O.$$P M6F$Q63!F*T=V;',P+S-L+TDK,WEB+V-6-G-L,6HK2W-4=U8O=T%L3W1F*W=4 M968K:G)7='974#1Q>&9"4#A!#0IY52LQ+W=#=U1E9BMJB]! M0UIR;6XO279Q9DPX,&5S,%5T1F97;G=1;$9,4E%!;$9,4E%!;$9,4E%!;$9, M4E%!;$9,#0I244%L1DQ244%L1DQ244%L1DQ244%L1DQ244%L1DQ244%L1DQ2 M44%L1DQ244%L1DQ244%L1DQ244%L1DQ244(U9CA64"M2=SA-+SA!#0I8;&8O M05!O>3%Q8E(K,5)F1E@O:V-01%`O6&QF+W=$;WDQ<5A2*S%F3%IP+W9,.45F M8S5,+W5#.5=89%B\P9&$Q=6%T.3`O M4W-4=U@O>54K,2\W0DXU+S9/=&%J3'8Y-F@X+WE:95HO=T,T5E!L*V%05C9+ M5VEVGAI4E5L M,515#0IN55-2=$=W0G9P>4UQ=T1+9EEG160V-F$V;E,R='!P-4))>5))6%E2 M>'1)>$%'5&A60EIJ-D%!:SEQ-7(T6GIP8RM'2EHT>$EQ4S9P#0IQ5'%*23)J M64$S,#5'-5=!6E0V9V=%9#9/<%9T1'%A*U)F,G4O=T1K<$]M+SEG;4PO=T)( M5%8Y9#$X:69T968X;$HP,R]S17AF*VIP#0IQ:7`X2G!2*TDK;"]H:5`K3&$K M12]W1'-%5VXO04M*4W5M>%A.+T1!9CA7,3A*+SEG:3`O.45P5W9Q1W`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`V371A:S!F=%10 M:78X03AJ:#19+S8X2]22#-'5&8W:796;#-6 M=G5N#0HV5FEE0W8X06MP.7(O=T)G:3@O.4A7=&)E5!4-C!$3U1N<#(U;T%41D=+4&TR M:F=B=4UJ4$AV4S@U2'`Y84%%>%)I;$=C#0IN4%1T>E-F3G1(03-C6D=E4&5G M07A2:6PU>5!4-C!$3U1N<#(U;T%41D=+4&TR:F=B=4UJ4$AV4S@U2'`Y84%+ M;7!8171P6E-4,CEL#0IC6#!Q67AB,C=2:#-Y44]$27ER>&Y03$1G9'IX6%!F M1$]2-79#.'-S:T5L=3&IB1$IN4'I:-EEW3W5E36HT6FU: M=D,X%)I9T)-55EP8U59;T$X=2M+=B]!0T]8#0IH:B]R>78X02]W0D=7 M;%1A4"]$55AX5R\U2$QW>"\Q-5@O.$$V371+;#!F*T=V;#@P+S-L+TDK,GEF M.$$S1F5R2F19+VER1SA$9CA!#0I*54QB+W-%6&XO;S8Q%)I;'A2:6="3559<&-566]!5$9'2UA&1TM!17A2:6QX4FEG#0I"3559 M<&-566]!5$9'2UA&1TM!17A2:6QX4FEG0DU567!C55EO051&1TM81D=+045X M4FEL>%)I9T)-55EP8U59;T$X78X02]W0D=7;%`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`K-2MY,TUC37AM:3-'2T]51DA+<5='>59--59C2&-/ M44%3-VA:;79832]#+R]K;6YH3"]S#0I%5VXO04M*4W5N68O8U8V78O=T0P6F%5=6HY<5!I M,R]Y3TAH9B]R>78O=T0P6F%585`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`X03)#3%0O=T)%<%A567)M9FAA4#A!:3)8:$@OD]Z6595,DM#>%!L*W,T;WA3 M#`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`O1694 M,W=T+S5*;#12+S=!.6XO=T-I#0I5C=I#0IA,3`W M56QT-V(W4DTX,&EO,7)B>6M'4GE88C4U6$]72DE"=T]!04IO9D)E:7AX>G)* M1F4S4FQ12C5L-7%&>&-Y4D1C1R]D4$DW3D5D#0IY;S)52VYC:4A/5E5J53!B M4TQ04C=6;TQ&2D%(8WE34U144$Y,2S)!3GIY3U,W;D%645=*=T951&=!07-$ M6E4Q;E8W-U0W<%ER5'C%X;B]#+TDK1U!H1$%*+S1L1FXP+S8T<%A667)L+VAA4#A!:3)0:$0O%)I9T)M5'1",DYK-"M8:DEO-3-!64]- M9&%F:6I&041":VLX15E0-3!:3S!(63)4#0IJ-65-:6XT;WA107IN8T)G-'@Q M;T=35'=29R]N5#A566]!6FLW461J6D]0;#1Y2T]D=T=$:DA7;C1O>%%!=UI* M4$)'1"MD1U1T0C).#0IK-"M8:DEP*TM-54%--3-!64]-9&%":VLX15E0-3`O M1D=+04=:3S!(63)4:C5E36EJ;F-"9S1X,7`K2TU504U'4U1W4F4M/9'=' M1&I(5VXT;WA107=:2E!"1T0K9$=4#0IT0C).:S0K6&I)<"M+355!334S05E/ M361A0FMK.$594#4P+T9'2T%'6D\P2%DR5&HU94UI:FYC0F#%P*TM-54%- M1U-4=U)G+VY2#0IK-U%D:EI/4&PT>4MF:6I&04A+-C-C*TMD37,W,E=Y=&)F M5S5P<%%L;D1A,C9W1S%1:S5E57DS045U,6-C3#5E-&I(>6AT>3A)9D10#0II M2'I0=&QN<'5T5V0T.7!,1%EJ*S!,9B]!15,X835N:V$W=71J9T9:0SA-:E)2 M8C!/,6QA3G9,:7(R6$9'2U9H<&Y+*TQ.5#$V2T),#0IF43E#,4M:-5IF3&QU M;TAT9#!%5WA736MA>7EQ1UEL:6DW=4%66FE'54MS;DHR2&A(57`W-U$W87DP M*SDX4&%(0S%L96%N6G9E451X#0I3>7=1>$=*26TR=DMX4C19161I,&%L66E6 M1$9Y,65R66]X4EE,;FYS=FAM.71K=7)V47105%1VF1Z='IN1V5C5F1X4FEM25IZ=4%W8UDV,$1*2C1)#0IW9GIP M*TM-54%->61O3WAS;DAY.%I&2$\T1$)X:G)4.%59;T%936MN9VI"+T]J2C)G M-T=Y8V9,>&M5+T9'2T%'8S=G34A'3W1!>5-E#0I#34@X-F9I:D9!1$UN841S M8DIX.'9'4E)Z=4%W8UDV,"]&1TM!36Y7=%1U.5!-6#)44713,51E5'4K>5!B M&XW#0IP>FIJ3U`X04,K4C4O0W-S&LS.#5+='1*6$DV2$)).4-A-E15-VUA>G-:2C=E>'5,*U9-670W9&\Q M:V9*#0I!-$UJ2W9'8SAS3T(S4$9C-3A,-4AN.$MY>7E14U'5+ M354W1D=+0451(=V@O,D(W4"]W0D5P6%9951(=V@O M,D(W4"]W0D5P44A1#0HV8D9'2V1I:D9!1&-567`R2TU504YX4FEN66]X44$S M1D=+9&EJ1D%$8U59<#)+355!3GA2:6Y9;WA103-&1TMD:6I&041C55EP,DM- M#0I504YX4FEN66]X44$S1D=+9&EJ1D%$8U59<#)+355!3GA2:6Y9;WA103-& M1TMD:6I&041C55EP,DM-54%.>%)I;EEO>%%!,T9'2V1I#0IJ1D%$8U59<#)+ M355!3GA2:6Y9;WA103-&1TMD:6I&041C55EP,DM-54%.>%)I;EEO>%%!,T9' M2V1I:D9!1&-567`R2TU504YX4FEN#0I9;WA103-&1TMD:6I&041C55EP,DM- M54%.>%)I;EEO>%%!,T9'2V1I:D9!1&-567`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`R2TU6=TAG&LX6DIR6B\T4FI6=BMH-#A2#0IF.2M.4"\X06M7:3173VUX4FEU M6B]W0T59,6(O04M(:GA&+S,T,"\O04]285`K15DQ8B]O95!%6"]F:E0O=T0U M1F]U1FIP'`O.$$X:3!80W@P,DM-5GI0+T--870O,%!(:4PO=GAP+W=$ M.&DP9CA)>'$S+U$X94EV.$%V>'`O#0HO=T%I,%A#>#`R2TU6=TAG&LX6DIR6B\T4FI6 M=BMH-#A29CA!#0IF:E0O05`U1F]U1FIP$8O,S0P+R]!3U)A3&A9-F)&1TLU;B]H#0I' M3E$8O,S0P+SA!*U)A4"M%63%B+V]E4$58+T%(-#`O=T0K4F%,:%DV M8D9'2S1$=U9P;75A-31.,$A6B]!34EX<3,O43AE278K+T=N+W=$>4Q2+W=J1W)F.41X-&DO M-SAA9CA!#0HO271&=W-D3FEJ1F-"-$LP>EA.8SA'-D1Q,3,T,3$U3&TO'$S+U$X94EV.$%V>'`O+W=!:3!80W@P,DM-5GI0+T%!:D=R9CA! M43AE278K+T=N+SA!>4Q2+W=J1W)F.41X-&DO-SAA9B]!4$ET#0I&=W-D3FEJ M1F-"-$LP>EA.8SA'-D1Q,3,T,3$U3&TO%)I=5HO-%)J M5G8K:#0X4F8Y*TY0+T%0:U=J+VA'3E$8O=T(K3E`X02]K5VDT5T]M M>%)I=5HO-%)J5G8K#0IH-#A29CDK3E`O.$%K5VHO04E2:E9V.$%O95!%6"]F M:E0O.$$U1F]U1FIP517>B]W04EX<3,O04502&E,+W9X<"\O04UI M,%A#>#`R2TU6>E`X07=J1W)F.41X-&DO-SAA9B]!4$ET#0I(+T--870O,%!( M:4PO=GAP+W=$.&DP6$-X,#)+359Z4"]#36%T+S!02&E,+T%,.&%F+SA!271( M+T%!:D=R9CA!43AE278K+T=N+SA!#0IY3%)C3$A466]X6$%E171-,7I73DMN M=6)N>')R>7E2,SDW86=2,CEG0G1H=7!95E!.')R>7E2,SDW86=2#0HR.6="=&AU<%E64$YS M95-S64HY.#E/;&)0+T--870O,%!(:4PO=GAP+W=$.&DP6$-X,$XPC9J3-),5A5>$LX4T=.1V(W9F-:2W%3>%5%.4%38V5P-C%0.$$X27AQ,R]1.&5) M=BLO1VXO#0I!4'E,5W`T83!74%%D2E=X:75B;361I<78S;F)G2T)J1D%';&EV:F8Y%)I;'A2:6="359Z9'@T,3!#0G-095--1F562EAJ=%IN4S,X=58T M;F5:;%5I1D$X8V496#0I0;'514T9*2%,T#-P:VQT3C1X'-8:TMQ4S=(4$1%1GAO M.4)T#0ID6#`K-S%I+S!Q,G4T<&11%1C96=*0T4T-C1W M8UE)>F9X6$IA6DM4.%9.9E4R,39S6C!Q>&I79#=35EE884]7#0HU6C%757)S M66=4>#A!;G%F-W)9-C=&1G=%>%)I;'A2:6=1;4LU=30X839"03)(=DI'0W9+ M:W)X,G-Z<&(K6$LX5'9->7%20V=E3U%B#0HU0W%N>3-)2D-K:G!C5C5D-#

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`W26IA-6QV0G'953T9K-U!�I&=T5X4FEL>%)I9U%M2S5U-#AA-D)!,DAV2D=# M=DMK3-)2D-K:G!C5C5D-#

5,R#0IM.%DR9&IP9'EF.$%H24Y"5W=S4EHR:G9(2F1L-W=U2D=24W-75W59 M,DQY1E9*9&IN:&E#-#!E9WIA=%IX87A"<%IE4CFAP M1U5&675%25B]&95@K1TQ(56),>&AG2%=J<4TR4XO>#4T24Q4#0I+=GE:0TE56#%(1D9W66U+355U M2TU50T5X5T)Q2&DS4C='-'5,95-A-6UU;TIJ0DIB,G1N3F-Y:&A(2$E44,U M;'-B2U,T:V%E4G)4>7DV4DMZ;DM7-T1E4F="1D))>6]*8UIE;CAA-D)$9%

&-00D=L>&$RD$U45HY0WA28T)-55EP8U59;T5*:7-$55!&=6HR3GAC5SAK M,7I.9%%41T-3,W1B3V$U;$1#3T]1#0IN6D=J359#>E):8T1A1$EO2D))1F1" M:75-.%%*1F]V:F)43F1A=W546G1:,VM&>DQ9,E5L>$DP.&I7;FQL,&E6;D]5 M=#)'.&I!0TM##0I2;%%3-'I46'AD;V(S,$9R1F9E9#4O;&A,:4=+4U,R0FM! M36%T3W%M2E=C36A65UE&=DU404\Y8S3,R6F9V1G)D;W9: M'5,:3-K#0IM=5IR<4-9=U-7.7): M>EA-;UE2>'E%-TDP6FEO5V%,3&=B45I&0DE*07)O359X;FE"271&.&)A6G)R M5T9Y8DYR3SAG=5IB1WEK=4I'#0IN:V$P.'-U:U-S-7EL=7G90.'-*8U%X4U-7=TUG0FI6<#%5>$MZ:&M+<7I! M=#5I64(S#0IR;F9X6&I8:&9W<')C5FYO;6$I32WHP0T]7,W-,;5=7#0IF5TY/=4IH63)5:SAJ*U9C M=T\X:FE*5UDT:6@K.&5Y<79884M,:DYI-3A4859B87=.36UU2D)C-S!I6GAB M>4Y$2$DK3FMB>D)F3%(R#0HS2FA'64UD-EE",W)N87A8;6US5W0S+V)'=#99 M=&IE=&,V:C1I,#-5-UHP='!':&$S:"MX95EZ5$%E5VA(,F%B-5=9361O=T1U M6%!P#0IM2TQH651&1TM81D=+0D-9B]W2&XO.$%J,4@O04$Q M3#0R+S9"9FAZ+W=!0C4O.$$T.5)C3$@R6E)8>&XO=T%.4RM.=BMG6#1C+SA! M#0I!968O04]0568X3E,K3G8K9U@T8R]W1$%E9CA!*U!56$-X.6U55CA:+W=$ M1%5V:F(O;T8K2%`X07=(;B]!4&HQ2"]$579J8B]!2T)F#0IH>B]W2&XO*U!5 M6$-X.6U55CA:+SA.4RM.=CA!;T8K2%`O065F+S0Y4B]W,4PT,B\V0F9H>B]W M2&XO.$%J,49WB]!34(U+W=$-#E28TQ(,EI26'AN+T%- M3E,K3G8K9U@T8R]W1$%E9CA!*U!59CA.4RM.=CA!;T8K2%`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` ` end